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Chapter 1
General introduction and outline of the thesis
Adapted from:
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Defense and counterdefense in the RNAi-based antiviral immune system in insects
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I n our daily lives we are exposed to numerous micro-organisms, ranging from benign commensal species to pathogenic microbes. Crucial for the fitness of a host organism is an immune system that can discriminate self from non-self, 
and distinguishes harmful pathogens from harmless microbes. In vertebrates, the 
immune response is divided into an innate and an adaptive immune response. The 
innate immune response forms the first line of defense that recognizes conserved 
pathogen associated molecular patterns (PAMPs). The innate immune response 
can in turn activate a highly specific adaptive immune response that generates 
immunological memory. Invertebrates, however, lack the adaptive immune 
responses that mediate immune defense in vertebrate animals, and they are thought 
to rely solely on their innate immune response to fight pathogens.
Viruses form a major challenge to the host immune system, as they are one of the 
most abundant biological entities on the planet and are believed to infect all living 
organisms [1]. Arthropods are no exception, and some viruses are of specific human 
interest as they can be pathogenic to arthropods of economical value, like honeybees 
and shrimp [2]. In addition, mosquitoes and other blood-feeding arthropods can 
transmit important viruses to humans and other animals (arthropod-borne (arbo) 
viruses) [3]. To limit the impact of these infections on public health and health care, 
it is important to understand the interplay between insect immune defense and viral 
counter-defense.
Drosophila as a model to study innate immunity
Drosophila melanogaster, generally referred to as fruit flies, are used for more than 
one hundred years as a model organism by experimental biologists [4]. Fruit flies 
have a short generation time along with a high production of progeny and can 
be easily and inexpensively maintained in the laboratory [5]. Together with the 
completion of the Drosophila genome sequence and an unprecedented variety of 
genetic methods and tools, these characteristics makes Drosophila a powerful model 
organism to analyze gene function and regulation in vivo [6,7].
Since Drosophila shares conserved developmental and cellular processes with 
vertebrates, studies in flies made seminal contributions to our understanding of 
fundamental biological processes in invertebrates as well as vertebrates [8-10]. 
Studies in Drosophila also provided important insights into the innate immune 
response against bacteria and fungi. One significant contribution was the discovery 
of Toll as an immune receptor, which also proved to play key roles in the immune 
system of mammals [11-14]. Although initial studies focused on the immune 
response against bacteria and fungi, increasing efforts are made to decipher the 
antiviral immune response in Drosophila using a selection of insect viruses.
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Model viruses in Drosophila
Only a limited set of viruses have been described as natural pathogens of Drosophila. 
Nevertheless, this model organism is permissive to experimental infection with 
various insect viruses, including arboviruses [15-17]. In combination with the wide 
array of Drosophila mutants available, this creates a powerful system to identify host 
factors required for viral infection as well as factors that are important for antiviral 
defense. 
A well-characterized natural pathogen of fruit flies is Drosophila C virus (DCV), a 
member of the Dicistroviridae family (order Picornavirales) [18-20]. In nature, DCV 
causes a non-pathogenic persistent infection with no obvious symptoms, and it 
is transmitted horizontally through feeding or close contact [20,21]. In contrast, 
experimental infection by injection of DCV in the body cavity of Drosophila leads to 
high mortality [22-25]. After injection, DCV rapidly disseminates to several organs, 
including the fat body, cells of the digestive tract, thoracic muscle fibers, and the 
epithelial sheath surrounding the egg chamber [22,24,26]. Cricket paralysis virus 
(CrPV) is a Dicistroviridae family member that is closely related to DCV. CrPV was 
originally isolated from field crickets, in which it causes a fatal paralysis [27]. Although 
obtained from a different host, CrPV replicates efficiently in Drosophila and causes 
high mortality after experimental infection [28-30]. Therefore, both DCV and CrPV 
can be used to model acute viral infections.
Flock House virus (FHV) (Nodaviridae), originally isolated from New Zealand grass 
grubs, is regularly used to study virus-host interactions in Drosophila [30-34]. Similar 
to DCV and CrPV, intrathoracic injection of FHV in adult flies causes high lethality 
[23,30,32,35]. The fat body, muscles, and trachea are the main target tissues during 
FHV infection [32]. Interestingly, FHV also efficiently infects cardiomyocytes, the 
heart muscle cells, of Drosophila [23]. Since viral infections are a major cause of 
acute myocarditis (inflammation of the heart muscle) in humans, FHV may become 
an important model to study cardiotropic virus infections [36]. 
Nora virus is another natural pathogen of Drosophila. It was recently identified as 
a non-pathogenic, persistent infection in Drosophila laboratory stocks and wild-
caught flies [37]. Despite its recent discovery, Nora virus was found to be associated 
with Drosophila stocks for at least twenty years [37]. Nora virus is excreted in the 
feces of infected flies, and horizontally transmitted through the fecal-oral route 
[38]. Although Nora virus particles are mainly found in the intestine of infected flies, 
the exact target cells remain elusive. In contrast to DCV, injection of Nora virus into 
Drosophila mirrors the natural infection in its persistent, non-pathogenic character 
[38]. This makes Nora virus a suitable model to study the interplay between the 
innate immune system and persistent infections.
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Insect innate immunity
The innate immune response relies on germline-encoded pathogen recognition 
receptors that recognize conserved molecular patterns of microbial pathogens. 
This response is composed of a cellular and humoral component. Three types of 
circulating blood cells, called plasmatocytes, lamellocytes and crystal cells, mediate 
the cellular response in Drosophila [39]. The plasmatocytes phagocytose invading 
pathogens, while lamellocytes are responsible for the encapsulation of objects 
too large to be phagocytosed, such as parasitic wasp eggs [40]. Both phagocytosis 
and encapsulation lead to the destruction of the invading pathogen, although the 
mechanisms are poorly understood [39]. Lamellocytes are not found in the embryo 
or adult and are restricted to the larval stage [40]. Crystal cells are non-phagocytic 
cells that mediate melanization needed for wound healing and encapsulation 
[39,41,42]. 
The humoral response against bacteria and fungi is characterized by the synthesis 
and secretion of antimicrobial peptides (AMPs) by the fat body. AMPs can insert 
into the membrane of pathogens to form transmembrane pores that induce lysis 
of microbial cells. Alternatively, some AMPs can translocate to the pathogen’s 
cytoplasm to inhibit cell-wall synthesis, nucleic-acid synthesis, protein synthesis, or 
enzymatic activity [43]. The strong induction of AMPs upon infection with bacteria or 
fungi is regularly used as a marker of an activated immune system, and mainly relies 
on the Toll and immune deficiency (IMD) pathway [11,44-46]. 
The Toll receptor, initially identified for its role in embryonic development, is 
important for the innate immune response against Gram-positive bacteria and 
fungi [11,46]. Unlike the vertebrate Toll-like receptors, the Drosophila Toll receptor 
is not directly activated by microbial motifs [47,48]. Instead, soluble receptors like 
Gram-negative binding protein (GNBP)-1 and -3, and peptidoglycan recognition 
protein (PGRP)-SA and -SD recognize molecular motifs of fungi and Gram-positive 
bacteria, respectively [49-51]. Activation of the GNBP and PGRP receptors initiates 
a proteolytic signaling cascade that results in the maturation of pro-Spätzle into the 
active cytokine Spätzle [47,48]. Binding of Spätzle to the Toll recepotor activates an 
intracellular signaling pathway eventually leading to the translocation of the NF-
κB like transcription factors Dorsal and Dorsal-related immunity factor (Dif) to the 
nucleus. Translocated Dorsal and Dif then induce the expression of AMPs, such as 
Drosomycin and Defensin [52-54].
The IMD pathway is activated by Diaminopimelic acid (DAP)-type peptidoglycans (PGN) 
of Gram-negative bacteria. Recognition of the DAP-type PGN by the peptidoglycan-
recognition protein-LC (PGRP-LC) or PGRP-LE leads to intracellular recruitment of 
IMD [55-58]. Subsequently, IMD initiates two distinct signaling cascades that both 
lead to the activation of the NF-κB transcription factor Relish. Translocation of Relish 
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to the nucleus induces the expression and secretion of another set of AMPs, which 
includes Diptericin and Cecropin [59,60].
The Janus kinase/signal transducers and activators of transcription (Jak/Stat) 
pathway also plays a role in innate immune defense [39,61]. Signaling of this 
pathway is triggered by damage and stress signals, and is initiated by the binding of 
a cytokine from the Unpaired (Upd) family to the domeless receptor (Dome) [62,63]. 
Activation of the Dome receptor induces phosphorylation of Stat92E via the JAK 
kinase hopscotch, leading to Stat92E dimerization and translocation to the nucleus 
[62]. Activated Stat92E subsequently induces expression of genes with Stat binding 
sites in their promoter [62,63]. 
Although the Toll, IMD, and Jak-Stat pathways are mainly implicated in the defense 
against bacteria and fungi, they were also reported to play a role during infection 
with some viruses [64-67]. In contrast to bacterial and fungal infection, however, 
virus infections do not consistently induce a robust AMP response [66]. In addition, 
transcriptional induction of pathway components differed between studies and 
seemed to be specific for a virus or virus family [66]. Due to this lack of consistency, 
the roles of the Toll, IMD, and Jak-Stat pathway in antiviral defense remain poorly 
understood.
Over the last years, it has become clear that RNA interference (RNAi) mediates 
a robust antiviral response in insects, nematodes, fungi and plants [68]. RNA 
interference is a small RNA-based mechanism for gene silencing that is triggered by 
the presence of double-stranded RNA (dsRNA). Double stranded RNA, which cannot 
be detected in uninfected cells [69], is produced during virus infections and sensed 
as a danger signal that triggers the antiviral RNAi response. Viral dsRNA is processed 
by an RNase of the Dicer family into 21-nt small interfering RNAs (siRNAs). These 
viral siRNAs (vsiRNAs) are incorporated in an Argonaute (AGO)-containing RNA-
induced silencing complex (RISC), where they guide the recognition and cleavage of 
viral target RNAs and thereby restrict viral replication. 
RNA silencing in insects
RNA silencing refers to a family of gene silencing mechanisms that are guided by 
small RNAs in association with an Argonaute family member. There are three major 
RNA silencing pathways in animals: the siRNA/RNAi pathway, the microRNA (miRNA) 
pathway and the piwi-associated RNA (piRNA) pathway. These pathways differ in the 
biogenesis of the small RNA, the Argonaute to which the small RNA associates, their 
targets, and their effector functions. 
12
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The siRNA pathway
The RNAi pathway is initiated by the ribonuclease Dicer-2 (Dcr-2) which processes long 
dsRNA into siRNAs [70] (Figure 1). Dicer proteins are type III members of the RNaseIII 
family that contain a DExD/H ATPase domain, a DUF283 domain, a Piwi/Argonaute/
Zwille (PAZ) domain, two tandem RNaseIII domains, and a dsRNA-binding domain. 
The PAZ domain interacts with the terminus of long dsRNA, which is then positioned 
along the surface of the protein towards the processing center of Dicer [71]. An 
intramolecular dimer of the two RNaseIII domains forms the processing center of 
the enzyme. Each RNaseIII domain cleaves one strand of the long dsRNA molecule, 
thereby generating 21-nt siRNAs with 2-nt 3’ overhangs that bear characteristic 5’ 
monophosphate and 3’ hydroxyl moieties [72-74]. The distance between the PAZ 
domain and the RNaseIII active sites determines the characteristic 21-nt size of 
siRNAs [74,75]. The DExD/H ATPase domain converts ATP to provide energy required 
for processive cleavage of long dsRNA [76,77]. In contrast to Drosophila Dcr-2, the 
activity of human Dicer is not enhanced by the addition of ATP [78,79]. No functions 
have thus far been assigned to the other Dcr domains. Efficient processing of dsRNA 
by Drosophila Dcr-2 requires Loquacious isoform PD (Loqs-PD). Loqs-PD probably 
acts as an adaptor molecule that enhances the affinity of Dcr-2 for long dsRNA [80-
83]. A similar activity has been proposed for Arsenic resistance protein 2 (Ars2), 
which promotes the efficiency and fidelity of Dcr-2-mediated cleavage [84].  
Following dsRNA cleavage, the resulting siRNA is bound by Dcr-2 and its dsRNA-
binding protein partner R2D2, generating a RISC loading complex (RLC). Binding 
of R2D2 to the siRNA is enhanced by the phosphate group at the 5’ terminus of 
the siRNA, thereby ensuring that only authentic siRNAs are efficiently bound by the 
complex [78,80,85]. The RLC is located in specific cytoplasmic foci termed D2 bodies. 
Presumably, the D2 bodies form the site where the RLC loads the siRNA duplex into 
an Argonaute-2 (AGO2) containing RISC [86]. 
RISC loading is an ATP dependent process that involves, in addition to the RLC, 
heat shock protein 90 (Hsp90), which presumably induces a conformational change 
in AGO2 needed to accommodate the siRNA duplex [87,88]. Within RISC, the PAZ 
domain of AGO2 binds the 3’ terminus of the strand of the siRNA duplex that will be 
retained in RISC (the guide strand) at the 2-nt overhang [89-91]. The 5’ phosphate of 
the guide strand is bound in a pocket in the AGO2 middle (Mid) domain [92,93]. Upon 
loading of the siRNA into RISC, the endonucleolytic activity of the Piwi domain of 
AGO2 cleaves the phosphodiester bond between nucleotides 9 and 10 of the strand 
that will be excluded from RISC (the passenger strand) [94-96]. The adaptor molecule 
C3PO degrades the 9- and 12-nt RNA fragments that result from passenger strand 
cleavage [97]. The fate of the two strands of an siRNA duplex is determined by its 
binding orientation to R2D2 and Dcr-2 in the RLC. R2D2 binds the thermodynamically 
most stable end of the siRNA, whereas Dcr-2 binds the other end. The strand that 
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Figure 1: Schematic overview of the RNAi pathway in insects. Viral dsRNA is processed by Dicer-2 (Dcr-2) 
into 21-nt small interfering RNAs (siRNAs), which are incorporated in an Argonaute-2 (AGO2) containing 
RNA-induced silencing complex (RISC). Within RISC, these siRNAs guide the recognition and cleavage of 
viral target RNAs and thereby restrict viral replication. Suppressors of RNAi from Cricket paralysis virus 
(CrPV 1A), Drosophila C virus (DCV 1A), and Flock House virus (FHV B2) interfere at different stages of 
the antiviral RNAi pathway (indicated on the right). Systemic spread of RNAi is thought to be essential 
for effective antiviral defense. The nature of the sequence specific silencing signal (dsRNA or siRNA) is 
still unknown.
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interacts with R2D2 at its 3’ terminus will become the guide strand [85]. 
After passenger strand cleavage and elimination, the guide strand is 2’-O-methylated 
at the 3’ terminal nucleotide by the S-adenosylmethionine-dependent 
methyltransferase Hen-1 (DmHen-1), resulting in the formation of a mature RISC 
[98]. The mature RISC uses the guide strand to bind complementary RNA sequences. 
When a fully complementary RNA is bound by RISC, the RNase activity of the AGO2 
Piwi domain cleaves the target RNA (Slicer activity), thereby inducing its degradation 
[99,100]. Alternatively, AGO2 may induce translational repression if central 
mismatches between guide strand and target RNA prevent Slicer activity [101].
The miRNA pathway
miRNAs are central regulators of gene expression that inhibit translation and/or 
induce degradation of their target mRNAs [102]. miRNAs derive from genomically 
encoded stemloop RNA transcripts produced by all eukaryotic cells. Canonical miRNA 
biogenesis starts with RNA polymerase II dependent production of primary miRNAs 
(pri-miRNAs) in the nucleus [103]. These pri-miRNAs form RNA structures with one 
or more stemloop structures. Typically, a pri-miRNA consists of an imperfect base-
paired dsRNA stem with a terminal loop and flanking sequence [104]. In the nucleus, 
the flanking sequences of the pri-miRNA are removed through processing by the 
RNaseIII enzyme Drosha and its binding partner Pasha, producing a precursor 
miRNA (pre-miRNA) [105,106]. Pre-miRNAs are subsequently transported to the 
cytoplasm by Exportin-5 [107]. In the cytoplasm, the RNaseIII enzyme Dicer-1 (Dcr-
1), together with the PB isoform of loquacious (loqs-PB), cleaves pre-miRNAs to 
produce the mature miRNAs [108,109]. Mature miRNAs are imperfect RNA duplexes 
of approximately 22-nt in length that contain a 5’ phosphate and a 2-nt 3’ overhang 
characteristic of an RNaseIII product [110]. Although the majority of miRNAs is 
produced by this canonical miRNA pathway, alternative biogenesis mechanisms that 
are independent of Drosha and/or Dicer exist [111,112]. 
To exert their regulatory function, mature miRNA duplexes generally associate with 
an Argonaute-1 (AGO1) containing RISC complex. Central mismatches in the miRNA 
duplex facilitate sorting of the miRNA into AGO1, whereas mismatches in the seed 
region (guide positions 2-8) or the middle of the 3’ region (guide positions 12-15) 
promote unwinding of the duplex. Duplex unwinding leads to a mature miRNA 
RISC (miRISC), in which one miRNA strand is retained, whereas the other strand is 
discarded [113-115]. Although both strands can potentially be loaded into AGO1, the 
strand most frequently associated with AGO1 is termed the mature miRNA strand, 
while the other is called the miRNA* strand. The mature miRNA serves as a sequence 
specific guide to target miRISC to messenger RNAs (mRNAs). In animals, the miRNA 
target sequences reside in general in the 3’ untranslated region (3’UTR), although 
some miRNA target sites have been identified in the 5’ UTR and open reading frame 
15
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of RNA transcripts [102]. miRNAs bind their target mRNAs through imperfect base-
pairing. Base-pairing between nucleotides 2-8 (the seed sequence) of the miRNA and 
the target mRNA is generally required for recognition [116]. Upon target binding, 
miRISC can either inhibit translation, facilitate deadenylation, and/or initiate the 
degradation of the mRNA [102]. 
In Drosophila, the miRNA and siRNA pathways were considered to be separate 
pathways, with Dcr-2 and AGO2 dedicated to the RNAi pathway, and Dcr-1 and AGO1 
dedicated to the miRNA pathway. Although the biogenesis of siRNAs and miRNAs 
are indeed separate processes, some cross-talk occurs at the level of RISC loading. 
More specifically, some miRNAs, especially those with more extensive base pairing, 
can be loaded into AGO2 [117,118]. Recently, it was shown that both the mature 
miRNA and miRNA* strands are frequently loaded into AGO2 by a Dcr-2 and R2D2-
dependent mechanism [117,119]. These findings render the mature miRNA/miRNA* 
strand nomenclature somewhat ambiguous. Therefore, the strand nomenclature 
changed to 5-p and 3-p, referring to the strands originating from the 5’ arm or the 3’ 
arm of the pre-miRNA, respectively. 
The piRNA pathway 
Piwi-interacting RNAs (piRNAs) are small silencing RNAs of ~24-30 nucleotides in 
size that interact with members of the Piwi subfamily of the AGO family [120]. The 
Piwi subfamily comprises Piwi, Aubergine (Aub) and Argonaute-3 (AGO3), which are 
predominantly expressed in germline tissues. In these tissues, the piRNA pathway 
prevents the activation of transposons. The biogenesis of piRNAs remains poorly 
understood, but in contrast to siRNAs and miRNAs, piRNAs are generated in a Dicer-
independent manner. They most likely arise from long single-stranded precursor 
RNAs that originate from intergenic regions, termed piRNA loci, which contain 
sequences of transposons and their defective remnants. How these precursors are 
processed into mature piRNAs is not completely clear. Recently, the endoribonuclease 
Zucchini was implicated in cleaving the 5’ end of the single-stranded precursor RNA, 
thereby determining the 5’ end of the piRNA. Piwi and Aub proteins preferentially 
bind cleavage products that contain a 5’ uridine after which the Piwi and Aub-
associated RNA molecules are trimmed from their 3’ ends by an unknown nuclease. 
In the presence of a target transposon RNA, these primary piRNAs engage in an 
amplification loop, known as the ping-pong mechanism. According to the ping-pong 
model, Piwi and Aub associated antisense piRNAs target transposon mRNAs, which 
are subsequently cleaved. The cleavage products are then transferred onto AGO3 
and further processed into sense piRNAs. The AGO3 associated piRNAs direct the 
cleavage of antisense transposon RNAs, leading to a feedback loop that results in 
amplification of the initial pool of piRNAs.
The ping-pong model was deduced from the characteristic features of the piRNAs 
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that are associated with the different Piwi proteins. First, piRNAs bound to Piwi 
and Aub are in general antisense to the transposon RNAs, whereas piRNAs bound 
to AGO3 are most often of sense orientation. Second, Piwi- and Aub-associated 
piRNAs have a strong bias for a uridine at position one, whereas AGO3-associated 
piRNAs have a strong preference for an adenine at position ten. Third, the first ten 
nucleotides of Piwi- and Aub-associated piRNAs are frequently complementary to 
the 5’ ten nucleotides of AGO3-associated piRNAs.
RNAi as an antiviral defense mechanism in insects
Viral dsRNA is a strong non-self signature. An appealing hypothesis is that viral dsRNA 
is sensed and processed by Dcr-2 into vsiRNAs. Once incorporated into AGO2/RISC, 
these vsiRNAs may guide the recognition and cleavage of single-stranded viral target 
RNAs. This model predicts that the RNAi pathway exerts antiviral activity at two 
levels, by Dicer-mediated cleavage of viral dsRNA and by AGO2-mediated targeting 
of viral single-stranded RNA.
Three major lines of evidence support a crucial role for the RNAi pathway in antiviral 
defense in insects. First, RNAi-deficient flies (Dcr-2, R2D2, or AGO2 null mutants) 
are more sensitive than wild-type flies to infection with several viruses, such as 
DCV, CrPV, FHV, vesicular stomatitis virus (VSV) (Rhabdoviridae), and Invertebrate 
Iridescent virus 6 (IIV-6) (Iridoviridae). Virus infections in these RNAi mutants result 
in higher viral RNA copy numbers, higher viral titers, and increased mortality 
[17,25,30,32,65,121,122]. AGO2 and R2D2 mutants are also hypersensitive to the 
dsRNA virus Drosophila X virus (Birnaviridae), but, surprisingly, Dcr-2 mutants are 
not [121]. The observation that AGO2 and R2D2 mutants (in which Dcr-2 is fully 
functional) are also hypersensitive to virus infection indicates that cleavage of viral 
dsRNAs by itself is not sufficient to control acute virus infection. RNAi also proved 
to be essential for controlling replication of several arthropod-borne (arbo-) viruses 
in mosquitoes. Knockdown of Dcr-2 or AGO2 expression in Aedes aegypti results in 
higher viral titers after infection with either Dengue virus (Flaviviridae) or Sindbis 
virus (Togaviridae) [123,124]. Comparable results were obtained upon infections of 
Anopheles gambiae mosquitoes with O’nyong-nyong virus (Togaviridae) after AGO2 
depletion [125]. Second, the accumulation of vsiRNAs during virus infections in 
both Drosophila and mosquitoes provides direct evidence for processing of viral 
RNAs by Dcr-2 [31,33,126-130] (discussed below). Third, insect viruses encode 
viral suppressors of RNAi (VSRs) as a counter-defense to the RNAi-based immune 
response [25,33,131] (discussed below).
In addition to cell-autonomous silencing, activation of the RNAi pathway can lead to 
systemic silencing in plants. In the setting of a viral infection, non-cell autonomous 
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RNAi may thus generate systemic protective immunity in non-infected tissues. 
Systemic RNAi in plants is a composite of short-range and long-range movement of 
a silencing signal. Movement of a silencing signal to distal sites in the plant requires 
amplification of the signal by a cellular RNA-dependent RNA polymerase (RdRP) 
[132]. In contrast, local spread of RNAi to 10-15 neighboring cells is independent of 
RdRP activity. The mobile silencing molecules in plants were recently identified as 
siRNAs; it remains to be established whether they are protein-bound or not [133]. 
Virus infections in Drosophila also trigger a systemic RNAi response, which depends 
on a mechanism for active uptake of dsRNA [134]. Accordingly, fly mutants with 
defects in dsRNA uptake are hypersensitive to virus infection. These observations 
suggest that, in addition to the cell-autonomous response, a systemic RNAi response 
is essential for effective antiviral immunity in flies. The nature of the mobile silencing 
signal remains unknown. In addition, it remains elusive whether flies express a 
protein with RdRP activity to amplify the silencing signal for systemic spread.
Small RNA profiles during virus infection
The antiviral RNAi pathway in plants and insects is triggered by viral dsRNA molecules, 
which are processed by Dcr-2 into vsiRNAs. In theory, there are several potential 
sources of viral dsRNA that can serve as a substrate for Dcr-2. These sources include 
genomic dsRNA, structural RNA elements in the viral genome or in viral transcripts, 
dsRNA replication intermediates and convergent transcripts of viral genes. The 
recent introduction of massive parallel sequencing created the opportunity to gain 
in-depth insight into the origin of the viral small RNAs for different classes of insect 
viruses (Table 1). 
Viral siRNA profiles
The first insect vsiRNA profiles came from a study designed to profile endogenous 
small RNAs from a Drosophila S2 cell line [135]. In addition to endogenous small RNAs, 
a large subset of AGO2-associated siRNAs was found to match the FHV genome. 
These vsiRNAs arose due to a persistent infection of the S2 cell line. Alignment of 
the available FHV-derived vsiRNAs to the viral genome indicated that they mapped 
in roughly equal proportions to both the positive (+) and negative (-) strand of the 
genome [136]. During (+) strand RNA virus infection, the (+) and (-) RNA strands 
accumulate asymmetrically, with the genomic (+) strands being approximately 50- 
to 100-fold more prominent than the (-) strands [137]. The equal distribution of the 
vsiRNAs over the (+) and (-) RNA strands of the FHV genome, therefore, suggests that 
dsRNA replication intermediates are the major substrates for vsiRNA biogenesis. 
Interestingly, although the vsiRNAs mapped across the entire viral genome, there 
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were a few specific hotspots from which the majority of the vsiRNAs were derived. 
These observations suggest that certain regions within the viral genome are more 
accessible to Dcr-2 than others. Results from this first study were confirmed by other 
reports on FHV small RNA profiles [31,127,138,139]. The equal distribution of vsiRNAs 
over the (+) and (-) strands of the viral genome seem to be a general theme in (+) 
strand RNA virus infection, as similar vsiRNA profiles were obtained during other (+) 
strand RNA virus infections in either Drosophila or mosquito [126,128,130,140-143]. 
Therefore, it seems that the dsRNA replication intermediate is a common target of 
the insect antiviral RNAi pathway during infection with (+) strand RNA viruses. For 
some RNA viruses, dicing of structural elements within the viral genomes have been 
suggested to contribute to vsiRNA production. For example, some studies reported 
a bias of vsiRNAs mapping to the genomic strand during FHV or DCV infection 
[138,144,145]. The reason for this positive-strand bias is unclear, but might be due 
to processing of the asymmetrically produced viral (+) RNA strand, presumably at 
structured RNA elements.
Interestingly, in contrast to most insect (+) strand RNA viruses, structural RNA 
elements within the viral genome have been identified as the main source for vsiRNA 
biogenesis for some plant (+) strand RNA viruses, such as Cymbidium ringspot 
virus (CymRSV) (Tombusviridae) [146]. This discrepancy might reflect differences in 
substrate-specificity between insect Dcr-2 and the plant Dcr-like enzymes.
In analogy to (+) strand RNA viruses, (+) and (-) strands accumulate asymmetrically 
during VSV infection, a (-) strand RNA virus, with the genomic (-) strand being five 
to ten fold more abundant than the antigenomic (+) strand [147]. In contrast to (+) 
strand RNA viruses though, (-) strand RNA viruses do not produce detectable amounts 
of dsRNA during infection [17,69]. Nevertheless, vsiRNAs are evenly distributed 
between the genomic and antigenomic strands in infections with VSV, Rift Valley 
fever virus (RVFV), La Crosse virus, and Schmallenberg virus [17,140,145,148,149]. 
Together with the uniform distribution of vsiRNAs along the entire length of the 
genome, these observations indicate that also in (-) strand RNA viruses the dsRNA 
replication intermediate is a substrate for Dcr-2. 
Recently, Wu et al. identified seven distinct RNA viruses in two Drosophila cell lines 
[130]. Among these viruses, of which some had not been identified before, are 
three viruses with a dsRNA genome (Drosophila totivirus, Drosophila birnavirus 
and Drosophila X virus). Interestingly, for all of the analyzed dsRNA viruses in both 
cell lines, the vsiRNAs mapped in roughly equal ratios to both strands of the viral 
genome. Furthermore, vsiRNAs mapped all along the genome without clustering at 
specific hotspots. Similar results were obtained for the segmented dsRNA virus Blue 
tongue virus in a Culicoides midge derived cell line [149]. Although dsRNA viruses 
are believed to shield their genome in the viral core, these results suggest that the 
genomic dsRNA is the predominant substrate for Dcr-2.  
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DNA viruses also produce viral dsRNA during infection, presumably through 
structured RNA transcripts or overlapping convergent transcripts [69]. These dsRNA 
species are potential substrates for Dcr-2. Indeed, vsiRNAs corresponding to the 
dsDNA virus IIV-6 were identified in IIV-6 infected flies [65,122]. The IIV-6 derived 
vsiRNAs clustered in hot spots and mapped equally to both strands of the viral 
genome. Interestingly, sense and antisense transcripts were detected at loci covered 
by the vsiRNA hotspots. Therefore, vsiRNAs were suggested to originate from 
overlapping convergent transcripts. Also in mosquitoes, vsiRNAs corresponding to 
a DNA virus, Culex tritaeniorhynchus virus, were reported [150]. The vsiRNAs were 
mainly derived from the viral RNA transcripts, although the mechanism of vsiRNA 
production in this infection remains unclear.
Taken together, vsiRNA profiling shows that all major classes of viruses are targeted 
by the insect antiviral RNAi response. To prevent activation of the innate immune 
defenses of their hosts, viruses protect their dsRNAs from immune sensors. For 
example, (+) strand RNA viruses shield their dsRNA replication intermediates in 
virus-induced membrane vesicles, whereas the dsRNA genomes of dsRNA viruses 
are protected in viral cores [151]. Similar to (+) strand RNA viruses, non-segmented (-) 
strand RNA viruses like VSV seem to replicate their genome in membranous vesicles 
[152,153]. Nevertheless, vsiRNA profiles indicate that the viral dsRNAs are available 
for Dcr-2-mediated cleavage. This suggests that Dcr-2 is capable of protruding the 
compartments in which viral dsRNAs are shielded or that, at certain stages of the 
viral replication cycle, viral dsRNA is released into the cytoplasm where it is exposed 
to Dcr-2. 
Virus-derived piRNA profiles
Massive parallel sequencing of small RNAs from infected insect material showed 
that vsiRNAs are produced during infection with insect viruses from all classes. In 
association with RISC, these vsiRNAs are thought to cleave complementary viral 
RNAs, allowing the RNAi pathway to act as a major antiviral response in insects. 
Interestingly, while analyzing vsiRNAs in a cell line derived from the ovarian somatic 
sheet (OSS), Wu et al. [130] implicated another class of small RNAs in antiviral defense. 
In addition to vsiRNAs, high levels of viral piRNAs were identified for two viruses: DCV 
and American Nodavirus (ANV) [130]. Although less abundant, viral piRNAs were also 
identified for other viruses that persist in this cell line. These observations suggest 
that viruses may be targeted by both the siRNA and piRNA pathway in insects.
The viral piRNAs detected in OSS cells were 24-30 nucleotides in length with peaks at 
27 and 28 nucleotides [130]. The OSS cell line expresses Piwi, but not Aub and AGO3. 
Primary piRNAs are therefore produced, but the lack of Aub and AGO3 precludes 
ping-pong amplification [154]. In agreement, viral piRNAs resemble primary piRNAs 
with a strong bias for a uridine at position one, but no enrichment for an adenine at 
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position ten [154]. Moreover, the viral piRNAs were almost exclusively of (+) polarity 
for both (+) strand RNA and dsRNA viruses. These data suggest that the genomic 
RNAs of the (+) strand RNA viruses and the sense transcripts of dsRNA viruses are 
processed by the primary piRNA pathway in Drosophila. These observations are not 
restricted to Drosophila, as viral piRNAs were also detected in different mosquitoes 
and mosquito cell lines using viruses from diverse families [138,140-142,148,155-
157]. In contrast to the Drosophila OSS cell line, mosquito cells produce piRNAs that 
map to both strands of the viral genome. Furthermore, viral piRNAs show a bias for 
uridine at position one, and enrichment for adenosine at position ten, indicative 
of the ping-pong-dependent amplification mechanism [138,141,148,156,157]. 
Strikingly, small RNA profiles from head and thorax of infected Aedes albopictus 
mosquitoes suggest that the ping-pong-dependent viral piRNA production also 
occurs in somatic tissues, which is in stark contrast to Drosophila where the piRNA 
machinery is believed to be restricted to the germline [141,158,159].
Maintenance of germline integrity is of crucial importance to ensure the proper 
development of offspring. The germline-specificity of the piRNA pathway and the 
detection of viral piRNAs in Drosophila led to the hypothesis that the piRNA pathway 
may protect the germline from invasion by viruses [160]. The detection of viral 
piRNA-like RNAs with a ping-pong signature in the mosquito germ line and soma 
suggests that the mosquito piRNA pathway provides another layer of small RNA-
mediated antiviral defense, additional to the antiviral siRNA pathway. A recent 
finding that Semliki Forest virus (SFV) infection is enhanced upon knockdown of 
piRNA components supports this hypothesis [156].
Viral suppression of RNAi
Despite the potent antiviral activity of the RNAi pathway in plants and insects, many 
viruses manage to persist in these organisms. Thus, viruses seem to be able to 
avoid recognition by the RNAi pathway or to counteract its antiviral activity. Indeed, 
plant and insect viruses encode VSRs that allow them to replicate in the presence 
of a potent RNAi-based antiviral immune response [30,68,144,161-164]. Since 
dsRNA is recognized as a “non-self” immune activator, it bears little surprise that 
many viruses prevent detection of dsRNA by the immune system. Many VSRs bind 
dsRNA in a sequence-independent manner, thereby shielding it from Dicer cleavage 
[25,163,165]. Other VSRs, such as P19 from Cymbidium Ringspot Tombusvirus 
(CymRSV), are able to specifically bind siRNAs [163,165-168]. In biochemical assays, 
these VSRs sequester siRNAs and prevent their incorporation into RISC. The 
mechanism of RNAi suppression in viral infection, however, may be more complex. 
P19, for example, is dispensable for virus accumulation in primary infected cells, but 
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prevents cell-to-cell movement of the virus-induced silencing signal. Accordingly, in 
the absence of P19, the virus accumulates normally within vascular bundles, but is 
unable to establish systemic infection of the leaves [168,169]. 
Binding of dsRNA or siRNA is a feature that is shared by many VSRs. Nevertheless, 
in analogy to the multitude of mechanisms by which mammalian viruses suppress 
innate and adaptive immunity, some plant and insect viruses suppress RNAi by a 
mechanism that is independent of dsRNA or siRNA binding. These mechanisms are 
discussed in the next sections.
RNAi suppressors encoded by plant viruses
Although dsRNA binding appears to be a common mechanism to suppress RNAi, 
some VSRs employ other mechanisms to counteract the RNAi pathway (Table 2). 
These VSRs rely on protein-protein interaction with key components of the RNAi 
pathway. One example of such a VSR is the P0 protein of Poleroviruses (Luteoviridae) 
[170-172]. Beet western yellows virus (BWYV) P0, for example, interacts with and 
induces degradation of AGO1, the main antiviral RISC component in plants. P0 
contains an F-box motif, which is commonly found in proteins within the E3 ubiquitin 
ligase complex. This suggests that P0 induces ubiquitination and subsequent 
proteosomal degradation of AGO1 [173]. Indeed, the VSR activity of P0 depends on 
an interaction with a protein from the E3 ubiquitin ligase complex. However, blocking 
proteosomal degradation did not prevent AGO1 degradation. These data suggest an 
ubiquitin-dependent, proteosomal-independent mechanism for P0 VSR activity. 
Through an interaction with part of the PAZ and Piwi domains of AGO1, the 
Cucumber mosaic virus (CMV) (Bromoviridae) 2b protein is able to suppress Slicer 
activity of a pre-assembled RISC in vitro [174]. In addition, CMV 2b binds small RNAs 
in vitro, which is suggested to contribute to VSR activity [175,176]. Which activity 
predominates during an authentic virus infection remains to be established. 
The P38 capsid protein of Turnip crinkle virus (TCV) (Tombusviridae) employs yet 
another mechanism of RNAi suppression. P38 contains two glycine-tryptophane (GW) 
motifs. Different cellular proteins use linear GW or WG motifs as an “AGO hook” for 
functional interactions with AGO proteins [177].  P38 mimics this cellular GW motif-
based interaction; its GW motifs allow P38 to bind AGO1 in vitro and to suppress RNAi 
in vivo [178,179]. Similarly, the sweet potato mild mottle virus (SPMMV) (Potyviridae) 
P1 protein uses three GW/WG motifs to bind AGO1 and suppress its function [180].
RNAi suppressors encoded by insect viruses
Plant viruses are extensively studied and most, if not all, viruses seem to encode one 
or multiple VSRs [163,181]. In contrast, few VSRs have thus far been identified and 
characterized in insect viruses. The B2 protein of FHV was the first VSR identified in an 
invertebrate virus [33]. Homodimers of B2 bind to dsRNA independent of sequence 
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and length. Indeed, viral dsRNA replication intermediates co-immunoprecipitate 
with B2 from FHV-infected S2 cells, confirming an interaction of B2 with dsRNA in 
vivo [31]. B2 seems to exert a dual mode of RNAi suppression. Binding of long dsRNA 
inhibits Dcr-2 cleavage; binding of siRNAs prevents their incorporation into AGO2 
[33,182]. The importance of a VSR for virus replication is genetically well-supported 
in the case of FHV. Its RNAi suppressor B2 allows the virus to replicate in the presence 
of a functional antiviral RNAi response, but it is dispensable for replication in RNAi 
mutants [30,144]. The VSR activity of the DCV 1A protein also depends on dsRNA 
binding. As a member of the Dicistroviridae, DCV encodes two polyproteins from 
two distinct open reading frames. The first open reading frame, ORF1, encodes the 
nonstructural proteins, whereas ORF2 encodes the viral capsid proteins [2]. DCV 
1A maps to the N-terminal part of ORF1. In contrast to FHV B2, DCV 1A binds long 
dsRNA, but not siRNAs, with high affinity in vitro, thereby inhibiting Dcr-2 cleavage 
of dsRNA [25]. Therefore, DCV 1A likely binds the viral replication intermediate to 
protect its degradation by Dcr-2. Protection of the viral dsRNA from Dcr-2 cleavage 
by VSRs is, however, not complete, as indicated by the detection of vsiRNAs in FHV 
and DCV infection.
CrPV is the closest relative of DCV within the Dicistroviridae family. The VSR of CrPV, 
1A, maps to the same genomic location as DCV 1A. Interestingly, whereas CrPV and 
DCV share a high degree of protein sequence identity within ORF1 (~55%), the ORF1 
N-terminal region that contains the VSRs is not well conserved. It is, therefore, no 
surprise that CrPV 1A suppresses RNAi through a different mechanism as DCV 1A. 
CrPV 1A directly interacts with AGO2, without affecting RISC assembly or stability. 
Since CrPV 1A is able to inhibit the activity of a pre-assembled RISC, it most likely 
Table 2: Viral suppressors of RNAi (VSRs) of selected plant and insect viruses.
Host Virus VSR Mechanism of suppression Ref.
Plant Cymbidium ringspot virus P19 siRNA binding [166]
Pothos latent virus P14 siRNA and dsRNA binding [193]
Beet western yellows virus P0 Interaction with and degradation 
of AGO1
[170-172]
Turnip crinckle virus P38 GW motif-based interaction with 
AGO1
[178]
Cucumber mosaic virus 2b siRNA binding and AGO1 
interaction, inhibition of Slicer 
activity
[174-176]
Insect Flock House virus B2 siRNA and dsRNA binding [33,182]
Drosophila C virus 1A dsRNA binding [25]
Cricket paralysis virus 1A Interaction with AGO2, inhibition of 
Slicer activity
[131]
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interferes with the Slicer activity of AGO2 [131]. 
The difference in mechanism and potency of RNAi suppression was suggested to 
explain the difference in pathogenicity between DCV and CrPV. DCV establishes a 
non-lethal, persistent infection, whereas CrPV causes high mortality [2,183]. This 
hypothesis was supported by expression of DCV 1A (Sindbis-DCV 1A) or CrPV 1A 
(Sindbis-CrPV 1A) from a recombinant Sindbis virus, which is thought not to suppress 
RNAi by itself [184,185]. In adult flies, Sindbis-CrPV 1A replicates to higher titers and 
causes higher mortality than Sindbis-DCV 1A, which correlates with the more potent 
RNAi suppression of CrPV 1A. Thus, VSRs may be important determinants of viral 
pathogenicity (Figure 2).
RNAi suppression by arboviruses
Arboviruses are maintained in a cycle that requires transmission by haematophagous 
arthropod vectors (mainly mosquitoes and ticks) to vertebrate hosts. After ingestion 
of a virus-infected blood meal, arboviruses replicate in the midgut epithelium 
of their vector. The virus then spreads through the hemolymph into the salivary 
glands for further amplification and transmission to a naive vertebrate host. Several 
arboviruses, including Dengue virus, Sindbis virus and O’nyong-nyong virus, are 
suppressed by RNAi in their mosquito vectors [123-125].
Arbovirus infection in the insect vector is typically persistent and non-pathogenic. 
The mosquito’s RNAi pathway thus restricts arbovirus replication, but is unable to 
fully clear these viruses. Since arboviruses rely on survival of their mosquito vector 
for transmission from host to host, the non-pathogenic phenotype is thought to be 
RNAi
Virus
RNAi
Virus
RNAi
Virus
Non-pathogenic
Persistent
Pathogenic Non-pathogenic 
Persistent
DCV CrPV Arbovirus
?
Figure 2: Defense and counter-defense in virus infection of insects. An antiviral RNAi response 
restricts virus replication, whereas viruses suppress the antiviral RNAi response via dedicated RNAi 
suppressor proteins (VSRs). VSR activity may be an important determinant of viral pathogenicity. A 
potent VSR may render a virus pathogenic to its host (for example, Cricket paralysis virus, CrPV).  Absent 
or mild VSR activity may result in non-pathogenic persistent infections, such as observed in natural 
Drosophila C virus (DCV) infections or in arbovirus infection of their invertebrate vector.
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of key importance for efficient virus spread. Hence, an arbovirus that effectively kills 
its vector would therefore be selected against in nature, since it would decrease the 
chance of spread to vertebrate hosts. Consequently, it was suggested that it might 
be deleterious for the survival of arboviruses to encode a potent VSR [184,186] 
(Figure 2).
Nevertheless, in recent years, suppressors of RNAi have been identified in arboviruses. 
The first suppressor identified in an arbovirus is the B2 protein of Nodamura virus 
(NoV, Nodaviridae) [187,188]. Like the B2 protein from FHV, the NoV B2 protein can 
bind long dsRNA and siRNAs, preventing the use of these RNA molecules in the RNAi 
pathway. In addition, the non-coding subgenomic flavivirus RNA (sfRNA) of West Nile 
virus and Dengue virus was recently shown to interfere with the RNAi response in 
mosquitoes [189]. Results from this study suggest that the sfRNA saturates Dicer in 
a concentration-dependent manner, thereby blocking the RNAi pathway. These data 
indicate that arboviruses might employ different strategies for RNAi suppression to 
tune the delicate balance of antiviral defense and virus counter-defense.
Concluding remarks and open questions 
Viruses and RNAi share an intricate relationship, in which the cellular RNAi machinery 
restricts virus replication and viruses suppress the antiviral RNAi response. In the 
current model, viruses produce dsRNAs that, after processing by Dicer into vsiRNAs, 
guide RISC to cleave viral target RNAs in a sequence specific manner. The advent of 
deep-sequencing technology has led to unanticipated insights into the biogenesis 
of vsiRNAs. Viral replication intermediates and genomic dsRNA seem to be the 
main targets for Dcr-2 in infections with single stranded RNA viruses (either of (+) 
or (-) polarity) and dsRNA viruses, respectively. Since viral replication intermediates 
and genomic dsRNA are crucial entities in the viral life cycle, it was proposed that 
Dicing of these dsRNA molecules is sufficient to control persistent infections [127]. 
The potency and mechanism of viral RNAi suppressors has also been suggested to 
play a role in viral pathogenesis. This notion was based on the observation that the 
RNAi suppressor of the pathogenic CrPV was more potent than that of the relatively 
benign DCV [131]. Yet, with only few insect RNAi suppressors identified, it remains 
unclear whether this hypothesis is valid for all insect VSRs. More generally, the 
identification of additional RNAi suppressors may illuminate the full extent by which 
viruses suppress RNAi. Moreover, characterization of immune antagonists sheds 
light on the critical steps of antiviral mechanisms and may result in the identification 
of new components and regulators of antiviral immune responses [190,191].
During co-evolution of viruses and their hosts, dynamic fine-tuned interactions have 
emerged that are best studied in natural virus-hosts combinations. Of special interest 
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in this regard are Drosophila pathogens, as virus-host interactions can be studied 
using the expansive experimental toolbox available in Drosophila. In addition, the 
use of recombinant Drosophila viruses would establish a system where both virus 
and natural host are amenable to genetic manipulation. 
The interaction between (arbo-)viruses and their mosquito hosts remain poorly 
understood. Arboviruses are targets of the RNAi pathway in their mosquito 
vector. Nevertheless, arboviruses in general do not seem to generally express 
RNAi suppressor proteins. This raises important questions as to whether some 
arboviruses and mosquito viruses lack, or only mildly suppress RNAi to prevent a 
pathogenic course of infection in their vector.
Aim and outline of this thesis
The RNAi pathway is the major antiviral defense mechanism in insects. The aim of 
this thesis is to gain more insight into the interaction between the antiviral RNAi 
pathway and viral counter-defense mechanisms. To identify viral proteins that 
suppress the RNAi pathway in insects, we describe in chapter 2 an RNAi sensor 
assay in Drosophila S2 cells. In chapter 3 we investigate whether Nora virus, which 
persistently infects Drosophila, is a target of the antiviral RNAi pathway. Using the 
RNAi sensor assay of chapter 2 and other functional and biochemical assays, we 
identify viral protein 1 (VP1) of Nora virus as a viral suppressor of RNAi. We extended 
the characterization of VP1 in chapter 4, in which we explore the possibility to use 
transgenic expression of VP1 as a tool to study RNAi in vivo. In chapter 5 we describe 
the interaction of VP1 with AGO2, the core component of RISC. Using Nora virus VP1 
sequences isolated from different Drosophila species, we report a species-specific 
suppression of RNAi by VP1. Therefore, we postulate that viral RNAi suppressors 
may act as a host-specificity factor. In chapter 6 we provide evidence that the 
entomobirnaviruses Culex Y virus, recently isolated from wild-caught mosquitoes, 
and Drosophila X virus, encode an RNAi suppressor. Finally, in chapter 7 the results 
of this thesis are discussed and future prospects are presented.
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Abstract
T he RNA interference (RNAi) pathway plays an important role in antiviral immunity in insects. To counteract the RNAi-mediated immune response of their hosts, several insect viruses, such as Flock house virus, Drosophila C 
virus and Cricket paralysis virus, encode potent viral suppressors of RNAi (VSRs). 
Because of the importance of RNAi in antiviral defense in insects, other insect viruses 
are likely to encode VSRs. In this chapter, we describe a detailed protocol for an RNAi 
reporter assay in Drosophila S2 cells for the identification of VSR activity.
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1. Introduction
During prolonged co-evolution of virus and host, viruses have developed various 
sophisticated strategies to evade the immune defenses of their hosts. In insects, 
RNA interference (RNAi) is an important antiviral defense mechanism (reviewed in 
[1-3]). The RNAi machinery is triggered by viral double-stranded RNA (dsRNA), which 
is cleaved by Dicer-2 into viral small interfering RNAs (v-siRNAs). The v-siRNAs are 
incorporated into an RNA-induced silencing complex (RISC) where they guide the 
recognition and cleavage of complementary viral RNAs by Argonaute-2 (Ago-2) and 
thereby restrict viral replication. To interfere with the antiviral RNAi defense system, 
several insect viruses encode potent viral suppressors of RNAi (VSRs). These VSRs 
include Flock house virus (FHV) B2 [4], Drosophila C virus (DCV) 1A [5], and Cricket 
paralysis virus (CrPV) 1A [6]. The VSRs target different steps in the RNAi pathway. For 
example, both FHV B2 and DCV 1A block Dicer-mediated cleavage of long dsRNA into 
siRNAs by binding long dsRNA molecules, whereas FHV B2 also sequesters siRNAs 
to prevent their incorporation into RISC [5,7-10]. In addition to these dsRNA-binding 
activities, several VSRs interact with components of the RNAi machinery directly. For 
instance, FHV B2 interacts with Dicer in order to suppress siRNA biogenesis [11], 
whereas CrPV 1A inhibits RISC activity via an interaction with Ago-2 [12]. 
Given the importance of RNAi as an antiviral defense mechanism in insects, many 
more insect viruses are likely to encode VSRs. This chapter provides a detailed 
protocol that can be used to routinely screen potential VSRs for their ability to 
suppress RNAi in the Drosophila Schneider 2 (S2) cell line. In brief, S2 cells are 
first co-transfected with a plasmid that expresses the potential VSR and copper-
inducible expression plasmids for the firefly and Renilla luciferases. Two days after 
transfection, the cells are treated with dsRNA to silence expression of the firefly 
luciferase reporter (dsRNA feeding). The Renilla luciferase reporter is not silenced 
and functions as an internal control which can be used to normalize the data. Several 
hours after dsRNA treatment, expression of the luciferase reporters is induced with 
CuSO4. The cells are lysed the next day and luciferase activity is quantified by dual-
luciferase reporter (DLR) assays. The data are presented as firefly/Renilla ratios and, 
therefore, increased ratios indicate RNAi suppression by a potential VSR. Once a VSR 
has been identified, additional reporter assays and biochemical experiments can 
be performed to determine which step in the RNAi pathway is targeted by the VSR.
A flow chart of the RNAi reporter assay and two variants thereof is shown in Figure 
1. In experiments to identify VSR activity, we routinely induce RNAi by adding 
dsRNA to the culture supernatant (dsRNA feeding, see Note 1). In Figure 2, a 
representative example is presented of an experiment that demonstrates the VSR 
activities of both DCV 1A and CrPV 1A, using the standard RNAi reporter assay and 
the two variants. In one of the variants, siRNAs are co-transfected with the plasmids 
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(siRNA co-transfection). In contrast to dsRNA, siRNAs do not require processing by 
Dicer-2. Successful suppression of RNAi in this variant therefore implies that the VSR 
interferes with steps downstream of Dicer-2 cleavage. In the other variant, dsRNA 
is co-transfected with the plasmids, rather than added to the culture supernatant 
(dsRNA co-transfection). Notably, whereas DCV 1A inhibits Dicer-2 cleavage of dsRNA 
[5], the protein is unable to suppress RNAi in this experimental set-up. Presumably, 
the co-transfected dsRNA is processed into siRNAs before the VSR is expressed at 
sufficient levels to suppress Dicer-2 cleavage. The main protocol (Sections 2 and 3) 
describes the RNAi reporter assay using dsRNA feeding to induce RNAi; details on 
the variants are described in the Notes section. 
2. Materials
2.1. Cell culture
1. Drosophila S2R+ cells (Drosophila Genomics Resource Center, https://dgrc.cgb.
indiana.edu) (see Note 1).
2. Culture medium: Schneider’s Drosophila Medium (Invitrogen, Carlsbad, CA) 
supplemented with 10% heat-inactivated Fetal Calf Serum (Biochrom, Berlin, 
Germany) and 1% Penicillin/Streptomycin (Invitrogen). Store at 4°C.
3. Cell scrapers (Corning, Corning, NY).
4. 25 cm2 cell culture flasks (Corning).
dsRNA co-transfectiondsRNA feeding siRNA co-transfection
Transfection of
pMT-FLuc, pMT-RLuc,
and test plasmid 
Transfection of
pMT-FLuc, pMT-RLuc,
and test plasmid, and
dsRNA 
Transfection of
pMT-FLuc, pMT-RLuc,
and test plasmid, and
siRNA 
Feeding of dsRNA
Induction of
reporters
DLR assays
Data analysis
t = 0 h
t = 48 h
t = 55 h
t = 72 h
Figure 1: Flow chart of the RNAi reporter assay. See text for details.
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5. 96 well cell culture plates (Corning).
6. Hemocytometer.
2.2. Generation of templates for in vitro transcription
1. Phusion High-Fidelity DNA Polymerase (Finnzymes, Espoo, Finland), including 5x 
Phusion HF Buffer (see Note 2).
2. 10 mM dNTP mix (Roche, Mannheim, Germany).
3. Plasmid templates for polymerase chain reaction (PCR) containing the GL3 
firefly luciferase and green fluorescent protein (GFP) target sequences.
4. The following primers (10 µM):
T7-FLuc-F: 5’-TAATACGACTCACTATAGGGAGATATGAAGAGATACGCCCTGGTT-3’
T7-FLuc-R: 5’-TAATACGACTCACTATAGGGAGATAAAACCGGGAGGTAGATGAGA-3’
T7-GFP-F: 5’-TAATACGACTCACTATAGGGAGAAGCTGACCCTGAAGTTCATCTG-3’
T7-GFP-R: 5’-TAATACGACTCACTATAGGGAGAGGTGTTCTGCTGGTAGTGGTC-3’
5. Thermal cycler.
2.3. In vitro transcription and dsRNA formation
1. T7-promoter-flanked firefly luciferase and GFP PCR products (see Section 3.2.).
2. RiboMAX Large Scale RNA Production System-T7 (Promega, Madison, WI), 
containing T7 Transcription 5x Buffer, rNTPs (25 mM each), and T7 Enzyme Mix 
(see Note 3).
3. GenElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, St. Louis, MO) (see 
Note 4).
4. Heating block.
5. Spectrophotometer.
2.4. Transfection
1. S2R+ cells cultured in a 96 well plate, seeded one day prior to transfection at 
a density of 5x104 cells per well (see Section 3.1.). The cells should be 40-80% 
confluent on the day of transfection.
2. Effectene Transfection Reagent (Qiagen, Hilden, Germany), including Buffer EC 
and Enhancer.
3. Plasmids pMT-FLuc and pMT-RLuc, which express the firefly (pMT-FLuc) and 
Renilla (pMT-RLuc) luciferases from the copper-inducible metallothionein 
promoter [5] (see Note 5).
4. Plasmids that express the potential VSRs which are to be tested for VSR activity 
as well as the corresponding empty plasmid (see Note 6).
5. A plasmid that expresses a known VSR (see Note 7).
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2.5. dsRNA feeding
1. Transfected S2R+ cells in a 96 well plate (see Section 3.4.).
2. Firefly luciferase and GFP dsRNA (see Section 3.3.).
3. Culture medium (see Section 2.1, item 2).
2.6. Induction of the reporters
1. Transfected S2R+ cells in a 96 well plate that are fed with dsRNA (see Section 
3.5.).
2. 50 mM CuSO4: Dissolve 2.5 g of CuSO4.5H2O in 200 ml of H2O. Filter sterilize, 
aliquot, and store at -20°C.
3. Culture medium (see Section 2.1, item 2).
2.7. DLR assays
1. Transfected S2R+ cells in a 96 well plate that are fed with dsRNA and of which 
the reporters have been induced (see Section 3.6.).
2. Phosphate-buffered saline (PBS): Dissolve 80 g of NaCl, 2 g of KCl, 11.5 g of 
Na2HPO4.7H2O, and 2 g of KH2PO4 in 1 l of H2O to prepare a 10x stock solution. 
Adjust the pH to 7.3 with HCl, sterilize by autoclaving, and store at room 
temperature. To prepare a working solution, add nine volumes of H2O to one 
volume of 10x PBS stock solution.
3. Dual-Luciferase Reporter Assay System (Promega), containing Passive Lysis 
Buffer (PLB), Luciferase Assay Reagent II (LAR II), and Stop & Glo Reagent (see 
Note 8).
4. Rocking platform or orbital shaker.
5. Luminometer tubes.
6. Luminometer. 
3. Methods
3.1. Cell culture
1. Culture S2R+ cells in 25 cm2 flasks at 25°C without CO2. The cells should be 
passaged when approaching confluency.
2. To split the cells, scrape the cells with a cell scraper in their culture supernatant 
and resuspend them by gently pipetting up and down several times.
3. Transfer the desired amount of cells to new cell culture flasks and/or plates in 
an appropriate volume of fresh culture medium. Split the cells 1:5 into 25 cm2 
flasks for routine maintenance. For RNAi reporter assays, count the cells using 
a hemocytometer and seed 5x104 cells in 100 µl of culture medium per well 
in a 96 well plate. Since the RNAi reporter assays are performed in triplicate, 
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seed three wells for each potential VSR that is to be tested as well as for all the 
controls (see Section 3.4.).
3.2. Generation of templates for in vitro transcription
1. Perform PCR reactions to generate T7-promoter-flanked templates for in vitro 
transcription (see Section 3.3.). Primers T7-FLuc-F and T7-FLuc-R are used for 
the amplification of firefly luciferase; primers T7-GFP-F and T7-GFP-R are used 
for the amplification of GFP. Both primer sets introduce a T7 promoter sequence 
at both the 5’ and 3’ end of the amplified fragment. Prepare 50-µl PCR reactions 
containing:
a. 1 pg to10 ng of plasmid template DNA
b. 10 µl of 5x Phusion HF Buffer
c. 1 µl of 10 mM dNTP mix
d. 2.5 µl of 10 µM forward primer
e. 2.5 µl of 10 µM reverse primer
f. 0.5 µl of 2 U/µl Phusion DNA Polymerase
g. H2O to 50 µl
Mix by gently pipetting up and down.
2. Place the PCR reactions in a thermal cycler. To amplify the target sequences, 
start with an initial denaturation at 98°C for 30 sec, followed by 30 cycles of 
denaturation at 98°C for 10 sec, annealing at 61°C for 20 sec, and extension at 
72°C for 20 sec. Finish with a final extension of 10 min at 72°C.
3. Analyze 5 µl of the PCR product by standard agarose gel electrophoresis and 
ethidium bromide staining. The T7-promoter-flanked firefly luciferase and GFP 
PCR fragments should have lengths of 489 and 483 bp, respectively (see Note 
9). The PCR products can be used directly in subsequent in vitro transcription 
reactions without purification.
3.3. In vitro transcription and dsRNA formation
1. Firefly luciferase and GFP dsRNA is generated by in vitro transcription reactions 
on their corresponding T7-promoter-flanked PCR fragments (see Section 3.2.). 
Since the PCR fragments contain a T7 promoter sequence at both the 5’ and 3’ 
end, both strands of the dsRNA duplex are generated in a single reaction. Set up 
20-µl in vitro transcription reactions containing:
a. 5 µl of T7-promoter-flanked PCR product
b. 4 µl of T7 Transcription 5x Buffer
c. 6 µl of rNTPs (25 mM each)
d. 2 µl of T7 Enzyme Mix
e. 3 µl of H2O
Mix by gently pipetting up and down.
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2. Incubate at 37°C for 2-4 h.
3. Place the reaction mixture in a heating block pre-heated to 80°C and incubate 
for 10 min.
4. Switch off the heating block, but do not take out the reaction mixture.
5. Let the reaction mixture slowly cool to room temperature in the heating block 
to allow dsRNA formation.
6. Clean up the in vitro transcribed dsRNA using the GenElute Mammalian Total 
RNA Miniprep Kit according to the manufacturer’s instructions (see Note 10).
7. Verify the integrity of the dsRNA by standard agarose gel electrophoresis and 
ethidium bromide staining, and determine its concentration and purity using a 
spectrophotometer.
8. Aliquot the purified dsRNA preparations and store at -80°C (see Note 11).
3.4. Transfection
1. Transfections are done in triplicate for the following experimental conditions:
1) Non-specific dsRNA control (no VSR; GFP dsRNA)
2) Specific dsRNA control (no VSR; firefly luciferase dsRNA)
3) Positive VSR control (known VSR; firefly luciferase dsRNA)
4) Test samples (each of the potential VSRs; firefly luciferase dsRNA)
The non-specific and specific dsRNA controls are included to monitor the 
efficiency and specificity of the dsRNA-induced silencing of the firefly luciferase 
reporter, whereas the positive VSR control is incorporated to determine whether 
the sensitivity of the assay allows detection of VSR activity.
2. For transfection of S2R+ cells in a well of a 96 well plate, combine the following 
amounts of plasmid DNA (see Notes 12 and 13):
a. 50 ng of one of the following plasmids:
1) The empty plasmid (non-specific and specific dsRNA control)
2) The plasmid that expresses a known VSR (positive VSR control)
3) A plasmid that expresses a protein which is to be tested as a VSR (test 
sample)
b. 12.5 ng of pMT-FLuc
c. 3 ng of pMT-RLuc
3. Adjust the volume to a total of 30 µl with Buffer EC.
4. Add 0.8 µl of Enhancer to condensate the DNA. Mix by vortexing for 1 sec.
5. Incubate at room temperature for 2-5 min.
6. Briefly spin down.
7. Dilute the Effectene Transfection Reagent 8x in Buffer EC and add 2.5 µl of 
the dilution to the DNA-Enhancer mixture to create condensed Effectene-DNA 
complexes. Mix by vortexing for 10 sec.
8. Incubate at room temperature for 5-10 min.
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9. Add the transfection mixture to the culture supernatant of the S2R+ cells. There 
is no need to refresh the medium prior to transfection.
10. Incubate the cells at 25°C for 48 h.
3.5. dsRNA feeding
1. Dilute the purified dsRNA preparations in culture medium to a final concentration 
of 20 ng/µl.
2. At 48 h after plasmid transfection, add 10 µl of the diluted dsRNA targeting 
either firefly luciferase (specific dsRNA control, positive VSR control and test 
samples) or GFP (non-specific dsRNA control) to the culture supernatant of the 
cells. There is no need to refresh the medium prior to dsRNA feeding (see Note 
14).
3. Incubate the cells at 25°C for 7 h.
3.6. Induction of the reporters
1. Dilute the 50 mM CuSO4 stock solution 10x in culture medium and induce 
expression of the firefly and Renilla luciferase reporters by adding 16 µl of the 
CuSO4 dilution to the culture supernatant of the cells at 7 h after dsRNA feeding.
2. Incubate the cells at 25°C for 17 h.
3.7. DLR assays
1. At 17 h after induction of the reporters, completely remove the culture 
supernatant from the cells.
2. Add 100 µl of PBS to the cells.
3. Gently swirl the culture plate.
4. Completely remove the PBS from the cells.
5. Apply 100 µl of 1x PLB to the cells.
6. Place the culture plate on a rocking platform or orbital shaker and shake gently 
at room temperature for 15 min to ensure complete lysis of the cells (see Note 
15).
7. Pre-dispense 25 µl of LAR II into the number of luminometer tubes required to 
complete the desired number of DLR assays.
8. Program a luminometer to perform a pre-measurement delay of 2 sec followed 
by a measurement period of 10 sec (see Note 16).
9. Transfer 10 µl of the cell lysate into a luminometer tube pre-dispensed with 
LAR II and mix by pipetting up and down several times (see Note 17). It is not 
necessary to clear the lysate of residual cell debris first.
10. Place the tube in the luminometer and measure the firefly luciferase reporter 
activity.
11. Remove the tube from the luminometer.
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12. Add 25 µl of Stop & Glo Reagent and mix by vortexing briefly.
13. Place the tube in the luminometer and measure the Renilla luciferase reporter 
activity.
14. Discard the tube and proceed with the next DLR assay (see Note 18).
3.8. Presentation of the data
1. To normalize the data from the DLR assays, calculate the firefly/Renilla ratio for 
each sample.
2. Determine the mean firefly/Renilla ratio as well as the standard deviation of the 
triplicates for each experimental condition.
3. Present the data in diagrams similar to those shown in Figure 2 (see Note 
19). The controls provide important information regarding the quality of the 
Fi
re
fly
 / 
R
en
ill
a 
ra
tio
 
VSR: DCV 1A CrPV 1A--
GFP Firefly luciferasedsRNA:
dsRNA feeding
0
1
Fi
re
fly
 / 
R
en
ill
a 
ra
tio
VSR: DCV 1A CrPV 1A--
GFP Firefly luciferasedsRNA:
dsRNA co-transfection
0
1
Fi
re
fly
 / 
R
en
ill
a 
ra
tio
VSR: DCV 1A CrPV 1A--
MDA5 Firefly luciferasesiRNA:
siRNA co-transfection
0
1
A B
C
Figure 2: Example of an experiment that 
demonstrates the VSR activities of DCV 1A 
and CrPV 1A. S2R+ cells were transfected with 
plasmids pMT-FLuc, pMT-RLuc, and either a 
plasmid that expresses one of the indicated 
VSRs or the corresponding empty plasmid. Firefly 
luciferase-specific or non-specific (GFP) dsRNA 
was introduced into the cells by feeding at 48 h 
after plasmid transfection (A) or by co-transfection 
with the plasmids (B). Firefly luciferase-specific or 
non-specific (MDA5) siRNAs were introduced into 
the cells by co-transfection with the plasmids (C). 
To induce expression of the firefly and Renilla 
luciferase reporters, the culture supernatant 
was supplemented with CuSO4 at 55 h after 
transfection. At 72 h after transfection, DLR assays were performed to determine the activity of the 
reporters. The firefly/Renilla ratios were calculated and the data were normalized to the non-specific 
dsRNA or siRNA controls. Error bars represent the standard deviations of three independent samples. 
DCV 1A interferes with RNAi at the level of Dicer and only suppresses RNAi if the luciferase reporter is 
silenced by dsRNA feeding after plasmid transfection. Notably, whereas DCV 1A inhibits Dicer-2 cleavage 
of dsRNA [5], the protein is unable to suppress RNAi after dsRNA transfection. Presumably, the co-
transfected dsRNA is processed into siRNAs before the VSR is expressed at sufficient levels to suppress 
Dicer-2 cleavage. CrPV 1A, which interferes with RNAi at the level of RISC, is active in all variants of the 
RNAi reporter assay.
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experiment. First, successful silencing of the firefly luciferase reporter should 
be evident from a lower firefly/Renilla ratio of the specific dsRNA control than of 
the non-specific dsRNA control (see Notes 20 and 21). Second, when compared 
to the specific dsRNA control, the positive VSR control must present a higher 
firefly/Renilla ratio (see Notes 22 and 23).
 4. Notes
1. To silence the firefly luciferase reporter, we add dsRNA to the culture 
supernatant of S2R+ cells (dsRNA feeding, or soaking). The dsRNA is taken up 
by the cells and processed by the RNAi machinery [13]. The S2 cell line is highly 
heterogeneous in morphology, growth rate, and other characteristics. Be aware 
that, due to variable passage history and culture conditions, not all sub-lines of 
the S2 cell line possess the ability to efficiently take up dsRNA from the culture 
supernatant. When using an S2 cell line other than S2R+, make sure that the 
cells are capable to do so. Different S2 cell lines might require optimization of 
the protocol. When using S2 cells that do not take up dsRNA from the culture 
supernatant, you can consider transfection of the dsRNA into the cells.
2. Phusion DNA Polymerase works very well in our hands, but any thermostable 
DNA polymerase (such as Taq) can be used to amplify the templates for in vitro 
transcription. Keep in mind that the indicated cycling conditions are optimized 
for amplification with Phusion DNA Polymerase. Use of other polymerases may 
require optimization of the PCR reaction.
3. The RiboMAX Large Scale RNA Production System-T7 is specifically designed 
to produce large amounts of in vitro transcribed RNA. However, other T7 RNA 
polymerase-based in vitro transcription methods can also be used.
4. The GenElute Mammalian Total RNA Miniprep Kit is designed to isolate total 
RNA from mammalian cells and tissues, but the kit can also be used to clean up 
RNA. Although the kit is not optimized for dsRNA, we obtain good results using 
the RNA clean up procedure of the kit. When using other commercial kits or 
methods to clean up dsRNA, verify its functionality.
5. Plasmids pMT-FLuc and pMT-RLuc are derived from vector pMT/V5-His B 
(Invitrogen).
6. We generally express our proteins of interest from vector pAc5.1/V5-His 
(Invitrogen). The Drosophila actin 5C (Ac5) promoter in this vector allows 
high-level, constitutive expression in S2 cells. In addition, the vector contains 
a C-terminal V5 epitope and a polyhistidine (6xHis) tag which can be used to 
confirm expression of the protein.
7. As a positive control, you can include a known VSR in your experiment. Essentially 
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all established VSRs can be used as a positive control when the firefly luciferase 
reporter is silenced by dsRNA feeding two days after plasmid transfection. 
However, when the reporter is silenced by co-transfection of dsRNA or siRNAs 
with the plasmids, it is important to use a VSR that interferes with RNAi at steps 
downstream of Dicer (for example, CrPV 1A, see Figure 2).
8. Instructions for preparation and storage of 1x PLB, LAR II, and the Stop & Glo 
Reagent are described in the manufacturer’s technical manual. It is important 
that all reagents and samples are at ambient temperature when performing 
the DLR assays, since the activity of the luciferase reporters is temperature 
sensitive.
9. The firefly luciferase and GFP PCRs should generate single T7-promoter-flanked 
fragments with the indicated sizes. If no products or non-specific products are 
observed on the agarose gel, optimization of the PCR reaction may be required. 
Alternatively, it might be necessary to purify the correct fragment from gel 
before continuing with in vitro transcription.
10. It is not necessary to remove the DNA template by digestion with DNase.
11. Avoid multiple freeze-thaw cycles and keep the RNA on ice whenever it is thawed 
for use.
12. Since the experiments are performed in triplicate, it is convenient to prepare a 
master mix for each experimental condition.
13. Instead of inducing RNAi by dsRNA feeding at 48 h after plasmid transfection, 
the firefly luciferase reporter can be silenced by co-transfection of dsRNA or 
siRNAs with the plasmids. For dsRNA co-transfection, add 10 ng of either firefly 
luciferase (specific dsRNA control, positive VSR control and test samples) or 
GFP (non-specific dsRNA control) dsRNA to the mixture of plasmids during the 
transfection procedure. For siRNA co-transfection, add 2 µl of a 1 µM stock 
solution to the mixture of plasmids during the transfection procedure. We 
purchase our firefly luciferase-specific and non-specific control (MDA5) siRNAs 
from Dharmacon (Lafayette, CO). When performing the dsRNA or siRNA co-
transfection variants of the assay, omit the dsRNA feeding step (see Section 
3.5.).
14. Some researchers use FCS-free culture medium during dsRNA feeding. In our 
experiments, we do not observe any difference in the efficiency of dsRNA-
mediated silencing when feeding is performed in either the presence or absence 
of FCS.
15. The cell lysates can be stored at -20°C for up to one month if you wish to continue 
with the DLR assays later. For long-term storage, the lysates should be stored 
at -80°C. Prevent multiple freeze-thaw cycles, since this can cause gradual loss 
of reporter activity.
16. Single-sample, multiple-sample, and plate-reading luminometers can be used 
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to perform the DLR assays. It is recommended that multiple-sample and plate-
reading luminometers are equipped with reagent injectors. This is not required 
for single-sample luminometers.
17. It is important not to mix by vortexing, but by pipetting up and down. Vortexing 
can create a microfilm of the luminescent solution along the sides of the tube 
which can escape mixing with the Stop & Glo Reagent in subsequent steps.
18. It is more convenient to first measure the firefly luciferase activities in all the 
samples, before measuring the Renilla luciferase activities.
19. As an alternative, you can present the data as fold silencing relative to the non-
specific dsRNA control. To calculate the fold silencing for a specific experimental 
condition, divide the mean firefly/Renilla ratio of the non-specific dsRNA control 
by that of the experimental condition.
20. If you do not observe silencing in the specific dsRNA control, make sure that the 
dsRNA preparations are of sufficient quality (see Section 3.3.). It is important to 
work under RNase-free conditions to prevent degradation of the RNA.
21. Low absolute firefly and Renilla luciferase counts may indicate a low transfection 
efficiency and may require optimization of the assay.
22. If you do not observe suppression of RNAi by either the positive VSR control 
or the test samples, confirm their expression (for example, by Western blot 
analysis).
23. When interpreting data from the RNAi reporter assay, it is important to realize 
that virtually any dsRNA-binding protein can suppress RNAi when over-
expressed [14]. Where possible, confirm the activity of an identified VSR in cells 
infected with the virus carrying the VSR.
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Abstract
R NA interference (RNAi) is a major antiviral pathway that shapes evolution of RNA viruses. We show here that Nora virus, a natural Drosophila pathogen, is both a target and suppressor of RNAi. We detected viral small 
RNAs with a signature of Dicer-2 dependent small interfering RNAs in Nora virus 
infected Drosophila. Furthermore, we demonstrate that the Nora virus VP1 protein 
contains RNAi suppressive activity in vitro and in vivo that enhances pathogenicity of 
recombinant Sindbis virus in an RNAi dependent manner. Nora virus VP1 and the viral 
suppressor of RNAi of Cricket paralysis virus (1A) antagonized Argonaute-2 (AGO2) 
Slicer activity of RNA-induced silencing complexes pre-loaded with a methylated 
single-stranded guide strand. The convergent evolution of AGO2 suppression in two 
unrelated insect RNA viruses highlights the importance of AGO2 in antiviral defense. 
Author summary
Multi-cellular organisms require a potent immune response to ensure survival under 
the ongoing assault by microbial pathogens. Co-evolution of virus and host shapes 
the genome of both pathogen and host. Using Drosophila melanogaster as a model, 
we study virus-host interactions in infections by Nora virus, a non-lethal natural 
pathogen of fruit flies. Insects depend on the RNA interference (RNAi) pathway for 
antiviral defense. A hallmark of the antiviral RNAi response is the production of viral 
small RNAs during infection. We detected Nora virus small RNAs during infection of 
Drosophila, demonstrating that Nora virus is a target of the antiviral RNAi pathway. 
Furthermore, we show that Nora virus viral protein 1 (VP1) inhibits the catalytic 
activity of Argonaute-2, a key protein of the RNAi pathway. The 1A protein of Cricket 
paralysis virus suppresses RNAi via a similar mechanism. Importantly, whereas Nora 
virus persistently infects Drosophila, Cricket paralysis virus induces a lethal infection. 
Our findings thus indicate that two distantly related viruses independently evolved 
an RNAi suppressor protein that targets the Argonaute-2 protein. Altogether, our 
results emphasize the critical role of Argonaute-2 in insect antiviral defense, both in 
lethal and persistent infections.
55
3
Argonaute-2 Slicer antagonism in two distinct insect RNA viruses
Introduction
An efficient antiviral immune response is essential for the control or elimination of 
virus infection and for survival of the infected host. The immune system exerts a 
strong evolutionary pressure that shapes the genetic makeup of viral pathogens. 
Indeed, viruses evolved counter-defense mechanisms to evade, suppress or 
inactivate host immunity. Studying these mechanisms provides important insight 
in the critical steps of antiviral responses and may uncover novel components and 
regulators of immune pathways. 
Plants, fungi, and invertebrate animals rely on the RNA interference (RNAi) pathway 
for antiviral defense [1,2]. The initial trigger of an antiviral RNAi response is the 
recognition and cleavage of viral double-stranded RNA (dsRNA) into viral small 
interfering RNAs (vsiRNAs), in insects by the ribonuclease Dicer-2 (Dcr-2). These 
vsiRNAs act as specificity determinants of the Argonaute-2 (AGO2) containing 
effector nuclease complex RISC (RNA-induced silencing complex). RISC maturation 
involves a number of sequential steps: loading of the vsiRNA into AGO2, cleavage 
and elimination of the passenger RNA strand, and 2'-O-methylation of the 
3’-terminal nucleotide of the retained guide strand. It is thought that vsiRNA-loaded 
RISC subsequently cleaves viral target RNA (Slicer activity). The hypersensitivity to 
viral infections of AGO2 mutant flies and of AGO2 knockdown mosquitoes provides 
genetic support for this hypothesis [3-7]. Nevertheless, direct evidence supporting 
this model, for example by the detection of viral Slicer products, is lacking. 
The evolution of viral suppressors of RNAi (VSRs) is a testament to the antiviral 
potential of the RNAi pathway in plants and insects. Given the central role of dsRNA 
and siRNAs as initiators and specificity determinants of the RNAi pathway, it is not 
surprising that many VSRs sequester dsRNA. For instance, the Drosophila C virus 
(DCV) 1A protein binds long dsRNA and shields it from processing by Dcr-2 [6]. Flock 
House virus (FHV) B2 displays a dual RNA binding activity: it binds long dsRNA as well 
as siRNAs, thereby preventing their incorporation into RISC [8-10]. Similarly, many 
plant VSRs display dsRNA binding activities, leading to the hypothesis that dsRNA or 
siRNA binding is a general mechanism for RNAi suppression [11,12]. Nevertheless, 
other mechanisms have been reported [1]. The RNAi suppressive activity of the 
Cricket paralysis virus (CrPV) 1A protein, for example, relies on a direct interaction 
with AGO2 [13].
VSRs have been identified in dozens of plant viruses from all major virus families 
[1]. In contrast, VSRs have thus far been identified in only three insect RNA viruses 
(FHV, CrPV, and DCV). These VSRs were characterized using genetic and biochemical 
approaches in the model organism Drosophila melanogaster. While these viruses 
indeed efficiently infect Drosophila laboratory stocks and cell lines, DCV is the only 
natural Drosophila pathogen among these three viruses [14,15]. Although FHV and 
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CrPV have a remarkable broad host range in the laboratory, they were originally 
isolated from non-Drosophilid host species: the New Zealand grass grub (Costelytra 
zealandica) and field crickets (Teleogryllus oceanicus and T. commodus), respectively 
[16-19]. 
Since viral counter-defense mechanisms co-evolve with the antiviral immune 
responses of the host species, it is essential to characterize a VSR within the correct 
evolutionary context. We therefore set out to identify an RNAi suppressor in Nora 
virus, a positive sense (+) RNA virus that persistently infects Drosophila laboratory 
stocks as well as Drosophila in the wild [20] (D.J. Obbard, personal communication). 
The genome organization and phylogeny suggest that Nora virus is the type member 
of a novel virus family within the order of Picornavirales [20]. Here we show that 
Nora virus VP1, the protein product of open reading frame 1 (ORF1), suppresses 
RNAi in cell culture as well as in flies. In accordance, VP1 is an RNAi-dependent viral 
pathogenicity factor. In a series of biochemical assays, we show that both Nora virus 
VP1 as well as CrPV 1A inhibit Slicer activity of a pre-assembled RISC loaded with a 
methylated guide strand. The lack of amino acid sequence similarity between CrPV 
1A and Nora virus VP1 suggests that their Slicer antagonistic activities resulted from 
convergent evolution, providing direct support for the critical role of AGO2 Slicer 
activity in antiviral defense. 
Results
Nora virus is a target of RNAi in vivo
Nora virus is an enteric (+) RNA virus that successfully establishes a persistent 
infection in flies [20]. The mechanism by which this virus establishes persistent 
infections is unknown. To determine whether Nora virus is a target for Dcr-2, we 
analyzed the presence of Nora virus small RNAs in the w1118 Drosophila strain that is 
widely used as a recipient strain for transgenesis. We isolated and sequenced 19-
29 nt small RNAs from body (abdomen and thorax), thorax and head of adult w1118 
flies. Sequence reads that perfectly matched the Drosophila genome were annotated 
and discarded. Of the remaining reads, 396.646 (7,8%, body), 237.265 (10,6%, 
thorax), and 1.099.496 (7,7%, head) matched the published Nora virus sequence 
(NC_007919.3), indicating that the w1118 strain was infected by Nora virus (Table 1). As 
RNA viruses rapidly evolve, viral small RNA sequences may have been missed in this 
initial matching step. We therefore reconstituted the Nora virus genome through 
an iterative alignment/consensus treatment of the viral small RNA sequences in our 
libraries [21]. The reconstituted Nora virus genome (rNora virus) differed at only 
3.2% of the nucleotides from the published genome sequence. Aligning small RNAs 
to the rNora virus genome instead of the published Nora virus sequence resulted 
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in an increased number of viral reads in the three libraries (~121%, Table 1). We 
therefore used the reconstituted genome as a reference genome in further analyses. 
In all three libraries, Nora virus-derived small RNAs were predominantly 21-nt long, 
the typical size of Dicer-2 products. The size distribution of small RNAs derived from 
the (+) RNA strand, however, were noticeably wider than those derived from the (-) 
RNA strand (Figure 1A). For 21-nt viral RNA reads, there was only a slight bias towards 
(+) small RNAs (ratio (+) RNA / total RNA ~0.58), whereas small RNAs of other sizes 
were predominantly derived from the (+) strand (Figure 1B). In all three libraries, the 
21-nt Nora virus-derived RNAs are distributed across the genome, covering both the 
(+) and (-) viral RNA strands with approximately equal numbers (Figure 1C). These 
data suggest that dsRNA replication intermediates of Nora virus are processed into 
21-nt long siRNAs. The origin of the other size classes of viral small RNAs remains 
unclear. However, as the predominance of (+) over (–) small RNA reads is reminiscent 
of the excess of (+) over (-) viral (full-length) RNA that is typically observed in (+) RNA 
virus infection, they may be due to non-specific RNA degradation. 
Drosophila Dcr-2 generates 21-nt duplex siRNAs in which 19 nucleotides are base-
paired leaving a 2-nt 3’ overhang at each end. For each library, we collected the 21-nt 
RNA reads whose 5’ ends overlapped with another 21-nt RNA read on the opposite 
strand of the Nora virus genome. Then, for each possible overlap of 1 to 21-nt, the 
numbers of read pairs were counted and converted into Z-scores (Figure 1D). This 
analysis revealed that 21-nt Nora virus-derived RNAs in body and thorax libraries 
tend to overlap by 19-nt, which is a typical feature of siRNA duplex precursors. This 
siRNA duplex signature was observed to a lesser extent in head libraries. Very little 
Nora virus RNA can be detected in the head [22], yet vsiRNA levels were similar 
in head, thorax, and body (Table 1). The origin of the vsiRNAs in the head and 
the reason for the less pronounced vsiRNA signature of those small RNAs remain 
unclear. Altogether, our results strongly suggest that Nora virus double-stranded 
replication intermediates are processed by Dcr-2 into vsiRNAs that trigger an RNAi 
response in infected flies.
Table 1: Annotation of small RNA sequences in libraries from body (abdomen and thorax), thorax, and 
head of Nora virus infected w1118 adult flies.
Body Thorax Head
Total library 18.296.275 17.280.520 49.633.458
Match to D. melanogaster* 13.184.119 15.033.831 35.435.546
Unmatched* 5.112.156 2.246.689 14.197.912
Nora virus (NC_007919.3)* 396.646 237.265 1.099.496
Nora virus (reconstituted)* 479.572 291.045 1.329.336
*The number of reads matching the Drosophila genome, reads that fail to map to the Drosophila genome 
(unmatched), and reads mapping to the Nora virus genome (isolate Umea 2007) and the reconstituted 
Nora virus genome are indicated for each library.
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Nora virus VP1 suppresses RNAi in vitro
Our small RNA profiles indicate that Nora virus is targeted by Dcr-2. Nevertheless, 
the virus efficiently establishes a persistent infection, suggesting that it is able to 
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Figure 1: Nora virus is targeted by RNAi in adult flies. (A) Size distribution of Nora virus-derived small 
RNAs in libraries from thoraxes, bodies and heads of w1118 flies. Read counts of small RNAs matching the 
(+) and (-) viral RNA strands are in gray and black, respectively. (B) Proportion of (+) Nora virus small RNA 
reads of total viral reads. Frequencies were computed from the distributions in panel A for each size 
class. (C) Viral siRNA distribution across the viral genome. The abundance of 21-nt small RNAs matching 
the (+) and (-) viral RNA strands of the reconstituted Nora virus (rNora) reference genome is shown in 
gray and black, respectively. (D) Z-scores for the number of overlapping pairs of sense and antisense 
21-nt Nora virus small RNAs matching the rNora virus reference genome. For each possible overlap of 1 
to 21-nt, the number of read pairs was counted and converted into a Z-score.
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evade or suppress the antiviral RNAi response. The Nora virus genome contains 
four open reading frames (ORFs) (Figure 2A). Nora virus ORF2 is predicted to encode 
the helicase, protease, and polymerase domains that together form a picornavirus-
like replication cassette. ORF4 encodes three proteins that make up the Nora virus 
capsid (VP4A, VP4B, and VP4C) [23]. To determine whether the Nora virus genome 
encodes an RNAi suppressor, we analyzed the four ORFs in an RNAi sensor assay 
in Drosophila cell culture (Figure 2B-2D). In this assay, S2 cells are transfected with 
firefly (FLuc) and Renilla luciferase (RLuc) reporter plasmids and a plasmid that 
expresses one of the four viral ORFs. Subsequently, FLuc expression is silenced using 
specific dsRNA, and FLuc and RLuc activity is monitored. As expected, DCV 1A, a well 
characterized VSR that binds long dsRNA, efficiently suppressed RNAi, whereas the 
inactive DCV 1A K73A mutant was unable to do so (Figure 2C and [6]). Cotransfection 
of the ORF1 expression plasmid also resulted in de-repression of FLuc, suggesting 
that VP1, the protein product of ORF1, is a suppressor of RNAi. Expression of ORF3 
and ORF4 did not affect FLuc activity (Figure 2C). However, since expression of ORF2 
and the production of mature capsid proteins from ORF4 were not detectable on 
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Figure 2: Nora virus VP1 
suppresses RNAi in vitro (A) 
Schematic representation of 
the Nora virus genome with its 
four predicted ORFs in three 
different reading frames. There 
is a 7-nt overlap between ORF1 
and ORF2 and a 26-nt overlap 
between ORF2 with ORF3. 
An intergenic region of 85 nt 
separates ORF3 and ORF4. 
(B) Western blot analysis of 
V5-epitope tagged Nora virus 
expression constructs. Two 
days after transfection of the 
indicated plasmids into S2 cells, 
expression of the constructs was 
analyzed by Western blot using 
the V5 antibody (αV5). Asterisks 
(*) indicate additional bands that do not correspond to the expected size of the full-length protein 
product. (C) RNAi reporter assay in Drosophila S2 cells. Copper-inducible plasmids encoding FLuc and 
RLuc were transfected into S2 cells together with a construct expressing Nora virus ORF1, 3, and 4, 
encoding viral protein 1 (VP1), VP3, and VP4, respectively. Two days after transfection, dsRNA targeting 
FLuc or GFP (Ctrl) was added to the medium. Seven hours later, expression of FLuc and RLuc was 
induced and luciferase activity was measured the next day. FLuc counts were normalized to RLuc counts 
and presented as fold silencing relative to the control GFP dsRNA. Plasmids encoding DCV 1A and the 
K73A mutant (DCV 1A mut) were used as controls. (D) siRNA-based RNAi reporter assay. The experiment 
was performed as described in panel C, but 21-nt FLuc siRNAs were cotransfected with the reporter 
plasmids to silence gene expression. An siRNA targeting the human MDA5 gene was used as a non-
silencing control (Ctrl). Bars in panel C represent averages and standard deviations of five independent 
samples; bars in panel D represent averages and standard deviations of three independent samples. 
Panel C and D are representative for two and three independent experiments, respectively.
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western blot, we cannot exclude the possibility that these protein products are able 
to suppress RNAi as well (Figure 2B). 
Next, we tested whether VP1 inhibits the production of siRNAs by Dcr-2 or a 
subsequent step in the RNAi pathway. To this end, we repeated the RNAi sensor 
assay using a synthetic siRNA that does not require Dcr-2 cleavage for its silencing 
activity. Also under these conditions, Nora virus VP1 suppressed silencing of the 
FLuc reporter. Furthermore, VP1 suppressed RNAi to a similar extent as CrPV 1A, 
which was previously shown to suppress the effector stage of the RNAi machinery 
[13] (Figure 2D).
In Drosophila, the microRNA (miRNA) and siRNA pathways are separate processes, 
with Dcr-1 and AGO1 dedicated to the miRNA pathway and Dcr-2 and AGO2 to the 
siRNA pathway. Nevertheless, crosstalk between the miRNA and RNAi pathways 
occurs. Using miRNA sensor assays in S2 cells, in which FLuc expression is silenced 
by endogenous miRNAs or co-expressed primary miRNAs, we observed that VP1 
does not suppress miRNA activity (Text S1 and Figure S1). Together, these data 
indicate that VP1 is able to suppress the RNAi, but not the miRNA pathway, at a step 
after dsRNA processing by Dcr-2.
The C-terminus of VP1 is essential for its suppressor activity
VP1 is highly conserved among different Nora virus isolates (Figure S2). We were 
unable to predict a protein domain in VP1 suggestive of a mechanism of action. 
Furthermore, we did not obtain a significant alignment to any other protein from 
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Figure 3: The C-terminus of 
Nora virus VP1 is essential for 
RNAi suppressor activity (A) 
Schematic presentation of full-
length (FL) and N- and C-terminal 
deletion mutants (ΔN and ΔC) of 
VP1. (B,C) Western blot analysis 
of VP1 expression constructs. 
V5 epitope tagged expression 
constructs were transfected into 
Drosophila S2 cells and expression 
of VP1FL and the deletion mutants 
was analyzed by Western blot 
using a V5 antibody (αV5). (D) 
RNAi reporter assay in S2 cells. 
The experiment was performed as 
described in the legend to Figure 
2D, using plasmids encoding either 
CrPV 1A, VP1FL or the VP1 deletion 
mutants. Bars represent averages 
and standard deviations of three 
independent samples. The graph is 
representative for two independent 
experiments.
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the non-redundant protein sequence database. To map the VSR region of VP1, we 
generated a series of N- and C-terminal (ΔN and ΔC) truncations and tested them 
in the RNAi reporter assay in S2 cells (Figures 3A and S3). With the exception of the 
VP1ΔN390 and VP1ΔN418 mutants, in which no protein could be detected on Western 
blot, all VP1ΔN and VP1ΔC constructs produced proteins of the expected size (Figure 
3B, C). Deletion of 74 amino acids (aa) or more from the C-terminus of VP1 resulted 
in loss of suppressor activity (Figure 3D). This suggests that the active domain of VP1 
resides in its C-terminal region. Indeed, deleting up to 351 aa from the N-terminus 
(VP1ΔN351), out of a total of 475 aa, did not affect VSR activity. These results show that 
VP1 FLC
VP1∆C74D
GFPE
CrPV 1AF
AGO2321/321B
AGO2321/+A
thRNAi
Figure 4: VP1 suppresses RNAi in vivo. (A-F) RNAi of Drosophila Inhibitor of Apoptosis1 / thread (th) 
in the eye of adult flies in the indicated genetic background or in the presence of several transgene 
constructs. RNAi-mediated knockdown of th results in a reduced size and pigmentation of the eye and 
roughening of the eye surface in AGO2321 heterozygotes (A), but not in AGO2321 homozygotes (B). Eye 
phenotype of transgenic flies co-expressing the thRNAi construct and Nora virus full-length VP1 (VP1 FL, 
C), a C-terminal deletion mutant of VP1 (VP1ΔC74, D), GFP (E) or CrPV 1A (F). Maximum silencing of th was 
examined in the presence of the GFP control transgene (E). For each line, five representative pictures of 
eyes of two- to four-day-old male flies are presented. Pictures are representative for three independent 
experiments.
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the RNAi suppressor activity of VP1 maps to the C-terminal 124 aa.
VP1 is an RNAi suppressor in vivo
We next evaluated the VSR activity of Nora virus VP1 in vivo using transgenic flies in 
which thread (th), also known as Drosophila inhibitor of apoptosis 1, can be silenced 
by expression of dsRNA targeting this gene (thRNAi [24,25]) (Figure 4). Eye-specific 
expression of thRNAi using the GMR-GAL4 driver leads to severe apoptosis in the 
developing eye. As a consequence, thRNAi flies display a reduced eye size, loss of eye 
pigmentation, and roughening of the eye surface (Figure 4A, results are shown for 
AGO2321 heterozygotes; thRNAi in a wildtype background shows the same phenotype, 
data not shown and [25]). Silencing of th in the eye of thRNAi flies is fully dependent on 
the RNAi pathway, since the phenotype is lost in an AGO2 null mutant background 
(Figure 4B). These results indicate that the thRNAi sensor fly is a robust system to 
monitor RNAi activity in vivo. 
Consistent with its RNAi suppressive activity in cell culture, expression of full-length 
VP1 (VP1FL) in thRNAi flies resulted in eyes with a normal size and a rescue of the rough 
eye phenotype (Figure 4C). The phenotype of thRNAi flies expressing the VP1ΔC74 mutant 
was similar to that of flies expressing GFP as a negative control, confirming that this 
mutant is functionally inactive (Figure 4D, E). Notably, while VP1 only partially rescued 
the RNAi-dependent phenotype, CrPV 1A fully reverted the thRNAi-induced phenotype 
(Figure 4F). Whether this difference is due to a more robust RNAi suppressive activity 
of CrPV 1A or to a difference in expression level remains to be established.
VP1 enhances viral pathogenicity in vivo 
Having established that VP1 displays RNAi suppressive activity in vitro and in vivo, we 
next analyzed the effect of VP1 on viral pathogenicity in adult flies. To this end, we 
generated recombinant Sindbis virus (SINV) expressing the functional VP1ΔN351 (SINV-
VP1) or GFP (SINV-GFP) from a second subgenomic promoter (Figure 5A). Although 
arboviruses are a target of the RNAi pathway during infection in insects [3,5,26], we 
and others have not detected VSR activity in infections with SINV and the related 
alphavirus Semliki Forest virus [27,28] (data not shown). Indeed, SINV recombinants 
expressing the viral RNAi suppressors FHV B2 and CrPV 1A were significantly more 
pathogenic than their controls in mosquitoes and Drosophila, respectively [13,28]. 
We injected wildtype w1118 flies with the SINV recombinants and monitored survival 
over time. SINV-GFP (and the parental SINV virus, data not shown) induced only 
modest mortality in these flies with a fully functional RNAi response. After 36 days 
of infection, 73% of the SINV-GFP infected flies and all mock infected flies were still 
alive. In contrast, SINV-VP1 infection resulted in more severe mortality. SINV-VP1 
infected flies died faster and only 9% of the flies survived the 36-days follow up period 
(Figure 5B). Although these results indicate that VP1 enhances viral pathogenicity, 
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they fail to show that this effect depends on its VSR activity. Viral proteins are often 
multifunctional and the effect of VP1 on the course of infection might be attributed to 
another, as yet unknown, activity of VP1. We therefore performed recombinant SINV 
infections in RNAi deficient Dcr-2 mutant flies. In this genetic background, an RNAi 
suppressor is not expected to enhance pathogenicity of the virus. Upon infection 
with SINV-GFP, the Dcr-2 mutants died much faster than wild-type flies, confirming 
that SINV is indeed a target of the RNAi pathway. In contrast to infections in RNAi 
competent flies, the course of infection of SINV-VP1 and SINV-GFP was remarkably 
similar in Dcr-2 mutants, with 100% mortality at 22 days after infection in both cases 
(Figure 5C). We therefore conclude that VP1 enhances virulence of an RNA virus in 
vivo through its RNAi suppressive activity. 
Nora virus VP1 interferes with the effector phase of RNAi
To further characterize the VSR activity of Nora virus VP1, we next analyzed the 
activity of VP1 in a series of biochemical assays that monitor individual steps of 
the RNAi pathway. To this end, we fused the active VP1ΔN284 mutant to the maltose 
binding protein (MBP-VP1) and purified it from Escherichia coli. We verified that 
MBP-VP1 fusion proteins are fully functional in VSR assays in S2 cells to exclude the 
possibility that MBP interferes with VP1 VSR activity (data not shown). 
The ability of VP1 to suppress siRNA-initiated RNAi in S2 cells (Figure 2D) suggests 
A
non-structural structural
sg1
SINV
non-structural structural VSR
sg1 sg2
Recombinant SINV
B Wildtype w1118 
0 10 20 30 40
0
20
40
60
80
100
Mock
Sindbis-V5-VP1∆N351
Sindbis-GFP
Time (days)
S
ur
vi
va
l (
%
)
Dcr-2L811fsX
0 10 20 30 40
0
20
40
60
80
100
Time (days)
S
ur
vi
va
l (
%
)
C
Figure 5: VP1 enhances viral pathogenicity via its 
RNAi suppressive activity. (A) Schematic representation 
of Sindbis virus (SINV) and SINV recombinant containing 
a duplicated subgenomic promoter (sg1 and sg2) driving 
expression of a viral suppressor of RNAi (VSR). (B and C) 
Survival curves of w1118 wildtype flies (B) and Dcr-2L811fsX 
mutants (C) infected with SINV recombinants expressing 
either GFP (black diamond) or VP1ΔN351 (gray triangle), 
or mock infected (black square). Survival curves are 
representative of two independent experiments.
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that VP1 inhibits a step downstream of siRNA production by Dcr-2. In accordance, 
recombinant VP1 was unable to bind long dsRNA in gel mobility shift assays and 
could not interfere with Dcr-2 mediated processing of long dsRNA into siRNAs in S2 
cell extract (Figure S4A, B). We next analyzed whether VP1 is able to bind siRNAs in 
a gel mobility shift assay. As a positive control, we used a fusion protein of MBP and 
the Rice hoja blanca virus non-structural protein 3 (NS3), which binds duplex siRNAs 
with high affinity [29]. Whereas NS3 efficiently bound siRNAs in our assays, we were 
unable to observe a shift in mobility of siRNAs after incubation with VP1, even at the 
highest concentrations used (Figure 6A). 
Since VP1 is incapable of interfering with the initiator phase of the RNAi pathway, 
we next examined the effect of VP1 on the effector phase of RNAi. For this purpose, 
we used an in vitro RNA cleavage assay (Slicer assay) in Drosophila embryo extract 
[30], in which a sequence-specific siRNA triggers cleavage of a target RNA. Since 
the 5’ cap of the target RNA is radioactively labeled, the 5’ cleavage product can be 
visualized by autoradiography after separation on a denaturing polyacrylamide gel. 
Indeed, a cleavage product of the expected size was detected if embryo extract was 
incubated with a target RNA and a specific siRNA. Specific cleavage products were 
not generated in the presence of a non-specific control siRNA (Figure 6B, lanes 1 
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Figure 6: (A) Mobility shift assays for binding of viral RNAi suppressor proteins to siRNAs. Radiolabeled 
siRNAs were incubated in buffer (lane 1) or with decreasing amounts of recombinant MBP-VP1ΔN284 
(lanes 2-5), MBP (lanes 6-9), and MBP-NS3 (lane 10-13). Ten-fold dilutions were used, starting at 2 µM 
for MBP-VP1ΔN284 (lane 2) and 2.6 µM for MBP (lane 6). MBP-NS3 was tested in two-fold dilutions (highest 
concentration of 8 µM, lane 10). RNA mobility shifts were analyzed on an 8% native polyacrylamide gel. 
(B) RISC Slicer assay in Drosophila embryo lysate. Lysates were incubated with non-targeting control 
siRNA (Ctrl, lane 1) or with FLuc siRNA (lanes 2-4) in the absence (lane 2) or presence of recombinant 
MBP-VP1ΔN284 (lane 3) or MBP (lane 4). RISC cleavage products were analyzed on an 8 % denaturing 
polyacrylamide gel. Slicer assay is representative for two independent experiments.
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and 2). Recombinant VP1 protein, but not control MBP protein, efficiently inhibited 
the production of cleavage product (Figure 6B, lanes 3 and 4). We note, however, 
that a minor fraction of the target RNA is still cleaved in the presence of VP1 (Figure 
6B, lane 3). Together, these experiments show that VP1 does not affect the initiator 
phase of the RNAi pathway, but interferes with RISC activity.  
Nora virus VP1 inhibits RISC activity of pre-assembled mature RISC
To discriminate between RISC assembly and target RNA cleavage by a pre-assembled 
RISC complex, we performed Slicer assays under two experimental conditions (Figure 
7A). In the first approach, a purified suppressor protein is added 30 minutes before 
the siRNA, which allows us to analyze the effect of the VSR on both RISC loading 
and target cleavage. In the second approach, the embryo extract is incubated with 
siRNAs for 30 minutes before addition of recombinant protein. This second protocol 
allows a mature RISC to form prior to the addition of a VSR, thereby allowing us to 
assess the effect of the VSR on slicing only. As CrPV 1A was previously shown to 
affect the effector phase of the RNAi pathway [13], we generated recombinant GST-
CrPV 1A as well as control GST. These proteins were included in our assays. 
Using the first protocol, cleavage of the target RNA was suppressed by VP1 (Figure 
7B, lane 3). Strikingly, VP1 was also able to inhibit target cleavage when added to 
an embryo lysate containing pre-loaded RISC (Figure 7B, lane 7). The observed 
suppression of slicing was VP1 specific, since MBP alone did not inhibit RNA cleavage 
(lane 4 and 8). Recombinant CrPV 1A also suppressed slicing in both experimental 
procedures (Figure 7B, lanes 5 and 9). 
To determine if VP1 affects the protein stability of AGO2, we incubated the 
recombinant proteins in Drosophila embryo extract and analyzed endogenous AGO2 
protein levels by Western blot. Neither VP1 nor CrPV 1A affected AGO2 protein levels 
in embryo lysate, indicating that these two proteins do not mediate RNAi suppression 
through degradation of AGO2 (Figure 7C).   
To further confirm the inhibitory effect of VP1 on Slicer activity rather than RISC 
assembly, we performed Slicer assays using different siRNA guides. During RISC 
maturation, guide strands in AGO2 are 2’-O-methylated at their 3’ terminal nucleotide 
by the Drosophila methyltransferase Hen1 [31]. This modification protects AGO2 
associated siRNAs from degradation by trimming and tailing events that occur when 
there is extensive base-pairing of the guide RNA with a target RNA [32]. To overcome 
a requirement for Hen1, an siRNA bearing a 2’-O-methylated 3’-terminal nucleotide 
on the guide strand was used in Slicer assays. Similar to the non-methylated siRNA, 
the methylated siRNA produced a specific cleavage product of the expected size 
(Figure 7D, lane 2). Both Nora virus VP1 and CrPV 1A inhibited the cleavage activity 
of RISC that was pre-loaded with the methylated siRNA (Figure 7D, lane 3 and 5). 
Again, the GST and MBP control proteins were unable to affect Slicer activity (Figure 
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Figure 7: VP1 inhibits Slicer activity of pre-assembled mature RISC. (A) Schematic overview of the 
two experimental conditions of the Slicer assay designed to monitor the effect of recombinant (rec.) 
proteins on RISC assembly and Slicer activity (top) or on Slicer activity of pre-assembled RISC (bottom) (B) 
Slicer assays in Drosophila embryo lysates. RISC activity was analyzed in the presence of a non-targeting 
control siRNA (lane 1) or a specific FLuc siRNA (lane 2-10). Recombinant proteins were added before 
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7D, lane 4 and 6).
After loading of the siRNA as a duplex, AGO2 cleaves the passenger strand which is 
then degraded by the C3PO nuclease complex [33]. To circumvent canonical loading 
of RISC, we induced RISC formation with a single-stranded methylated guide RNA. 
Although less efficient, loading of single-stranded guide strands into AGO2 is possible 
via a bypass mechanism [34,35]. Indeed, at high concentrations, methylated single-
stranded guide RNA-induced specific cleavage of cap-labeled target RNA (Figure 
7E, lane 2). Interestingly, single-stranded guide RNA-induced target cleavage was 
specifically inhibited both by Nora virus VP1 and by CrPV 1A (Figure 7E, lanes 3 and 
5). These results indicate that both CrPV 1A and Nora virus VP1 inhibit Slicer activity 
of mature RISC rather than RISC assembly. 
Following maturation, RISC binds, cleaves, and releases complementary target 
RNA, and returns to a Slicer-competent state. Drosophila RISC is a multiple turnover 
complex, in which release of the cleaved target RNA is a rate-limiting step that is 
greatly enhanced by ATP [36]. We therefore analyzed suppression of Slicer activity 
under ATP-limiting conditions with a 20-fold molar excess of siRNA over target RNA. 
RISC was loaded in the presence of ATP, after which creatine kinase was inactivated 
by NEM, and ATP was depleted (-ATP) by addition of hexokinase and glucose (Figure 
S5). In parallel, ATP levels were restored (+ATP) after NEM treatment by adding back 
creatine kinase, and omitting hexokinase treatment. As expected, RISC shows a 
lower cleavage rate in –ATP conditions than in +ATP conditions (Figure 7F, compare 
lanes 3 and 5 with lanes 8 and 10). Even under –ATP conditions, Nora virus VP1 and 
CrPV 1A were able to inhibit Slicer activity (Figure 7F, lanes 2 and 4), suggesting that 
these two VSRs inhibit the catalytic target cleavage by AGO2.   
(lanes 3-6) or after (lanes 7-10) assembly of RISC as indicated. As a control for possible buffer effects, 
recombinant protein was substituted by protein storage buffer (lanes 1 and 2).  (C) Western blot showing 
the endogenous AGO2 protein levels in embryo lysate after incubation for 2 hours with the indicated 
recombinant proteins.  The blot was developed with AGO2 antibody 4D2. (D) Slicer assay using an siRNA 
with a 2’-O-methylated guide strand. A non-modified control siRNA (lane 1) or a FLuc siRNA duplex 
containing a 2’-O-methyl group at the 3’ terminal nucleotide of the guide strand (lanes 2-6) was added 
to embryo lysate 30 minutes prior to the addition of the indicated recombinant proteins. (E) Slicer assay 
using a 2’-O-methylated simplex guide RNA. A control siRNA duplex (lane 1) or a single-stranded FLuc 
specific guide strand with a 2’-O-methyl group at the 3’ terminal nucleotide (lane 2-6) was added prior 
to the addition of the indicated recombinant proteins. (F) Slicer assays in the presence or absence of 
ATP. Embryo lysate was incubated with a control siRNA (lanes 1 and 6) or a specific FLuc siRNA (lanes 2-5 
and 7-10). ATP was then depleted (lanes 1-5) or depleted and subsequently regenerated (lanes 6-10) 
and Slicer activity was monitored. An asterisk (*) indicates a non-specific band appearing in RISC assays 
under ATP depleted conditions.
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Discussion
The mechanisms by which RNA viruses evade sterilizing immunity and establish 
chronic persistent infections remain poorly understood [37]. Nora virus successfully 
establishes a persistent infection in Drosophila, providing an excellent model to 
study mechanisms of persistence. We show here that Nora virus is a target of the 
antiviral RNAi machinery and that it encodes a potent suppressor of RNAi. Of note, 
Nora virus RNA levels are unaffected by mutations in the RNAi pathway [38]. These 
observations therefore suggest that dynamic interactions between the antiviral 
RNAi response and viral counter-defense mechanisms determine viral persistence. 
The production of viral siRNAs is a hallmark of an antiviral RNAi response. By detection 
of Nora virus-derived vsiRNAs in infected fly stocks, we provide direct evidence that 
Nora virus is a target of Dcr-2. Nora virus vsiRNAs are distributed across the viral 
genome, with similar amounts derived from the (+) and (-) RNA strands. During (+) 
RNA virus infection, (+) viral RNA accumulates in large excess over (-) viral RNA (~50-
100 fold). Cleavage of structured RNA elements by Dcr-2 is therefore expected to 
produce viral small RNAs that mirror this asymmetric distribution. Thus, similar to 
other RNA viruses, our results imply that Dcr-2 targets the dsRNA intermediates in 
Nora virus replication [2,4,39-41]. 
The current model proposes that the antiviral RNAi response relies on dicing of viral 
dsRNA and on slicing of viral target RNAs using vsiRNAs as a guide. Genetic analyses 
support the role of AGO2 in antiviral defense: AGO2 mutants are hypersensitive to a 
number of RNA virus infections [3-7,42]. Yet, interpretation of this AGO2 phenotype 
is complicated by other cellular functions of AGO2, such as regulation of cellular 
gene transcription and control of transposon activity [43-45]. An alternative model 
proposes that dicing of double-stranded replication intermediates plays an important 
role in latent virus infection [46]. Dicing of an essential replication intermediate by 
Dicer-2 should theoretically be sufficient to abort a productive virus replication 
cycle. The convergent evolution of VSRs that suppress the catalytic activity of AGO2 
in two distantly related RNA viruses, Nora virus and CrPV, underlines the essential 
role of AGO2 Slicer activity in antiviral defense, also in persistent infections in vivo. 
Importantly, these two viruses display a strikingly different course of infection – CrPV 
causes a lethal infection, whereas Nora virus establishes a non-lethal, persistent 
infection – suggesting that the interaction between a VSR and the host RNAi 
machinery is not the main determinant for viral pathogenicity. 
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Materials and Methods
Small RNA sequencing and analysis
Total RNA was extracted from dissected heads, bodies (abdomens and thoraxes) 
and thoraxes from w1118 male flies using Trizol reagent (Invitrogen), and RNA quality 
was verified on a Bioanalyzer (Agilent). Small RNAs were then cloned using the DGE-
Small RNA Sample Prep Kit and the Small RNA v1.5 Sample Preparation Kit (Illumina) 
following the manufacturer’s instructions. Libraries were sequenced on the Illumina 
HiSeq platform. 
Sequence reads were clipped from 3’ adapters using fastx_clipper (http://
hannonlab.cshl.edu/fastx_toolkit/). Reads in which the adapter sequence 
(CTGTAGGCACCATCAATCGT) could not be detected were discarded. Only the clipped 
19-30 nt reads were retained. Sequence reads were first matched against the 
Drosophila genome (v5.37) using Bowtie (http://bowtie-bio.sourceforge.net/index.
shtml). Reads not matching the Drosophila genome were then matched against the 
published Nora virus sequence (NC_007919.3, isolate Umeå 2007), allowing one 
mismatch during alignment. Viral small RNAs were then used to reconstitute a small 
RNA-based consensus genome sequence (rNora virus, JX220408) using Paparazzi 
[21] with NC_007919.3 as a starting viral reference genome. Distributions of Nora 
virus small RNA sizes were computed by parsing the Bowtie outputs with a python 
script (available upon request). Small RNA profiles were generated by collecting the 
21-nt reads that matched the rNora virus sequence allowing one mismatch, and 
their frequency relative to their 5’ position in the rNora virus (+) or (-) genomic strand 
was plotted in R. siRNA duplex signatures were calculated according to an algorithm 
developed to calculate overlap in piRNA sequence reads [47,48]. The distribution of 
siRNA overlaps was computed by collecting the 21-nt rNora virus RNA reads whose 5’ 
ends overlapped with another 21-nt read on the opposite strand. For each possible 
overlap of 1 to 21 nt (i), the number of read pairs (O) was counted and converted 
to a Z-score with the formula Z(i) = (O(i)-mean(O))/standard deviation (O). Small 
RNA sequences were deposited to the Sequence Read Archive (SRA) at the National 
Center for Biotechnology Information (NCBI) under accession number SRA054241.
Cell culture and viruses
Drosophila S2 cells were cultured at 25°C in Schneider's medium (Invitrogen) 
supplemented with 10% heat inactivated fetal calf serum, 50 U/mL penicillin, and 
50 µg/mL streptomycin (Invitrogen). DCV was cultured and titered on S2 cells as 
described previously [6]. For the production of recombinant SINV, the coding 
sequence of either GFP or the N-terminal V5 epitope tagged VP1ΔN351 was cloned 
into the XbaI site of the double subgenomic pTE3’2J vector [49]. The resulting 
plasmids were linearized by XhoI restriction, purified and used as template for in 
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vitro transcription using the mMESSAGE mMACHINE SP6 High Yield Capped RNA 
Transcription kit (Ambion). In vitro transcribed RNA was purified using the RNeasy 
kit (Qiagen) and transfected into BHK cells. Viral titers in the supernatant were 
determined by plaque assay on BHK cells.
RNAi reporter assay in S2 cells
RNAi reporter assays were performed as described previously using 25 ng pMT-GL3, 
6 ng pMT-Ren, and 25 ng suppressor plasmid per well of a 96-well plate [50]. Plasmids 
encoding Nora virus cDNA constructs were generated as described in Protocol S1.
 
Flies and fly injections
Flies were maintained on standard medium at 25°C with a light/dark cycle of 12 
hours/12 hours. Fly stocks that were used for Sindbis virus infection and for 
preparation of embryo lysate were cleared of Wolbachia and endogenous virus 
infection (see Protocol S1). 
We used the following fly stocks and alleles: UAS-CrPV 1A [13,51], AGO2321 [52], 
Dcr-2L811fsX [53], thRNAi [24,25]. The coding sequences of the full-length VP1 and the 
inactive VP1ΔC74 mutant with an N-terminal V5 epitope tag were cloned into the 
pUAST vector using the SacII and XbaI restriction sites [54]. The resulting plasmids 
were microinjected into Drosophila w1118 embryos to generate transgenic fly lines 
(Bestgene Inc). Virus infections of adult female flies were performed as described 
previously using 5,000 PFU of recombinant SINV [6]. Survival was monitored daily. 
In vivo RNAi experiments were performed by crossing GMR-GAL4, UAS-thRNAi/CyO 
virgins [25] with UAS-VSR/TM3 Sb flies. The eye phenotype was monitored in two- to 
four-day-old male F1 offspring lacking the CyO and TM3 Sb balancers.
Production of recombinant proteins in E. coli
The GST and MBP fusion proteins were purified from E. coli as described in Protocol 
S1. Purified recombinant proteins were dialyzed against dialysis buffer (20 mM Tris-
HCl, 0.5 mM EDTA, 5 mM MgCl2, 1 mM DTT, 140 mM NaCl, 2.7 mM KCl) Recombinant 
proteins were stored as aliquots at -80°C in dialysis buffer containing 30% glycerol. 
Gel mobility shift, Dicer and Slicer assays
Gel mobility shift assays were performed as described [6]. Briefly, uniformly radio-
labeled 113 nt long dsRNA (50 cps/reaction) or end-labeled siRNAs (200 cps/
reaction) were incubated with purified recombinant protein for 30 minutes at room 
temperature. Samples were then separated on an 8% native polyacrylamide gel and 
exposed to a Kodak Biomax XAR film.
Dicer and Slicer assays were performed according to the protocol of Haley and 
colleagues with minor modifications, described in Protocol S1 [30]. For Slicer assays 
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with the methylated duplex, FLuc guide strand 5’- UCG AAG UAC UCA GCG UAA 
GU[mU] and passenger strand 5’- CUU ACG CUG AGU ACU UCG AUU were annealed 
by incubating 20 µM of each siRNA strand in annealing buffer (100 mM potassium 
acetate, 30 mM HEPES-KOH at pH 7.4, 2 mM magnesium acetate) for 1 min at 
90°C, followed by incubation for 1 hour at 37°C. For guide strand loading of RISC, 
embryo lysates were incubated with FLuc single-stranded guide strand RNA at a final 
concentration of 10 µM. Radiolabeled probes and target RNA for gel shift and Slicer 
assays are described in Protocol S1.
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Supporting information
Text S1.
Nora virus VP1 is unable to suppress the miRNA pathway
Several plant virus RNAi suppressors influence the miRNA pathway, thereby inducing 
strong developmental defects in transgenic plants that express RNAi suppressors 
during development [55,56]. This effect may be due to convergence of the antiviral 
RNAi and miRNA pathways on Argonaute-1 (AGO1) in plants. In Drosophila, the miRNA 
and siRNA pathways are parallel pathways. Nevertheless, there is crosstalk between 
these pathways with miRNA and miRNA-star sequences being loaded into AGO2 and, 
conversely, with siRNAs being loaded into AGO1 [57,58]. To determine whether VP1 
suppresses the miRNA pathway, we used a miRNA sensor assay in S2 cells (Protocol 
S1). In this assay, an FLuc reporter containing the 3’UTR of the Drosophila par6 gene 
(FLuc-par6), a target for miRNA1, is co-transfected with a plasmid expressing the 
primary miRNA1 (pri-miR1), or a control plasmid expressing pri-miR12 [59,60]. Co-
transfection of pri-miR1 led to specific silencing of the FLuc-par6 gene (Figure S1). 
We verified whether the reporter was suppressed in an AGO1 dependent manner, 
by cotransfection of dsRNA targeting AGO1 or, as a control, AGO2. As expected, the 
miRNA reporter assay monitors the canonical miRNA pathway, since knockdown of 
the AGO1 gene by dsRNA led to de-repression of FLuc-par6 expression (although this 
did not reach statistical significance, p=0.09). In contrast, co-transfection of AGO2 
dsRNA did not lead to de-repression, but even enhanced silencing of the miRNA 
reporter, perhaps reflecting more efficient AGO1 loading under conditions in which 
AGO2 is depleted. Expression of Nora virus VP1 did not de-repress the FLuc-par6 
construct, indicating that VP1 does not suppress the miRNA pathway. Similarly, 
VP1 did not affect silencing of a miRNA sensor consisting of a luciferase construct 
containing two perfect complementary target sites for the endogenous miR2 in its 
3’UTR (data not shown) [6]. In addition, transgenic flies expressing VP1 driven by a 
strong ubiquitous promoter (Tubulin-GAL4) are viable and fertile, lending further 
support to the conclusion that VP1 does not inhibit miRNA biogenesis and function 
(data not shown).   
Protocol S1. 
Extended Experimental Procedures and Supplemental Methods
Molecular cloning
To construct plasmids encoding C-terminal V5 epitope tagged proteins of Nora virus, 
cDNA prepared from Nora virus infected flies was amplified using primers 5’-AGT 
GGT ACC AAC ATG ATT AAC AAT CAA ACA AAC and 5’-GGT GGG CCC TTG ACA TTG 
TTG TTT CTG CG for ORF1, primers 5’-AGT GGT ACC AAC ATG TTA ATT GAA GCT TTC 
ATC and 5’-GGT GGG CCC TCC AAG ATC TCC TCT TTT AAT G for ORF2, primers 5’-AGT 
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GGT ACC AAC ATG GCA TTA AAA GAG GAG ATC and 5’-GGT GGG CCC TTG CAT AGA 
GTC ATA AAT TAC for ORF3, and primers 5’-AGT GGT ACC AAC ATG CAG AAT CCA ACA 
CAA ACC and 5’-GGT GGG CCC CTG CTG CCT CAC GGA AGG GAA for ORF4. Amplified 
products were cloned as KpnI and ApaI fragments into pAc5.1-V5-His-A (Invitrogen).
For the expression of VP1 mutants tagged at the N-terminus with the V5-His epitopes, 
the pAc5.1-V5-His-Ntag plasmid was constructed. This plasmid was created by 
annealing and cloning the oligonucleotides 5’-CAA CAT GGG TAA GCC TAT CCC TAA 
CCC TCT CCT AGG TCT CGA TTC TAC GCG TAC CGG TCA TCA TCA CCA TCA CCA TG 
and 5’-AAT TCA TGG TGA TGG TGA TGA TGA CCG GTA CGC GTA GAA TCG AGA CCT 
AGG AGA GGG TTA GGG ATA GGC TTA CCC ATG TTG GTA C into the EcoRI and KpnI 
restriction sites of pAc5.1-V5-His-A. The sequences of all VP1 deletion mutants were 
cloned into pAc5.1-V5-His-Ntag using the EcoRI and SacI restriction sites. For mutant 
sequences see supplemental Figure S3.
miRNA sensor assay
The miRNA sensor assay and its plasmids were described previously [59,60] . Briefly, 
5x104 S2 cells were seeded per well in a 96-well plate one day before transfection. 
Subsequently, the cells were transfected with 54.5 ng suppressor plasmid, 6.8 ng 
pMT-FLuc-par6, 1.6 ng pMT-Ren, and 2.7 ng pMT-miR1 or pMT-miR12 using the 
Effectene transfection reagent (Qiagen) according to the manufacturer’s protocol. To 
knockdown AGO1 or AGO2 expression, 5.4 ng of dsRNA was cotransfected with the 
plasmids. Expression of the reporter constructs was induced with CuSO4 at 48 hrs 
post transfection and luciferase activities were measured at 72 hrs post transfection.
Clearance of Wolbachia and endogenous viruses from fly stocks 
Fly stocks used for Sindbis virus infection and preparation of embryo lysates were 
cleared from endogenous viruses by collecting eggs on apple-juice agar plates, 
followed by a treatment with 50% household bleach for 5 minutes. Subsequently, the 
bleached eggs were washed three times in a large volume of water, after which they 
were transferred to clean vials containing standard fly food. After culturing the fly 
stocks for two generations we confirmed the absence of Nora virus and Drosophila 
C virus (DCV) by RT-PCR. Fly stocks were then cleared from Wolbachia infection by 
raising the flies for two generations on standard fly food supplemented with 0.05 
mg/mL tetracycline hydrochloride (Sigma). To verify the clearance of Wolbachia 
infection, PCR amplification was performed with Wolbachia specific primers on DNA 
extracts of adult flies, as described earlier [61]. 
Production of recombinant proteins in E. coli
To fuse the VP1ΔN284 protein to the C-terminus of maltose binding protein (MBP), 
the coding sequence of the VP1ΔN284 mutant was cloned as an EcoRI-SalI fragment 
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into the pMal-C2X vector (New England Biolabs). The resulting pMal-C2X-VP1ΔN284 
and parental pMal-C2X plasmids were transformed into the E.coli BL21 (DE3) strain. 
Expression of the recombinant fusion proteins was induced at 1.0 OD600 by adding 
0.2 mM IPTG followed by incubation at 37°C for 3 hours. MBP and MBP-VP1ΔN284 
fusion proteins were purified using amylose resin (New England Biolabs) according 
to the manufacturer’s protocol.
The coding sequence of CrPV 1A (amino acids 1-148) was amplified using primers 
5’- CGG GAA TTC ATG TCT TTT CAA CAA ACA AAC AAC and 5’- AGA GTC GAC TTA GAA 
GGC TCT GCA TT and cloned into the pGEX-4T-1 plasmid (GE healthcare) as an EcoRI-
SalI fragment. After transformation of the E. coli BL21 (DE3) strain with the resulting 
pGEX-CrPV 1A plasmid, expression was induced at 1.0 OD600 using 0.2 mM IPTG. 
Protein production was allowed to continue overnight at 20°C. The GST-CrPV 1A 
fusion protein was purified using glutathione sepharose 4 fast flow (GE healthcare) 
according to the manufacturer’s protocol. GST (pGEX-4T-1) and GST-DCV 1A (pGEX-
DCV 1A) fusion proteins were purified using the same method, after induction of 
protein expression at 37°C for 3 hours [6].
Radioactively labeled probes and target RNA
Uniformly radio-labeled 113 bp long dsRNA was generated by in vitro transcription 
in the presence of α-[32P]-UTP using a T7 promoter flanked firefly luciferase (GL3) 
PCR product as a template. T7 promoter flanked PCR products were generated 
with primers 5’-TAA TAC GAC TCA CTA TAG GGA GAT ATG AAG AGA TAC GCC CTG 
GTT and 5’-TAA TAC GAC TCA CTA TAG GGA GAA TAG CTT CTG CCA ACC GAA C. 
Unincorporated nucleotides were removed using a G-25 sephadex column (Roche) 
followed by purification of the dsRNA from an 8% polyacrylamide gel. Gl3 siRNAs 
(Dharmacon) were 32P end-labeled using T4 polynucleotide kinase (Roche) after 
which unincorporated nucleotides were removed using a G-25 sephadex column 
(Roche).
To generate target RNA for the Slicer assay, a 492 bp region of the GL3 luciferase 
gene was PCR amplified using the primers 5’-TAA TAC GAC TCA CTA TAG GGA GAA 
TGG AAG ACG CCA AAA ACA T and 5’-CAT CGA CTG AAA TCC CTG GT. The GL3 PCR 
product was used as a template for in vitro transcription using the Ampliscribe T7 
flash transcription kit (Epicentre). After purification from an 8% urea-polyacrylamide 
gel, the RNA was cap-radiolabeled with the Scriptcap m7G capping system (Epicentre) 
according to the manufacturer’s protocol. The capped RNA was purified from an 8% 
Urea-polyacrylamide gel before use in the Slicer assay. 
Dicer assay
Dicer assays were performed in a final volume of 12 µL containing 4µL S2 cell 
extract, 3 µL dicer buffer, 1 µL uniformly labeled dsRNA (200 cps), and 4 µL purified 
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recombinant protein. Dicer buffer contained 0.175 µg/µL creatine kinase (Roche), 
16.7 mM DTT, 0.02 mg/µL creatine monophosphate (Roche), 3.3 mM MgAc, 50 mM 
Hepes-KOH, 33.3% glycerol, 0.67 U/µL RNasin (Roche), and 3.3 mM ATP. Reactions 
were incubated for 3 hrs at 27°C after which they were deproteinized by proteinase 
K and phenol extracted [30]. After precipitation, the RNA was dissolved in Ambion 
loading buffer II and loaded on a 12% denaturing polyacrylamide gel. Dicer products 
were visualized by exposing the polyacrylamide gel to a Kodak Biomax XAR film.
Slicer assay
Drosophila embryo lysates were produced from w1118 flies as described [30]. Slicer 
reactions contained 5 µL embryo lysate, 3 µL cleavage buffer, 100 nM siRNA, 0.3 
µM recombinant protein, and 1 µL capped target RNA (~1000 cps) in a final volume 
of 11 µL.  The GL3 siRNA (Dharmacon) was used to induce cleavage of the firefly 
luciferase target RNA, whereas the negative control siRNA (Qiagen) was used as a 
negative control. After assembly of the reaction, samples were incubated for 2 hours 
at 25°C. Samples were then treated with proteinase K, extracted with phenol, and 
precipitated as described [30]. Precipitated RNA was dissolved in Loading buffer II 
(Ambion) and analyzed on an 8% urea-polyacrylamide gel. Slicer products in ATP 
depleting conditions were analyzed on a 6% urea-polyacrylamide gel. Kodak Biomax 
XAR films were used to visualize the radioactive Slicer products.
Supplemental figures
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Figure S1: VP1 is unable to suppress the miRNA 
pathway. A firefly luciferase (FLuc) construct containing 
the par6 3’UTR, a target for miRNA1 (FLuc-par6), was 
co-transfected with plasmids encoding Renilla luciferase 
(RLuc) and either Nora virus VP1 or the inactive VP1ΔC74 
mutant. FLuc-par6 expression was silenced by co-
transfecting a plasmid encoding pri-miRNA1, whereas 
a pri-miRNA12 expressing construct was used as a 
negative control. AGO1 or AGO2 gene expression was 
knocked-down by co-transfection of dsRNA targeting 
these genes (dsAGO1 and dsAGO2, respectively). 
Expression of FLuc and RLuc was induced two days after 
transfection, and reporter activities were measured 
three days after transfection. RLuc activity was used to 
normalize FLuc activity within each sample, and data 
were normalized to the pri-miR12 treated sample. 
Bars represent averages and standard deviations of biological triplicates. A representative graph of two 
independent experiments is shown. The numbers represent p-values relative to pri-miR1 treated vector 
control samples in a two-tailed Student’s t-test assuming equal variances.
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NoraV Umea 2007          MINNQTNKKGPQLERVHFGSTQVVGKSTKRRQRGTKLDIEYTVRRNDAPKEQKFLISEIF 60 
NoraV NL1                MINNQTNKKGPQLERVHFGSTQVVGKSTKRRQRGTKLDIEYTVRRNDAPKEQKFLISEIF 60 
NoraV NL2                MINNQTNKKGPQLERVHFGSAQVVGKSTKRRQRGTKLDIEYTVKRNDAPKEQKFLVSEIF 60 
NoraV reconstituted FR1  MINNQTNKKGPQLERVHFGSAQVVGKSTKRRQRGTKFDIEYTVKRNDAPKEQKFLVSEIF 60 
                         ********************:***************:******:***********:**** 
 
NoraV Umea 2007          DEKLDKQIKYEKKQNHTFIKPKLNLVIKEEQHITKKVLRGKERAATHAFMKEMVESNKIQ 120 
NoraV NL1                DEKLDKQIKYEKKQNHTFIKPKLNLVIKEEQHIIKKVLRGKERAATHAFMKEMVESNKIQ 120 
NoraV NL2                DEKLDKQIKYEKKQNHTFIKPKLNLVTREEQHMTKKVLRGKERAATHAFMKEMVESNKIQ 120 
NoraV reconstituted FR1  DEKLDKQIKYEKKQNHTFIKPKLNLVTREEQHVTKKVLRGKERAATHAFMKEMVESNKIQ 120 
                         ************************** :****: ************************** 
 
NoraV Umea 2007          PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSIDEIV 180 
NoraV NL1                PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSIDEIV 180 
NoraV NL2                PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSINEIV 180 
NoraV reconstituted FR1  PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSTNEIV 180 
                         ******************************************************* :*** 
 
NoraV Umea 2007          TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIKSVKKEAKKIKQE 240 
NoraV NL1                TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIKSVKKEVKKIKQE 240 
NoraV NL2                TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIESVKKEAKRTKQE 240 
NoraV reconstituted FR1  TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIKSVKKEAKRTKQE 240 
                         ***********************************************:*****.*: *** 
 
NoraV Umea 2007          KPQIVKKTQHKSLGVNLKITKTKVVGQEQCLEIENTQHKKFVEKPSMPLKVSKKMTEHQL 300 
NoraV NL1                KPQIVKKTQHKSLGVNLKITKTKVVGQEQCLEIENTQHKKFVEKPSMPLKVSKKMTEHQL 300 
NoraV NL2                KPQIAKKTQHKSLGVNLKITKIKVVGQEQCLEIENTQHKKFVEKPSMPSKVSKKMKGQQL 300 
NoraV reconstituted FR1  KPQIAKKTQHKSLGVNLKITKTKVVGQEQCLEIENTQHKKFVEKPSMPSKVSKKMKGQQL 300 
                         ****.**************** ************************** ******. :** 
 
NoraV Umea 2007          KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYVAKPPAEEKRSI 360 
NoraV NL1                KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYIAKPPAEEKRSI 360 
NoraV NL2                KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYTAKPPAEEKRSI 360 
NoraV reconstituted FR1  KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYTAKPPAEEKRSI 360 
                         ************************************************ *********** 
 
NoraV Umea 2007          HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADRYLYHQFKREMMIYRNKWVKFSKEFNPY 420 
NoraV NL1                HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADRYLYHQFKREMMIYRNKWVKFSKEFNPY 420 
NoraV NL2                HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADRYLYHQFKREMMVYRNKWVKFSKEFNPY 420 
NoraV reconstituted FR1  HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADHYLYHQFKREMMVYRNKWVKFSKEFNPY 420 
                         ********************************:***********:*************** 
 
NoraV Umea 2007          LSKPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
NoraV NL1                LSKPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
NoraV NL2                LSEPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
NoraV reconstituted FR1  LSEPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
                         **:**************************************************** 
 
Figure S2: Alignment of VP1 sequences from different Nora virus isolates. Alignment of VP1 
sequences of Nora virus isolate Umeå 2007 (accession number GQ257737) and Nora virus sequences 
from infected fly stocks from our own laboratory (isolates NL1 and NL2, GenBank accession number 
JQ288019 and JQ288020). We analyzed VP1 sequences in a total of eight Nora virus infected fly stocks. 
Five VP1 sequences were identical to NL1, one was the NL2 sequence, and two stocks contained a mixed 
population of Nora virus sequences. These eight stocks were obtained from five different laboratories 
or stock centers. However, they have been maintained in our laboratory before we tested them for 
Nora virus infection, and we cannot exclude the possibility that they became infected in our laboratory. 
Although we therefore cannot infer overall virus diversity from these data, they do indicate that VP1 
is a conserved protein. The FR1 isolate is the Nora virus genome that was reconstituted from small 
RNA sequences from wildtype w1118 flies from a laboratory based in France (GenBank accession number 
JX220408).
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Figure S4: Nora virus VP1 is unable to bind long dsRNA or to interfere with Dcr-2 activity. (A) Mobility 
shift assay of suppressor proteins with long dsRNA. Uniformly radiolabeled long dsRNA was incubated 
for 30 minutes with buffer (lane 1) or recombinant MBP-VP1ΔN284 (lanes 2-4) , MBP (lanes 5-7), GST-DCV 
1A (lanes 8-10) or GST (lanes 11-13). Ten-fold dilutions of recombinant protein were used starting from 
the following concentrations: MBP-VP1ΔN284 (2 µM, lane 2), MBP (2.6 µM, lane 5), GST-DCV 1A (1 µM, lane 
8), and GST (2.24 µM, lane 11). RNA mobility shifts were analyzed on an 8 % native polyacrylamide gel. 
(B) Dicer activity in S2 cell extract in the presence of viral suppressor proteins. Uniformly radiolabeled 
long dsRNA was incubated in S2 cell extract for 3 hours with buffer (lane 3) or the indicated recombinant 
proteins. Two-fold dilutions were used for MBP-VP1ΔN284 (lanes 4-7, highest concentration 1.1 µM) and 
MBP (lanes 8-11, highest concentration 4.2 µM). Two independent preparations of GST-DCV 1A were 
used (lane 12, concentration of 0.54 µM and lane 13, concentration of 0.03 µM). GST was used at a 
concentration of 1.2 µM (lane 14). As size markers, dsRNA input (lane 1) and end-labelled siRNAs (lane 2) 
were used. Dicer products were analyzed on a 12% denaturing polyacrylamide gel.
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Figure S5: ATP depletion during Slicer assay. (A) Schematic representation of the protocol used to 
deplete (-ATP) or to regenerate ATP after initial depletion (+ATP) for Slicer assays of Figure 7F. For RISC 
loading, Drosophila embryo lysate was incubated with an siRNA for 30 minutes under standard conditions. 
Subsequently, N-ethylmaleimide (NEM) was added in both conditions to inhibit the ATP regenerating 
activity of creatine kinase. After incubating the reactions for 10 minutes on ice, DTT was added to quench 
the NEM in both conditions. Hexokinase, glucose, and milliQ water (MQ) were added in the –ATP protocol 
to deplete the pool of ATP. For the +ATP condition, Hexokinase was substituted by hexokinase buffer, 
and MQ was substituted for Creatine kinase to restore the ATP regenerating activity. Subsequently, the 
reactions were incubated for 30 minutes after which recombinant protein (rec. protein) was added. 
Following another 30 minutes incubation period, the 32P-cap-labelled RNA was added to the reaction, 
after which the incubation was continued for another 2 hours. Subsequently, reactions were analyzed 
on a polyacrylamide gel. (B) ATP concentrations before and after the Slicer assay under –ATP and +ATP 
conditions. ATP levels were measured at the moment of target RNA addition (0 hrs) or after 2 hours of 
incubation with target RNA. For ATP concentration measurements, recombinant protein was substituted 
for protein storage buffer, and target RNA was substituted for MQ. ATP levels were measured using the 
Celltiter-Glo Luminescent Cell Viability Assay (Promega) according to the manufacturer’s protocol.
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Abstract
P lants and insects rely on the RNA interference (RNAi) pathway – gene silencing mediated by small interfering RNAs (siRNAs) – for antiviral defense. Consequently, plant and insect viruses express viral suppressors 
of RNAi (VSRs) to counteract the antiviral RNAi pathway. The identification and 
characterization of viral RNAi suppressors provides important insights into virus-
host interactions. In addition, these proteins may be used as powerful experimental 
tools to study RNAi function. We recently identified the viral protein 1 (VP1) of Nora 
virus as an RNAi suppressor. In this report, we further characterize the activities 
of VP1 in transgenic Drosophila melanogaster. We show that the VP1∆N351 protein, a 
mutant lacking the 351 N-terminal amino acids, efficiently suppresses the siRNA 
pathway in vivo without affecting the related microRNA pathway. Ubiquitous or 
fat body specific expression of VP1∆N351 sensitized flies to Drosophila C Virus (DCV) 
infection. In addition, ubiquitous expression of VP1∆N351 led to an increase in viral 
RNA specifically in the fat body tissue. These results establish VP1∆N351 as a useful tool 
to study the RNAi pathway in D. melanogaster and to inhibit RNAi in a tissue specific 
manner.
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Introduction
Small RNAs are important regulators of gene expression that play critical roles in 
many cellular processes in eukaryotes. In association with Argonaute proteins, small 
RNAs can silence gene expression in a sequence specific manner. Currently, small 
RNAs are divided in three main classes, small interfering RNAs (siRNAs), microRNAs 
(miRNAs), and piwi-interacting RNAs (piRNAs). 
MicroRNAs are encoded in the genome of eukaryotes, and function as important 
regulators of endogenous gene expression. In the fruit fly Drosophila melanogaster, 
miRNA biogenesis depends on the nuclear RNaseIII enzyme Drosha and its double 
stranded RNA (dsRNA) binding partner Pasha. In the cytoplasm, the RNaseIII 
enzyme Dicer-1 (Dcr-1) and its dsRNA binding partner protein Loquacious (Loqs) are 
responsible for subsequent miRNA maturation. Mature miRNAs then associate with 
an Argonaute 1 (AGO1) containing protein complex to exert their regulatory function 
[1]. In contrast, piRNAs are generated in a Dicer-independent manner, and associate 
with the PIWI subclass of Argonaute proteins to suppress the activity of transposons 
in the germline [2]
RNA interference (RNAi) is initiated by processing of long double stranded (ds)
RNA into siRNAs in the cytoplasm [3]. dsRNA is readily detectable in infections with 
viruses with dsRNA, positive-stranded RNA, or DNA genomes [4]. As a consequence, 
these viruses have the potential to trigger the siRNA pathway. Indeed, viral dsRNA 
is recognized and cleaved by the RNaseIII enzyme Dicer-2 (Dcr-2) into viral siRNAs 
(vsiRNAs) which are loaded into an Argonaute-2 (AGO2) containing RNA-induced 
silencing complex (RISC) [5-9]. Subsequently, one strand of the vsiRNA duplex 
is retained in RISC, and guides recognition and cleavage of complementary viral 
sequences thereby restricting virus replication [10-14]. 
Plant and insect viruses express viral suppressors of RNAi (VSRs) that allow them 
to replicate in the face of the antiviral RNAi response. Many of these proteins bind 
either long dsRNA molecules and/or small RNA duplexes, precluding their use as 
trigger and guides of the RNAi pathway [15-17]. However, suppression of RNAi 
through interaction with key proteins of RNA silencing pathways has also been 
reported in both insect and plant viruses [8,18-25].
The critical role of RNAi in antiviral defense is supported by the observation that 
RNAi deficient flies (Dcr-2 or AGO2 null mutants) are hypersensitive to virus infection 
[17,26-28]. Although these null mutants are viable and fertile, multiple defects have 
been reported. For instance, genetic loss of AGO2 leads to the activation of mobile 
genetic elements and the deregulation of Drosophila fragile X protein (dFMR1) 
expression, the latter resulting in neurogenesis and oogenesis defects [29-31]. In 
addition, Dcr-2 and AGO2 were shown to operate in the nucleus, contributing to 
transcriptional control probably by influencing the processivity of RNA polymerase II 
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[32]. Recently, AGO2 was also implicated in the regulation of pre-mRNA splicing [33] . 
These defects complicate the interpretation of the phenotype of RNAi mutants upon 
virus infection. Spatio-temporal controlled inactivation of RNAi would be a useful 
approach to minimize these effects. 
Recently, we identified an RNAi suppressor, viral protein 1 (VP1), in the positive-
stranded RNA virus Nora virus [8,34]. We mapped the RNAi suppressor activity to 
the C-terminal 124 amino acids of VP1. Furthermore, we showed that Nora virus VP1 
inhibits slicer activity of a mature RISC. Although a full-length VP1 (VP1FL) transgene 
suppressed RNAi in transgenic flies, its suppressive activity was only mild. Therefore, 
we characterized in this report the RNAi suppressor activity of the N-terminal deletion 
mutant VP1∆N351, which retains 124 C-terminal amino acids, in vivo. We show that 
the VP1∆N351 transgene is a potent suppressor of the RNAi pathway in vivo, and that 
it does not affect the miRNA pathway. Furthermore, we show that transgenic flies 
have an increased sensitivity to Drosophila C virus (DCV) when VP1∆N351 is expressed 
ubiquitously in all tissues or specifically in the fat body. Altogether, our results imply 
that the VP1 transgene is a useful reagent to probe RNAi regulated processes in vivo.
Results
Nora virus VP1ΔN351 suppresses RNAi in vivo
Recently, we identified Nora virus VP1, the protein product from open reading frame 
1, as a viral suppressor of RNAi [8]. The RNAi antagonistic activity mapped to the 
C-terminus of VP1, since a 74 amino acid C-terminal deletion mutant (VP1∆C74) is 
inactive. In support, we showed that the N-terminal deletion mutant VP1∆N351, which 
codes for the 124 C-terminal amino acids, is fully functional in RNAi suppressor 
activity in vitro [8].
To further characterize the RNAi suppressor activity of VP1 and its mutants in adult 
flies, we made use of the GAL4/UAS system [35]. In this system, a responder fly 
line, containing a transgene of interest under the control of an Upstream Activating 
Sequence (UAS), is crossed with a driver line that expresses the yeast transcriptional 
activator GAL4. In the F1 offspring, GAL4 induces expression of the UAS-regulated 
transgene. Therefore, regulated expression of GAL4 in the driver line can be used to 
control transgene expression in a spatiotemporal manner. Recently, we described 
transgenic fly lines expressing the VP1FL or the inactive VP1∆C74 sequence [8]. In this 
report, we generated responder flies containing the V5-tagged VP1∆N351 sequence 
downstream of the UAS sequence. Crossing the VP1FL and VP1∆C74 responder lines with 
actin-GAL4 (act-GAL4) or tubulin-GAL4 (tub-GAL4) driver lines resulted in expression of 
the VP1 transgenes in the offspring (Figure 1A). Although the tub-GAL4 driver induced 
higher expression levels of both the VP1FL and VP1∆C74 construct, it produced only 
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limited offspring for the VP1FL cross. Therefore, we chose to use the act-GAL4 driver 
in further experiments. Crossing three independent VP1∆N351 responder fly lines with 
the act-GAL4 driver resulted in expression of the VP1∆N351 protein (Figure 1B). Since all 
VP1∆N351 fly lines were viable and express the VP1∆N351 protein in equal amounts, we 
choose one line for further analysis. We will refer to this transgenic line as ‘VP1∆N351’ 
in the rest of the manuscript.
Having established that the VP1FL, VP1∆C74, and the VP1∆N351 transgenes are expressed, 
we determined the RNAi suppressor activity of these proteins in vivo. To this end, 
we used a transgenic RNAi sensor line, in which the inhibitor of apoptosis thread 
(th) is silenced by expression of dsRNA targeting this gene (thRNAi) [36,37]. Expression 
of thRNAi in the developing eye results in severe apoptosis leading to a reduced eye 
size and loss of pigmentation together with roughening of the eye surface (Figure 
1C). In line with earlier reports [8,37], the thRNAi phenotype depends on functional 
RNAi, since no developmental defects were observed in an AGO2 null background 
(Figure 1D). Likewise, suppressing AGO2 activity by expression of VP1FL resulted in 
larger eyes size and an increase in pigmentation, whereas expression of VP1∆C74 did 
not restore the RNAi phenotype (Figure 1E,F). Expression of VP1∆N351 fully restored 
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Figure 1: VP1∆N351 suppresses RNAi in vivo. (A,B) Western blot analysis of VP1 expression. Transgenic 
flies containing full-length VP1 (UAS-VP1FL), a C-terminal deletion mutant of VP1 (UAS-VP1∆C74), and a 
N-terminal deletion mutant of VP1 (UAS-VP1∆N351, three independent transgenic lines) behind the GAL4 
responsive UAS element were crossed with the actin-GAL4 (act-GAL4) or the tubulin-GAL4 (tub-GAL4) driver 
lines. Expression of VP1 in the F1 progeny was analyzed by western blot using the anti-V5 antibody. (C-G) 
Knockdown of thread by RNAi (thRNAi) in the eyes of adult flies in the background of an AGO2 heterozygote 
(AGO2321/+) (C), an AGO2 homozygous mutant (AGO2321/321) (D) or in flies co-expressing VP1FL (E), the inactive 
VP1∆C74 mutant (F), and the active VP1∆N351 mutant (G). For every cross, three representative pictures of 
eyes of two- to four-day-old male flies are shown.
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the eye size and increased pigmentation in the eye (Figure 1G). In addition, VP1∆N351 
reduced roughening of the eye surface to a greater extent than VP1FL. These results 
indicate that the VP1∆N351 transgene is a more potent RNAi suppressor than VP1FL, 
which is likely a result of the higher expression level of VP1∆N351.
Nora virus VP1 does not affect miRNA function in vivo
The miRNA pathway regulates expression of many endogenous transcripts. 
Transgenic plants expressing RNAi suppressor proteins from plant viruses often 
show developmental phenotypes, suggesting that these VSRs affect the miRNA 
pathway [38,39]. Transgenic flies expressing Nora virus VP1∆N351 are viable and fertile, 
and appear normal (data not shown). Since defects in miRNA pathway genes are 
associated with developmental defects, these observations suggest that VP1 does 
not affect miRNA biogenesis and function. To directly assess the effect of VP1 on the 
miRNA pathway in vivo, we used a previously described miRNA sensor fly [40,41]. In 
this sensor, ectopic expression of miR7 inhibits Notch target gene activity, leading 
to notched wings and a proximal growth defect in the wings of these miR7 sensor 
flies. Indeed, ectopic expression of miR7 along with a GFP control transgene in the 
developing wing resulted in a clear distal wing notch and loss of the proximal L3/
L4 domain (Figure 2A). We verified that the Notch phenotype is miR7 dependent, 
since in the absence of miR7 expression, a normal wing phenotype was observed 
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> UAS-GFP
> UAS-VP1ΔN351
> UAS-IR-Pasha
> UAS-VP1FL 
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affect miRNA function in 
vivo. (A) Ectopic expression 
of miR7 in the wing leads to 
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(Figure 2B). In contrast, expression of miR7 under conditions in which expression of 
AGO1 or Pasha is knocked-down did not induce wing notching and growth defects 
(Figure 2C,D). These results indicate that the wing phenotype of the miR7 sensor 
indeed depends on a functional miRNA pathway. We then tested if VP1 expression 
could affect the miR7-induced phenotype. Neither the full-length, nor the VP1∆N351 
construct altered the wing phenotype induced by ectopic expression of miR7 (Figure 
2E,F). These results demonstrate that VP1 is unable to affect the miRNA pathway in 
vivo, which is in line with our previous observations in cell culture [8].
Nora virus VP1 enhances DCV pathogenicity in vivo
A functional RNAi pathway is important for control of virus infection, as inactivation 
of crucial components of this pathway renders flies more sensitive to virus infection 
[17,26-28]. Since Nora virus VP1FL and VP1∆N351 specifically suppress the RNAi 
pathway in vivo, we investigated whether these transgenes alter the sensitivity to 
DCV infection, a natural pathogen of Drosophila [42,43]. Therefore, we injected 
transgenic VP1 flies with DCV and monitored survival thereafter. 
Two genetic control lines, one expressing no VP1 transgene (act-GAL4 x wt), the other 
expressing the inactive VP1∆C74 protein (act-GAL4 x UAS-VP1∆C74), showed a median 
survival of 8 days post infection (dpi) (Figure 3A). Flies expressing VP1FL or VP1∆N351 
died faster than these controls, with a median survival of 6 and 4 dpi, respectively 
(Log-rank, p<0.0001). Because flies expressing an active VP1 protein show a higher 
mortality after DCV infection, we determined whether DCV replicated to higher titers 
in these flies. To this end, we injected flies with DCV, and analyzed viral load over 
time. In all transgenic lines, titers of DCV initially increased at 24 and 48 hours post 
infection (hpi) before reaching a plateau at 72 hpi (Figure 3B).  Surprisingly, we did 
not detect a significant difference in viral load at any time point in flies expressing 
VP1∆N351 relative to flies expressing the inactive VP1∆C74 protein, or to two fly lines that 
do not express a VP1 transgene (wt x act-GAL4 and wt x VP1∆N351).
Since the fat body is one of the main target tissues of DCV, we reasoned that expression 
of VP1∆N351 might increase viral replication in this tissue [44,45]. To examine this 
possibility, we injected VP1∆N351 expressing flies and two genetic controls with DCV. 
Subsequently, we determined viral RNA levels in the whole fly and, in parallel, in 
isolated fat body tissue. Consistent with our observations on infectious virus titers, 
similar levels of viral RNA were detected in the three different crosses when using 
total RNA from whole flies (Figure 3C). We did, however, observe an increase in viral 
RNA levels in the fat body of VP1∆N351 expressing flies, although this difference did not 
reach statistical significance (p = 0.096, one-way ANOVA). This result suggests that 
ubiquitous expression of VP1∆N351 during DCV infection specifically increases viral 
loads in the fat body. 
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VP1 expression in fat body tissue enhances DCV pathogenicity
Fat body and hemocytes are considered the main immune organs of insects. The 
fat body plays an important role in the humoral immune response by producing 
various immune effector molecules. Hemocytes are involved in the cellular immune 
response through phagocytosis, melanisation, and encapsulation of invading 
pathogens [46]. In addition, hemocyte-mediated phagocytosis has been implicated 
in the defense against viral infections [47]. Since VP1∆N351 expressing flies showed 
an increased mortality and higher viral RNA levels in fat body tissue compared to 
control flies, we wondered if specific expression of VP1 in immune tissues enhances 
DCV pathogenicity. To achieve expression of VP1∆N351 and VP1∆C74 in the fat body and 
hemocytes, we crossed the responder flies with the c564-GAL4, and the hemolectin-
GAL4 (hml-GAL4) driver lines, respectively [48-50]. As a negative control we drove 
expression of VP1∆N351 and VP1∆C74 in the nervous system, which is not implicated 
in immune defense, using the Nervana2-GAL4 (nrv2-GAL4) driver [51]. As genetic 
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Figure 3: VP1∆N351 expression 
sensitizes flies to DCV 
infection. (A) Survival 
curves of DCV infected flies 
expressing the VP1FL (circle), 
VP1∆C74 (diamond) and VP1∆N351 
(squares), or in control flies that 
only express the GAL4 driver 
(triangle). At least 20 flies were 
injected with DCV and survival 
was monitored daily. Survival 
curves are representative of 
two independent experiments. 
(B) DCV titers in the progeny 
of the indicated crosses at 
0, 24, 48, and 72 hours post 
infection (hpi). Input levels were 
determined at 0 hpi in one pool 
of five flies. Three pools of 4-5 
flies were collected at the other 
time points, except for the wt 
x act-GAL4 cross at 48 hpi, and 
the wt x VP1∆N351 cross at 24 
and 48 hpi (n=2 pools). Bars 
represent means and standard 
deviation. (C) DCV RNA levels in 
three pools of 5 whole flies or 
in isolated fat body tissue from 
5 flies collected at 48 hpi. DCV 
RNA levels were determined 
by quantitative RT-PCR. Data 
are normalized to RP49 and 
presented as fold-change 
relative to the act-GAL4 x wt 
control.
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controls, we crossed wild-type flies with the respective driver lines. 
To assess the effect of tissue specific VP1 expression on survival, we injected the 
offspring of all crosses with DCV. Similar to the genetic control, flies expressing the 
inactive VP1∆C74 in the fat body showed a median survival of 7 days after DCV injection 
(Figure 4A). In contrast, VP1∆N351 expressing flies had a median survival of 4 days and 
showed a higher mortality rate compared to VP1∆C74 flies and the genetic control that 
does not express VP1, which showed a median survival of 6 and 7 days, respectively 
(Log-rank, p<0.0001). In contrast, VP1∆N351 expression in hemocytes or the nervous 
system did not affect survival, compared to flies expressing the inactive VP1∆C74 in 
these tissues (Figure 4B,C). These results indicate that specific expression of VP1∆N351 
in the fat body can sensitize flies to DCV infection to a similar extent as ubiquitous 
expression of VP1∆N351.
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Figure 4: Fat body specific 
expression of VP1∆N351 
enhances sensitivity to DCV. 
(A-C) Survival curves of DCV 
infected flies with the indicated 
genotypes. Tissue-specific 
expression of VP1 transgenes 
in fat body (A), hemocytes (B), 
and nervous systems (C) was 
induced by the C564-GAL4, 
hml-GAL4, and nrv2-GAL4 
drivers, respectively. Survival 
of flies expressing the VP1∆N351 
(squares) or VP1∆C74 (triangles) 
transgenes and control 
flies expressing the GAL4 
driver, but no VP1 transgene 
(diamonds) and control flies 
in which the VP1 transgene is 
not induced due to the lack 
of a GAL4 driver (circles) were 
analyzed. For survival analysis, 
at least 22 flies were injected 
with DCV and survival was 
monitored daily.
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Discussion
The RNAi pathway is the major antiviral defense system in Drosophila. Although 
genetic inactivation of key components of this pathway have yielded crucial insights 
into virus-host interactions, multiple defects have been identified in genetic null 
mutants [29,32]. To minimize these defects, inactivation of RNAi by viral suppressors 
of RNAi in a spatiotemporal manner would be a useful complementary approach. 
Here, we show that expression of the Nora virus VP1∆N351 transgene leads to potent 
suppression of the RNAi pathway in vivo. VP1∆N351 suppressed RNAi more potently 
than VP1FL, which is likely due to the higher expression level of the VP1∆N351 construct. 
Furthermore, VP1∆N351 did not affect miRNA function, which is important to prevent 
global changes in gene expression. Similar to earlier reports on AGO2 knockout 
flies, we show that antagonizing AGO2 function by expression of VP1∆N351 induced 
hypersensitivity to DCV infection [17]. In contrast to AGO2 knockout lines, however, 
we were unable to detect a higher viral load in whole flies expressing VP1∆N351 
compared to genetic controls. However, we could identify an increase in viral RNA 
levels in VP1∆N351 flies in the fat body, the main target tissue of DCV. In line with 
this observation, we showed that specific expression of VP1∆N351 in fat body tissue 
decreased survival to a similar extent as ubiquitous expression of VP1∆N351. These 
results underline the importance of the fat body in DCV infection, and suggest that a 
tissue specific increase in viral titer can reduce the fitness of the host.
RNAi is important for posttranscriptional gene silencing in the cytoplasm, as well as 
for control of nuclear processes, such as transcriptional regulation and splicing of 
host genes [32,33]. Consequently, AGO2 mutants display defects at the transcriptional 
as well as the post-transcriptional level [29,32]. Our unpublished observations 
indicate that VP1 localizes exclusively in the cytoplasm in S2 cells. Thus, the VP1∆N351 
transgene efficiently inhibits cytoplasmic RNAi, but is unlikely to affect nuclear RNAi. 
Altogether, we propose that the VP1∆N351 transgenic fly is a useful experimental tool 
to study RNAi regulated processes in Drosophila.
Materials and Methods
Fly stocks and cell lines
Drosophila S2 cells were cultured at 25ºC in Schneider’s medium (Invitrogen), 
supplemented with 10% heat inactivated fetal calf serum, 50 µg/mL streptomycin, 
and 50 U/mL penicillin (Invitrogen). Fly stocks were maintained on standard medium 
at 25ºC using a light/dark cycle of 12 hours/12 hours. All fly stocks used in survival 
experiments were cleared of Wolbachia and endogenous viruses as described 
previously [8]. 
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The following fly stocks and alleles were described previously: tub-GAL4 [52], C564-
GAL4 [49], hml-GAL4 [48,50], nrv2-GAL4 [51], AGO2321 [53], UAS-thRNAi [36,37], UAS-GFP 
(C. antoniewski and C. Carré, unpublished), UAS-mir7 [41], UAS-VP1FL, and UAS-VP1∆C74 
[8]. The Act-GAL4, ptc-GAL4, and UAS-IR-AGO1 transgenic flies were obtained from the 
Bloomington Stock Center (http://flystocks.bio.indiana.edu), and UAS-IR-Pasha was 
obtained from the Vienna Drosophila RNAi Center (http://stockcenter.vdrc.at). w1118 
flies were used as wild-type control. To generate UAS-VP1∆N351 transgenic flies, the 
VP1∆N351 sequence, fused to a V5-tag at its the N-terminus, was cloned into the XbaI 
and SacII restriction sites of the pUAST vector [35]. The resulting plasmid was micro-
injected into Drosophila w1118 embryos (Bestgene). 
Virus infections
For survival and titration experiments, two- to four-day-old female flies were injected 
with 1000 TCID50 units of DCV. Subsequently, survival was monitored daily, and flies 
were transferred to fresh food every two days. Differences in survival were evaluated 
with a Log-rank (Mantel-Cox) test as implemented in Graph pad prism (version 5).
For DCV titration, three groups of 4-5 flies were collected at 24, 48, and 74 hours post 
infection (hpi). Flies were homogenized in 300 µL PBS and fly debris was removed 
twice by centrifugation for 5 minutes at 13.000 rpm. Subsequently, 20 µL supernatant 
was used to determine the viral titer by end-point dilution on Drosophila S2 cells 
(Invitrogen) [54].
Viral RNA levels in whole flies or fat bodies were determined at 48 hpi using 
quantitative RT-PCR (qRT-PCR). To this end, RNA from five whole flies or from 
dissected fat body tissue of five flies was isolated using isol-RNA lysis reagent 
according to the manufacturer’s protocol (5 PRIME). After DNase I treatment, the RNA 
was used as a template for cDNA synthesis using the Taqman reverse transcription 
kit (Roche). Subsequently, qPCR was performed using the primer pair DCV-F, 
5’-AAAATTTCGTTTTAGCCCAGAA-3’ and DCV-R, 5’-TTGGTTGTACGTCAAAATCTGAG-3’. 
DCV levels were normalized to RNA levels of ribosomal protein 49 (RP49). Primers 
for amplification of RP49 were RP49-F, 5’-ATGACCATCCGCCCAGCATAC-3’ and RP49-R, 
5’-CTGCATGAGCAGGACCTCCA-3’.
Western blot detection
For expression of the VP1 constructs in transgenic fly lines, act-GAL4 or tub-GAL4 
driver lines were crossed with the VP1 responder lines. From the F1 offspring, ten 
flies lacking the CyO and TM3 Sb balancers were homogenized in Laemli buffer. 
Homogenates were centrifuged for 5 minutes at 13.000 rpm to remove insoluble 
fly material. The supernatant was then analyzed by SDS-PAGE followed by western 
blot using a V5 antibody (Life technologies) followed by a goat-α-mouse IRdye680 
antibody (LI-COR). Western blots were imaged using the LI-COR Odyssey imager.
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In vivo RNAi assay
The thRNAi experiment was performed as described [8]. Briefly, to assess the effects 
of VP1 transgenes on RNAi-mediated silencing of thread, a thRNAi construct was co-
expressed with VP1 in the developing eye by crossing GMR-GAL4, UAS-thRNAi/CyO 
virgins with UAS-VP1/TM3 Sb flies. To establish the RNAi dependence of the assay, the 
GMR-GAL4, UAS-thRNAi/CyO construct was crossed into an AGO2321 background using 
standard genetic methods. From the F1 offspring, the eye-phenotype of two- to four-
day-old male flies, lacking the CyO and TM3 Sb balancers, was determined using a 
Leica EC3 camera mounted on a Leica S6D stereo microscope.
In vivo miRNA sensor assay
For the miRNA sensor assay in flies, the ptc-GAL4 and UAS-miR7/CyO alleles were 
recombined using standard genetic methods. Subsequently, ptc-GAL4, UAS-miR7/
CyO virgins were crossed with either the UAS-VSR/TM3 Sb male flies, or with UAS-
GFP, UAS-IR-AGO1, or UAS-IR-Pasha male flies. Two-day-old adult flies lacking the CyO 
balancer were incubated at -20ºC for one day, after which the wings were mounted 
with Euparal for examination of the phenotype.
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Abstract 
T he ongoing conflict between viruses and their hosts can drive the co-evolution of host immune genes and viral immune suppressors. It has previously been suggested that an evolutionary ‘arms race’ could be occurring between 
rapidly evolving components of the Drosophila antiviral RNAi pathway and viral genes 
that antagonize it. Recently, we have shown that Drosophila melanogaster Nora virus 
(DmelNV) is a target of the antiviral RNA interference (RNAi) pathway. As a counter-
defense, DmelNV viral protein 1 (VP1) suppresses the RNAi pathway by antagonizing 
Argonaute-2 (AGO2)-mediated RNA cleavage (slicer activity). Here we show that Nora 
virus VP1 can develop a species-specific RNAi suppressor activity that depends on 
the ability to interact with AGO2. We have identified novel Nora-like viruses in wild-
caught populations of D. immigrans (DimmNV) and D. subobscura (DsubNV) that are 
36% and 26% divergent from DmelNV at the amino acid level, and have analyzed 
their interactions with the RNAi machinery from host and non-host species. We 
show that DimmNV and DsubNV VP1 are unable to suppress RNAi in D. melanogaster 
S2 cells, which is in contrast to the potent RNAi suppressive activity of DmelNV VP1 
in these cells. Moreover, we show that the RNAi suppressor activity of DimmNV 
VP1 is restricted to its natural host species, D. immigrans. Specifically, we find that 
DimmNV VP1 interacts with D. immigrans AGO2, but not with D. melanogaster AGO2, 
and suppresses slicer activity in embryo lysates from D. immigrans, but not from D. 
melanogaster. Surprisingly, the activity of DmelNV VP1 does not seem to be restricted 
to its host species, as it interacts with both D. melanogaster and D. immigrans AGO2 
and suppresses slicer activity in both D. melanogaster and D. immigrans embryo 
lysates. Our results emphasize the importance of analyzing viral RNAi suppressor 
activity in the relevant host species. Moreover, these results suggest that rapid co-
evolution between Nora viruses and their hosts may result in host species-specific 
activities of RNAi suppressor proteins, and therefore that viral RNAi suppressors 
could be host-specificity factors.
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Introduction
As obligate intracellular parasites, viruses modulate and exploit the host cellular 
environment for their replication. The host antiviral defense system restricts virus 
infections, and in turn, viruses dedicate a significant fraction of their coding capacity 
to produce virulence factors that antagonize the antiviral immune response. Co-
evolution of virus and host may lead to a host-specific adaptation of viral counter-
defense mechanisms to the host antiviral defense system, which can contribute to 
host specificity of the virus [1].
The RNA interference (RNAi) pathway is a major antiviral defense system in plants, 
arthropods, nematodes and fungi [2-5]. Double stranded RNA (dsRNA), which is 
typically produced during virus infection but absent from non-infected cells [6], 
triggers the RNAi pathway. In insects, cleavage of viral dsRNA by the ribonuclease 
Dicer-2 (Dcr-2) generates viral small interfering RNAs (vsiRNAs) [7-19]. Dcr-2 and 
its binding partner R2D2 bind these vsiRNAs and subsequently load the small RNA 
duplexes into an Argonaute-2 (AGO2) containing RNA-induced silencing complex 
(RISC) [20]. One strand of the vsiRNA is retained and guides the recognition and 
cleavage of complementary viral RNAs by AGO2 [7,21-24]. In response, insect and 
plant viruses encode suppressors of RNAi (VSRs) to counteract the antiviral RNAi 
pathway. Different mechanisms for RNAi suppression have been identified, for 
example some VSRs bind long dsRNA and/or siRNAs to shield them from Dicer 
cleavage or prevent their loading into Argonaute, respectively [7,25-33]. Other 
suppressors interact with Argonaute proteins to inhibit their activity or induce their 
degradation [10,34-40]. 
The ongoing arms race with viruses can impose a strong selective pressure on 
immune genes of the host [41]. Strikingly, Dcr-2, R2D2, and AGO2 belong to the 3% 
fastest evolving genes in D. melanogaster and D. simulans, showing very high rates of 
adaptive amino acid substitution and recent selective sweeps in multiple Drosophila 
species [42-44]. It has been hypothesized that this rapid adaptive evolution may 
be driven by antagonistic co-evolution with viral suppressors of RNAi [45], as the 
RNAi pathway continues to evolve new ways to escape viral antagonists, leading to 
counter-adaptations by viruses that require further adaptations in the RNAi pathway 
of the host. A potential outcome of this ever-lasting antagonistic co-evolution is that 
viral RNAi suppressors become specialized to suppress RNAi in their host species, 
while losing this activity in non-host species. This may be unlikely for viral antagonists 
that bind dsRNA, which often efficiently suppress RNAi in both host and non-host 
species, and in some cases even across kingdoms [46-50]. However, when viruses 
antagonize protein components of the RNAi pathway, there is ample opportunity for 
co-evolution and the evolution of host-specificity.
Nora virus of Drosophila melanogaster (DmelNV) is a natural fruit fly pathogen 
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that causes a persistent infection in laboratory stocks as well as in wild caught 
flies [51]. Persistent infections are thought to reflect a dynamic equilibrium 
between host defense responses and viral counter-defense mechanisms [52]. The 
widespread abundance and persistent nature of DmelNV infections may suggest a 
metastable equilibrium between antiviral RNAi responses and viral counter-defense 
mechanisms. Indeed, we recently showed that DmelNV is a target and a suppressor 
of the antiviral RNAi pathway [10]. We identified viral protein 1 (VP1), the product 
of open reading frame 1, as an RNAi suppressor that counteracts AGO2-mediated 
target RNA cleavage (Slicer activity). 
Here we present two novel Nora-like viruses identified by metagenomic sequencing 
of wild populations of D. immigrans (DimmNV) and D. subobscura (DsubNV), and use 
these viral genomes to study RNAi antagonism from an evolutionary perspective. 
We find that DmelNV VP1 does not display host specificity: DmelNV VP1 co-localizes 
and interacts with the AGO2 protein from its natural host D. melanogaster, as well as 
from non-host D. immigrans. In accordance, DmelNV VP1 suppressed slicer activity 
in embryo lysates from D. melanogaster as well as from D. immigrans. In contrast, 
we find that the RNAi suppressor activity of DimmNV VP1 is restricted to its natural 
host species, D. Immigrans: DimmNV VP1 was unable to interact with D. melanogaster 
AGO2 (Dmel AGO2), but specifically interacted with AGO2 from its natural host, D. 
immigrans (Dimm AGO2). In line with this observation, we show that recombinant 
DimmNV VP1 protein inhibits Slicer activity in embryo lysates of its host D. immigrans, 
but not in lysates of its non-host D. melanogaster. We conclude that co-evolution 
between Nora viruses and their Drosophila hosts can result in a host species-specific 
interaction with, and antagonism of, AGO2, and therefore that viral suppressors of 
RNAi are candidate host specificity determinants. 
Results
Dmel Nora virus VP1 co-localizes with Dmel AGO2
We recently showed that DmelNV VP1 inhibits RNA cleavage (slicer) activity of a pre-
assembled RISC in D. melanogaster [10], which suggests that VP1 and mature RISC 
reside in the same cellular compartment. To determine the subcellular localization of 
VP1 and AGO2, the catalytic core component of RISC, we generated recombinant full-
length VP1 protein fused to the enhanced green fluorescent protein at its C-terminus 
(VP1-EGFP). We first verified that VP1-EGFP was competent in suppressing RNAi using 
a reporter assay in S2 cells. In contrast to a control vector, VP1-EGFP protein potently 
suppressed siRNA-induced silencing of a firefly luciferase reporter, indicating that 
this fusion protein is a functional RNAi suppressor (Figure S1). We next determined 
the subcellular localization of DmelNV VP1 and Dmel AGO2 in S2 cells after co-
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transfection of the VP1-EGFP expression plasmid along with AGO2 expression 
plasmids. We used two AGO2 constructs, one containing the genomic sequence [53], 
the other containing the cDNA sequence of AGO2 [54], both fused to a FLAG epitope 
at their N-termini. VP1-EGFP localized in perinuclear foci in the cytoplasm (Figure 1). 
Both FLAG-AGO2 constructs showed a diffuse cytoplasmic pattern with enrichment 
at cytoplasmic foci. Merging the two detector channels demonstrated that some of 
the VP1-EGFP foci overlap with the FLAG-AGO2 foci. This co-localization suggests 
that VP1 may directly interact with AGO2 to exert its suppressor activity.
Dmel Nora virus VP1 interacts with Dmel AGO2
To investigate a physical interaction between VP1 and AGO2, we analyzed DmelNV 
VP1 immunoprecipitations (IPs) for the presence of AGO2. To this end, we transfected 
S2 cells with an active V5 epitope-tagged VP1 construct (V5-VP1) that encodes the 
C-terminal 124 amino acids of VP1 along with a FLAG-tagged AGO2 cDNA construct. 
IP of V5-VP1 resulted in specific co-precipitation of the FLAG-AGO2 protein (Figure 
2A). In contrast, a V5-control vector failed to co-purify FLAG-AGO2. To confirm the 
interaction between VP1 and AGO2, we performed the reverse experiment. IP of 
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Figure 1: DmelNV VP1 co-localizes with Dmel AGO2 in S2 cells. Confocal images of S2 cells expressing 
full-length VP1-GFP fusion protein together with FLAG-tagged Dmel AGO2 protein. AGO2 was expressed 
either from a cDNA sequence or from a genomic sequence. After transfection, AGO2 was detected by 
immunofluorescence using the anti-FLAG antibody. Nuclei were visualized using Hoechst staining. Right 
panels show superposition of red and green signal along the marked line in the merged pictures.
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FLAG-AGO2 protein co-precipitated V5-VP1, while a FLAG-control vector was unable 
to do so (Figure 2B). Although the interaction between VP1 and AGO2 is evident, only 
a minor fraction of VP1 was immunoprecipitated along with AGO2. This observation 
is in agreement with our microscopic analyses, in which only a small fraction of 
FLAG-AGO2 protein co-localizes with VP1-EGFP (Figure 1). To confirm these results, 
we immunoprecipitated V5-VP1 protein and probed for endogenous AGO2 in the 
IP fraction. As expected, we observed a strong enrichment of endogenous AGO2 
protein after VP1 IP, whereas IP of cells transfected with V5-control plasmid did not 
co-precipitate AGO2 protein (Figure 2C). These results indicate that DmelNV VP1 
interacts with Dmel AGO2 in Drosophila S2 cells.
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Figure 2: DmelNV VP1 interacts 
with Dmel AGO2 in S2 cells. (A) 
Western blot (WB) analysis of V5 
immunoprecipitation on lysates 
from S2 cells transfected with a 
FLAG-AGO2 expression plasmid 
and either V5-tagged DmelNV 
VP1∆N351 (V5-VP1) or V5-control 
plasmid (Vector). The epitope-tagged 
proteins were detected in the input, 
supernatant after IP (Sup), and the 
immunoprecipitate (V5-IP) with 
the indicated antibodies. (B) FLAG 
immunoprecipitation of lysates 
from S2 cells transfected with V5-
tagged DmelNV VP1∆N351 (V5-VP1) 
and either FLAG-AGO2 or FLAG-
control plasmids (Vector), followed 
by SDS-PAGE, and western blotting 
with the indicated antibodies. (C) 
V5 immunoprecipitation of lysates 
from S2 cells transfected with V5-
tagged DmelNV VP1∆N351 (+) or V5-
control (-) plasmids. After SDS-PAGE, 
endogenous AGO2 or DmelNV 
VP1∆N351 proteins were detected 
by western blot using anti-AGO2 
(α-AGO2) and anti-V5 (α-V5) antibody, 
respectively. Asterisk (*) indicates a 
non-specific background band, and 
triangle indicates AGO2.
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Identification of novel Nora-like viruses from D. immigrans and D. subobscura
AGO2 evolves rapidly and adaptively in multiple species of Drosophila [42,43]. We 
therefore hypothesized that the AGO2-VP1 interaction may also evolve rapidly as 
Nora-like viruses adapt to different hosts. In particular, optimization of host AGO2-
VP1 interaction may come at the cost of losing efficient AGO2-VP1 interactions in 
non-host species. As a consequence, viral suppressors of RNAi are candidate host 
specificity determinants. To test whether the AGO2-VP1 interaction is host-specific, 
we set out to identify novel Nora-like viruses from divergent Drosophila species. 
During an exploratory RT-PCR survey of Nora virus prevalence in wild Drosophila, 
we identified the presence of two novel Nora-like viruses in wild populations of 
D. immigrans (DimmNV) and D. subobscura (DsubNV). Following this, we took a 
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Figure 3: Phylogenetic analysis and non-synonymous divergence between Nora viruses. (A) 
Phylogenetic analysis of the most conserved Nora virus gene (VP4) suggests that the three Drosophila 
Nora viruses are each other’s closest relatives, and that they are all closely related to the Nora-like 
sequence derived from Haematobia irritans. Note that DimmNV is much more divergent from DsubNV 
and DmelNV in VP1 and VP2 (which are not available for the other two viruses), and that although 
DimmNV appears to be most closely related to DmelNV based on VP4, the extreme divergence from the 
Nasonia Nora sequence may make the rooting unreliable. The tree presented is the mid-point rooted 
Bayesian maximum a posteriori tree (99% of the posterior set) inferred under a protein substitution 
model. (B) A sliding-window analysis of nonsynonymous divergence between the three Drosophila Nora 
viruses, calculated as the number of nonsynonymous substitutions per nonsynonymous site in windows 
of 50 codons wide, is plotted against the position along the protein-coding regions of the viral genome. 
Dashed lines show a nominal 95% significance threshold for genome-wide peaks in divergence derived 
from randomisation tests, such that peaks crossing the line are unlikely to occur by chance, given the 
overall divergence for that virus. In addition, inset for each viral protein is an unrooted tree with branch 
lengths proportional to overall divergence for that gene. Note that DimmNV is more divergent for VP1 
and VP2 than for VP3 or VP4, while VP3 shows the highest overall divergence between the three viruses.
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metagenomic RNA-sequencing approach to recover near-complete viral genomes 
for both viruses (lengths 12,265 nt and 12,276 nt) from population samples of D. 
immigrans and D. subobscura collected in the United Kingdom. These novel viruses 
are more closely related to the Nora virus originally identified in D. melanogaster 
(DmelNV) [51] than to the Nora-like virus recently described from the fly Haematobia 
irritans [55], or the much more distantly related Nora-like virus described from the 
wasp Nasonia vitripennis [56] (Figure 3A). Overall, DmelNV is more divergent from 
DimmNV than it is from DsubNV (65% vs. 71% overall base identity, respectively), 
but phylogenetic analysis based on the coat protein VP4 suggests that DmelNV and 
DimmNV may be each other’s closest relatives. Divergence between the three viruses 
is too high to reliably estimate the true number of synonymous substitutions per 
codon [57,58], and the low nonsynonymous to synonymous substitution ratio (dN/
dS=0.076, SE=0.003) may therefore represent an upper limit. Amino-acid divergence 
between the viruses varies substantially between genes (Figure 3B). For example, 
amino-acid identity between DimmNV and DmelNV varies from 82% for VP4 to 
only 43% for VP3 (unknown function), with VP1 showing an intermediate level of 
conservation (51% amino acid identity). A sliding-window analysis of nonsynonymous 
divergence shows that DmelNV and DsubNV are more similar to each other than to 
DimmNV in VP1 and VP2, but that the three viruses are equidistant from each other 
in VP3 and VP4. This may be a result of host-mediated selection, reflecting the closer 
relationship between D. melanogaster and D. subobscura, or it may be a result of 
recombination in the history of these three viruses.
VP1 of Dimm and Dsub Nora-like virus do not suppress RNAi in 
D. melanogaster S2 cells.
To test whether there is host-specificity in the interaction between antiviral RNAi 
components and viral RNAi antagonists, we analyzed whether the DimmNV 
and DsubNV VP1 proteins are able to suppress RNAi in the S2 cell line from D. 
melanogaster. To this end, we cloned the full-length (FL) VP1 sequences and N- and 
C-terminal deletion mutants thereof (∆N and ∆C) as N-terminal fusions to the V5 
epitope in an insect expression plasmid (Figure S2). We verified expression of the 
DimmNV VP1 constructs by western blot after transfection in Drosophila S2 cells 
(Figure 4A). With the exception of the DimmNV VP1∆N362, all DimmNV VP1 constructs 
were expressed at least at the level of DmelNV VP1FL that efficiently suppresses RNAi 
in reporter assays in S2 cells [10]. We then analyzed the ability of the DimmNV VP1 
constructs to suppress RNAi in reporter assays. We transfected S2 cells with FLuc 
reporter plasmids, along with VP1 expression plasmids and induced silencing of 
the FLuc reporter by soaking the cells in FLuc specific dsRNA. As reported earlier 
[10], all DmelNV VP1 constructs, except DmelNV VP1∆C74, suppressed RNAi-mediated 
silencing of the FLuc reporter. In contrast, none of the DimmNV VP1 constructs 
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efficiently suppressed silencing of the reporter (Figure 4B). To confirm these results, 
we used an RNAi sensor assay that is independent of dsRNA uptake by S2 cells. In 
this sensor assay, the RLuc reporter is silenced by expression of an inverted repeat 
that folds into an RLuc-specific RNA hairpin. In line with the previous RNAi sensor 
assay, DimmNV VP1 did not suppress hairpin-induced silencing of the RLuc reporter 
in D. melanogaster S2 cells, whereas DmelNV VP1 efficiently suppressed RNAi (Figure 
4C). In addition, we tested if the VP1 constructs can suppress RNAi in a sensor assay 
in which silencing is induced by co-transfection of siRNAs. Also in this assay, DimmNV 
VP1 was unable to suppress silencing of the FLuc reporter, whereas DmelNV VP1 
efficiently suppressed RNAi-based silencing (Figure S3C). Similarly, the DsubNV 
VP1 constructs were unable to suppress long dsRNA- or siRNA-induced RNAi in D. 
melanogaster derived S2 cells (Figure S3A-C).
50
37
25
20
Ve
ct
or
FL ∆C
74
∆N
35
1
∆N
31
5
∆N
28
4
FL ∆C
71
∆N
36
2
∆N
32
6
∆N
29
5
DmelNV VP1 DimmNV VP1
α-V5
α-Tub
A B
C
DmelNV VP1 DimmNV VP1
Ctrl
dsRNA
FLuc
dsRNA
Ve
cto
r
Ve
cto
r FL
∆C
74
∆N
35
1
∆N
31
5
∆N
28
4 FL
∆C
71
∆N
36
2
∆N
32
6
∆N
29
5
0
5
10
15
20
Fo
ld
 s
ile
nc
in
g
RLuc
hairpin
Ctrl
Ve
cto
r
Ve
cto
r
Dm
elN
V 
VP
1
Di
mm
NV
 V
P1
0
10
20
30
40
Fo
ld
 s
ile
nc
in
g
Figure 4: VP1 suppressor activity is species-specific. (A) Western blot 
analysis of S2 cells expressing V5 epitope-tagged VP1 from D. melanogaster 
Nora virus (DmelNV) and D. immigrans Nora-like virus (DimmNV). S2 cells 
were transfected with plasmids encoding full-length VP1 (FL) or C-terminal 
(∆C) or N-terminal (∆N) deletions thereof. Expression of the VP1 constructs 
was analyzed by western blot using the anti-V5 (α-V5) antibody. Detection 
of tubulin with anti-tubulin (α-tub) antibody was used as a loading control. 
Molecular mass (in kDa) is indicated on the left. (B) RNAi sensor assay in 
S2 cells. Firefly luciferase (FLuc) and Renilla luciferase (RLuc) reporter 
plasmids were transfected into S2 cells, together with plasmids encoding 
the indicated VP1 constructs. Two days after transfection, the S2 cells 
were soaked in either control (Ctrl) dsRNA or FLuc dsRNA. The next day, 
luciferase activities were measured. FLuc counts were normalized to RLuc 
counts, and presented as fold silencing relative to the corresponding 
control dsRNA transfection. (C) Hairpin-based RNAi sensor assay in S2 cells. 
S2 cells were transfected with plasmids coding for FLuc, RLuc, and an RLuc-
hairpin together with a control vector (Vector) or constructs expressing 
N-terminal deletion mutants of DmelNV VP1 (DmelNV VP1∆N285) or DimmNV VP1 (DimmNV VP1∆N281). 
RLuc counts were normalized to FLuc counts, and presented as fold silencing over non-hairpin control 
transfections. Bars in Panels B and C represent means and standard deviations of three independent 
biological replicates.
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Dimm Nora virus VP1 inhibits Slicer activity in its natural host species, 
D. immigrans
The inability of DimmNV VP1 and DsubNV VP1 to suppress RNAi in Drosophila S2 
cells may be explained in two ways. First, viral RNAi suppressors may have a species-
specific activity, following the prediction that RNAi antagonists efficiently suppress 
RNAi in host species, but not in non-host species. Second, some Nora-like viruses 
may either be unable to suppress RNAi, or they may encode RNAi suppressor activity 
in different regions of the viral genome, as was previously observed for members 
within a single plant virus family [59-61]. To address the first possibility, we tested the 
ability of DimmNV VP1 and DmelNV VP1 to suppress RNAi in both host species using 
in vitro RNA cleavage (Slicer) assays [62] in lysates of embryos from D. melanogaster 
and D. immigrans. We excluded D. subobscura and DsubNV from this and subsequent 
analyses, as members of the obscura group encode multiple AGO2-like proteins, for 
which the biochemical and antiviral activity remain to be established [63].
In slicer assays, RNAi dependent cleavage of a 5’-32P cap-labelled target RNA is 
induced by the addition of a target specific siRNA. Since the target RNA is radio-
labeled at its 5’ cap, the 5’ cleavage product can be visualized by autoradiography 
after polyacrylamide gel electrophoresis. As expected, in both D. melanogaster 
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Figure 5: Species-specific inhibition of AGO2 slicer activity. (A) In vitro RNA cleavage (slicer) assays 
in lysates from D. melanogaster embryos (left panel) or D. immigrans embryos (right panel). Radioactively 
cap-labelled target RNA was incubated in embryo lysate together with a non-specific control siRNA (lanes 
1,6) or a target specific siRNA (lanes 2-5,7-10). Target cleavage was determined either in the absence 
of recombinant protein (lanes 2,7) or in the presence of 0.3 µM of MBP (lanes 3,8), MBP-DmelNV 
VP1∆N284 (lanes 4,9), or DimmNV VP1∆N295 protein (lanes 5,10). (B) Quantification of target cleavage in D. 
melanogaster and D. immigrans embryo lysate in the presence of MBP, DmelNV VP1∆N284, or DimmNV 
VP1∆N295 protein. The fraction of cleaved RNA was normalized to MBP and determined by dividing the 
intensity of the cleavage product by the total intensity of cleavage product and non-cleaved target. Bars 
represent means and standard deviations of two independent experiments.
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and D. immigrans embryo lysates a specific cleavage product was observed after 
incubation with a target specific siRNA (Figure 5A, lanes 2 and 7). In line with our 
earlier report [10], recombinant DmelNV VP1 protein potently inhibited cleavage 
of the target RNA in D. melanogaster embryo lysate, whereas the control, Maltose 
Binding Protein (MBP), was unable to do so (Figure 5A, compare lanes 3 and 4). 
In contrast, recombinant DimmNV VP1 protein did not inhibit Slicer activity in D. 
melanogaster embryo lysate (Figure 5A, lane 5), which is in line with our observation 
that DimmNV VP1 did not suppress RNAi in cell-based reporter assays in D. 
melanogaster cells (Figure 4). Surprisingly, in the D. immigrans embryo lysate both the 
DmelNV VP1 and the DimmNV VP1 protein inhibited target RNA cleavage (Figure 5A, 
lanes 9 and 10). As expected, the MBP control protein did not inhibit Slicer activity 
(Figure 5A, lane 8). Quantification of independent experiments indicates that both 
DmelNV and DimmNV VP1 proteins suppressed Slicer activity to a similar extent in 
the D. immigrans embryo lysate (Figure 5B). These results, together with those from 
the cell-based reporter assays indicate that DimmNV VP1 inhibits Slicer activity in 
its natural host D. immigrans, but is unable to suppress RNAi in a heterologous D. 
melanogaster background. In contrast, DmelNV VP1 inhibits Slicer activity in both a D. 
melanogaster and a D. immigrans background.
Species-specific interaction between DimmNV VP1 and Dimm AGO2 
The results shown in figures 1 and 2 indicate that DmelNV VP1 interacts with Dmel 
AGO2 to suppress its Slicer activity. Similarly, given the observation that DimmNV 
VP1 suppresses slicer activity in D. immigrans lysates, it is likely that DimmNV VP1 
interacts with Dimm AGO2. We hypothesized that the inability of DimmNV VP1 
to suppress RNAi in D. melanogaster may then be due to an inefficient interaction 
with Dmel AGO2. To test these hypotheses, we analyzed VP1 interactions with host 
and non-host AGO2 proteins by co-immunoprecipitations. First, we co-expressed 
DmelNV VP1 or DimmNV VP1 with a Dmel FLAG-AGO2 construct in S2 cells and 
immunopurified the VP1 proteins using V5 affinity beads. As controls, we analyzed 
IPs of cells transfected with empty vector. As observed above (Figure 2), IP of DmelNV 
VP1 co-precipitated Dmel FLAG-AGO2 protein. In contrast, IP of DimmNV VP1 did 
not enrich for Dmel FLAG-AGO2 in the IP fraction, compared to IP of the V5-control 
vector (Figure 6A). To confirm these results, we analyzed the interaction between 
VP1 proteins and endogenous D. melanogaster AGO2. Similar to our observations 
in Figure 2, DmelNV VP1 co-immunoprecipitated endogenous Dmel AGO2, whereas 
the control vector failed to do so (Figure 6B). In contrast, DimmNV VP1 failed to 
co-IP Dmel AGO2, which mirrors our observation with epitope-tagged Dmel AGO2. 
These observations imply that the inability of DimmNV VP1 to suppress RNAi in D. 
melanogaster is due to its inability to efficiently interact with Dmel AGO2.
We then analyzed the interaction of DimmNV VP1 with Dimm AGO2. To this end, 
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we cloned the D. immigrans AGO2 cDNA sequence downstream of FLAG (Dimm 
FLAG-AGO2). As expected, the predicted protein domains of Dimm FLAG-AGO2 
are similar to those of Dmel AGO2, suggesting that the overall protein structure of 
Dimm and Dmel AGO2 are alike. We thus analyzed the interaction of DmelNV VP1 or 
the DimmNV VP1 with Dimm FLAG-AGO2 in co-IP. Both DmelNV VP1 and DimmNV 
VP1 efficiently co-purified the Dimm-AGO2 protein (Figure 6C). These results show 
that AGO2-VP1 interactions correlate with RNAi suppressor activity: DmelNV VP1 
interacts with both Dmel and Dimm AGO2 and suppresses slicer activity of these 
hosts; DimmNV VP1 interacts with Dimm AGO2, but not Dmel AGO2, and suppresses 
slicer activity in D. immigrans, but not in D. melanogaster.
DimmNV VP1 specifically suppresses Dimm AGO2 activity
The species-specific interaction of DimmNV VP1 with Dimm AGO2 suggests that 
this interaction is the major determinant for the observed species specificity 
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Figure 6: Species-specific interaction 
between VP1 and AGO2. (A) V5 
Immunoprecipitation (V5-IP) of lysates from 
S2 cells transfected with FLAG-tagged Dmel 
AGO2 expression plasmid and either V5-
tagged DmelNV VP1∆N284, DimmNV VP1∆N295, 
or V5-control plasmids. Input, supernatant 
after IP (Sup.), and the immunoprecipitate 
(V5-IP) were analyzed by western blot (WB) 
using anti-V5 (α-V5) or anti-FLAG (α-FLAG) 
antibodies. (B) V5 immunoprecipitation of S2 
cells transfected with plasmids encoding V5-
tagged DmelNV VP1∆N284, DimmNV VP1∆N295, 
or V5-control vector. Fractions were analyzed 
by western blot (WB) using antibodies for 
endogenous AGO2 (α-AGO2) and V5 (α-
V5). (C) V5 immunoprecipitation on lysates 
from S2 cells co-transfected with plasmids 
encoding FLAG-tagged Dimm-AGO2 and 
either V5-tagged DmelNV VP1∆N284, DimmNV 
VP1∆N295, or V5-control vector. VP1 and Dimm-
AGO2 proteins were detected on western 
blot (WB) using anti-V5 (α-V5) and anti-FLAG 
(α-FLAG) antibodies, respectively. Asterisk (*) 
indicates a non-specific background band, 
and triangle indicates AGO2.
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in Slicer activity. To test this hypothesis, we set out to reconstitute Dimm AGO2-
based silencing in D. melanogaster S2 cells and analyze whether DimmNV VP1 could 
suppress this reconstituted pathway. To this end, we knocked-down endogenous 
AGO2 expression in D. melanogaster S2 cells, and rescued its activity with either the 
Dmel AGO2 or Dimm AGO2 cDNA construct. 
First, we assessed the efficacy of knockdown of AGO2 expression in S2 cells using 
dsRNA against the coding sequence (CDS) or the 3’ untranslated region (3’ UTR) of 
the endogenous Dmel AGO2 transcript. To monitor AGO2 activity in these S2 cells we 
induced RNAi with the RLuc-specific RNA hairpin. Compared to a non-specific dsRNA 
control, dsRNAs against the CDS or the 3’UTR of AGO2 severely reduced hairpin-
induced silencing of the RLuc reporter (Figure 7A). This experiment thus creates the 
opportunity to knockdown endogenous AGO2 expression with UTR-targeting dsRNA 
and rescue silencing defects with Dmel AGO2 or Dimm AGO2 cDNA constructs, 
which lack the AGO2 3’UTR sequence and are therefore not targeted by the RNAi 
approach. Strikingly, both Dmel AGO2 and Dimm AGO2 rescued silencing activity 
in D. melanogaster cells, whereas Dmel AGO1 or the control vector were unable to 
do so (Figure 7B). These results indicate that Dimm AGO2 is fully functional in a 
D. melanogaster background and that the limited sequence identity to Dmel AGO2 
(only 63% amino-acid identity, excluding the glutamine-rich region) does not impede 
its ability to interact with Dmel Dcr-2 and R2D2 or other components of the D. 
melanogaster RISC complex.
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Figure 7: DimmNV VP1 
inhibits Dimm AGO2 
function. (A) RNAi reporter 
assay using hairpin-induced 
silencing of an RLuc 
reporter that shows the 
AGO2 dependence of the 
RLuc hairpin RNAi reporter 
assay. The experiment was 
performed as described in 
Figure 3D, only a non-specific 
control dsRNA (dsCtrl) or 
dsRNA targeting the coding 
sequence or the 3’UTR of 
Dmel AGO2 (dsAGO2 CDS and 
dsAGO2 3’UTR, respectively) 
was co-transfected along 
with the reporter plasmids. (B) Rescue of endogenous AGO2 knockdown in RLuc hairpin RNAi reporter 
assay. Endogenous AGO2 expression was knocked-down by transfection of dsRNA targeting the AGO2 
3’UTR along with the reporter plasmids (described in Figure 3D) and with control plasmid (Vector), 
or expression plasmids encoding D. melanogaster AGO1 (Dmel AGO1) or AGO2 (Dmel AGO2), or D. 
immigrans AGO2 (Dimm-AGO2). Control vector (-) or a plasmid encoding D. immigrans Nora virus VP1 
(DimmNV VP1∆N281) was co-transfected. Bars in all panels represent means and standard deviations of 
three biological replicates.
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Using this AGO2 rescue assay, we investigated whether DimmNV VP1 suppressed 
Dmel AGO2 and Dimm AGO2-mediated silencing. DimmNV VP1 expression did not 
impede Dmel Ago2-mediated RNAi (Figure 7B), which is in line with our observations 
that DimmNV VP1 did not inhibit RNAi in D. melanogaster S2 cells (Figure 4A). 
In contrast, we observed that Dimm AGO2-mediated silencing was efficiently 
suppressed by DimmNV VP1 (Figure 7B). 
We were unable to analyze DmelNV VP1 in this assay, as its potent RNAi suppressive 
activity would impede silencing of endogenous Dmel AGO2, which is required for 
this assay. Together, these results indicate that the interaction of VP1 with AGO2 is 
the major determinant for its RNAi suppressive activity. Moreover, these data imply 
that the VP1-AGO2 interaction is a major determinant for the species-specific effects 
of VP1. 
Discussion
Viruses and hosts engage in an ongoing arms race in which viral counter-defense 
mechanisms drive the adaptive evolution of host immune genes, which in turn 
requires ongoing counter-adaptations in viral immune antagonists [1,41]. This ever-
lasting cycle of adaptations and counter-adaptations may result in species-specific 
interactions between virus and host [41,64].
The antiviral RNAi genes R2D2, Dcr-2 and AGO2 belong to the 3% fastest evolving 
genes of Drosophila melanogaster and show evidence of positive selection in multiple 
species [42]. Strikingly, rapid evolution is observed in the antiviral RNAi pathway, 
whereas the microRNA pathway does not show evidence for rapid evolution. It is 
therefore possible that antagonistic host-parasite interactions – either through 
prolonged coevolution or through invasion by novel pathogens – are responsible for 
the observed rapid adaptive evolution in RNAi genes.
Nora virus is a positive stranded RNA virus that was recently identified in laboratory 
stocks of Drosophila melanogaster [51]. Its unique genome organization and capsid 
structure suggests that Nora virus is the founding member of a novel virus family 
[65]. We report here that divergent Nora-like virus sequences are found in wild-
caught D. immigrans and D. subobscura flies. Together with the recent isolation of 
Nora-like virus sequences from the horn fly Haematobia irritans and the parasitoid 
wasps Nasonia vitripennis and N. giraulti, these observations suggest that Nora virus 
is a member of a large family of widespread pathogens that infects multiple insect 
species [55,56].
Although little is known regarding the natural host range of Nora viruses, it is worth 
noting that neither of our population samples of D. immigrans and D. subobscura 
showed sequences derived from the alternative viral lineages (i.e. DmelNV was 
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not identified in D. immigrans or D. subobscura, and similarly for the other Nora-
like viruses), despite being collected in mixed samples containing multiple species 
of Drosophila. It is therefore possible that, as is the case for the purely vertically 
transmitted Sigma viruses, Nora viruses move between hosts very rarely [66].
Plant and insect viruses can suppress the antiviral RNAi pathway of their hosts via 
a variety of mechanisms [7,10,25,30,33,38,67,68]. Recently, we showed that Nora 
virus VP1 suppresses RNAi by inhibiting AGO2 slicer activity of a pre-assembled 
RISC [10]. In this report we show that the RNAi suppressor activity of VP1 from 
Nora-like viruses can be species-specific and that its RNAi suppressive activity 
correlates with its ability to interact with AGO2. DimmNV VP1 efficiently interacts 
with Dimm AGO2 and suppresses AGO2-mediated target cleavage (slicer) activity in 
D. immigrans embryo lysates. In contrast, DimmNV VP1 was unable to suppress RNAi 
in D. melanogaster cells, did not interact with Dmel AGO2, and did not inhibit Slicer 
activity in D. melanogaster embryo lysates. These results are consistent with a model 
in which adaption and co-evolution of DimmNV with its host resulted in a species-
specific AGO2-VP1 interaction. 
Our findings have important practical implications. Experimentally amenable 
model systems, such as Drosophila melanogaster or Arabidopsis thaliana are often 
used to identify and characterize viral suppressors of RNAi, including in viruses that 
naturally do not infect these hosts. Our observation that RNAi suppressor proteins 
may have species-specific activity, indicates that it is important to take into account 
the correct evolutionary context in experiments aimed at the identification of viral 
suppressors of RNAi. For example, we note that we would not have been able to 
detect RNAi suppressive activity in DimmNV, if we had solely relied on experiments 
in D. melanogaster.
In striking contrast to DimmNV, DmelNV VP1 did not show a species-specific 
interaction. It can engage in an interaction with both Dimm and Dmel AGO2 and, 
accordingly, it inhibited slicer activity in both D. immigrans and D. melanogaster 
embryo lysates. We suggest that there are two potential explanations for this. First, 
it may be that the viruses differ in natural host range, and if DmelNV has a wider 
host range than DimmNV then the broader-spectrum functionality of its VSR across 
divergent hosts could be maintained by selection. Although none of these three 
viruses was identified from the other host species, DmelNV has been isolated from 
wild Drosophila simulans (DJO, unpublished data). Second, if there is not a substantial 
trade-off associated with host-specialisation and if DmelNV has colonised D. 
melanogaster quite recently, it could just be a matter of time until DmelNV loses its 
broad-spectrum VSR.
Strikingly, the species-specific interaction between AGO2 and VP1 is the sole 
determinant for the species-specific activity of DimmNV VP1. As we were able to 
reconstitute Dimm AGO2-based silencing in D. melanogaster cells, it indicates that 
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Dimm AGO2 is fully functional in a D. melanogaster background and that the limited 
amino acid identity with Dmel AGO2 (~64%) does not impede its ability to interact with 
Dmel Dicer-2 and R2D2 or other components of the RISC complex. Thus, even though 
RNAi genes are rapidly evolving and show high rates of adaptive substitution, these 
results imply that this diversification has not impeded cross-species interactions of 
RNAi genes, even over the tens of millions of years that separate D. melanogaster and 
D. immigrans. This conservation of function may imply that the need for interaction 
between Dicer-2, R2D2, AGO2, and other RNAi-pathway genes imposes a constraint 
on the evolution of these genes, and thus their opportunity to evolve in response to 
virus-mediated selection.
 
Materials and Methods
Identification and sequencing of novel Nora-like viruses
While surveying wild Drosophila populations for the prevalence of Nora virus using RT-
PCR (unpublished data; PCR primers: forward 5’-GACCATTGGCACAAATCACCATTTG-3’, 
reverse 5’-TCTTAGGCCGGTTGTCTTCACCC-3’) we unexpectedly identified Nora Virus-
like PCR products from D. immigrans and from members of the obscura group 
(sampled in Edinburgh, UK; longitude 55.928N, latitude 3.170W). Following this, 
we took a metagenomic approach to obtain near-complete viral genomes. Flies 
were collected from elsewhere in the UK, and samples pooled by species for RNA 
extraction and Illumina double-stranded nuclease normalized RNA-sequencing. 
For D. subobscura, only male flies were used as females are difficult to distinguish 
morphologically from close relatives. RNA was extracted from each collection using a 
standard Trizol (Invitrogen) procedure, according to the manufacturer’s instructions, 
and pooled in proportion to the number of contributing flies. In total, the two pools 
comprised 338 male D. subobscura (60 flies July 2011 Edinburgh 55.928N, 3.170W; 60 
flies October 2011 Edinburgh 55.928N, 3.170W; 38 flies July 2011 Sussex 51.100N, 
0.164E; 180 flies August 2011 Perthshire 56.316N, 3.790W) and 498 D. immigrans (63 
flies, July 2011 Edinburgh 55.928N, 3.170W; 285 flies July 2011 Edinburgh N55.921, 
W3.193; 150 flies July 2011 Sussex 51.100N, 0.164E). Total RNA was provided to the 
Beijing Genomics Institute (Hong Kong) for normalization and 100nt paired-end 
Illumina sequencing. Paired-end reads were quality trimmed using ConDeTri version 
2 [69] and assembled de novo using the Trinity transcriptome assembler with default 
settings (r2011-08-20; [70]). We used tblastn with a DmelNV protein query to identify 
two partially overlapping Nora-like contigs from D. immigrans, and a single contig 
from D. subobsura. Quality-trimmed paired-end reads were mapped back to these 
contigs using stampy (version 1.0.21: [71]) to obtain a consensus sequence, based 
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on majority-calls at each position. In total, 286,242 reads mapped to DimmNV (0.45% 
of all reads, median read depth 1200-fold) and 68,914 reads mapped to DsubNV 
(0.13% of all reads, median read depth 133-fold). Consensus sequences have been 
submitted to Genbank under accession numbers KF242510 (DsubNV) and KF242511 
(DimmNV).
Tree inference and sequence analysis
The relationship between Nasonia vitripennis Nora-like virus (Genbank FJ790488; 
[56]), Haematobia irritans Nora-like virus (Genbank HO004689, HO000459, and 
HO000794; [55]), DmelNV (Genbank NC_007919.3; [65]), DsubNV, and DimmNV 
was inferred from VP4 (capsid protein), which is the most conserved gene and the 
one with the most coverage in the non-Drosophila sequences. For the N. vitripennis 
Nora-like virus we selected the longest sequence (FJ790488) for inclusion here. 
Phylogenetic inference used MrBayes (v3.2.1: [72]) with discrete gamma-distributed 
rate variation and model-jumping between fixed-rate amino acid models. Two 
parallel runs of four heated chains were used, and convergence was assessed 
by examination of the potential scale reduction factor and the variance in split-
frequencies between runs (PSRF ~1 for all parameters; variance in split-frequencies 
<0.0001). The nonsynonymous divergence along each of the branches leading 
to DmelNV, DsubNV, and DimmNV (Figure 3B) was inferred using the method of 
Li [73], relative to an ancestral sequence inferred by maximum likelihood. Sliding 
windows were 50 codons wide, and placed every 30 codons. Nominal genome-wide 
‘significance’ thresholds were derived by repeating the sliding-window analysis on 
1000 randomizations of codon order.
Cloning
The following constructs were described previously: all DmelNV VP1 constructs 
[10], pCasper_FLAG-HA-AGO2 [53], pAFW-AGO2 [54], pAFW (Drosophila Genomics 
Resource Center, http:// https://dgrc.cgb.indiana.edu), pMT-FLuc [33], pMT-RLuc 
[33], pRmHa-Renilla-hairpin [74], pAc5-V5-His-A (Invitrogen), and pAc5-V5-His-Ntag 
[10].
For the localization of VP1 in S2 cells, the EGFP sequence was amplified 
using primer pair 5’-AGTAAGCTTATGGTGAGCAAGGGCGAG-3’ and 
5’-GGTTCTAGATTACTTGTACAGCTCGTCCATGC-3’. Subsequently, the HindIII and XbaI 
restriction sites were introduced into pAc5-V5-His-VP1FL [10], and used to insert the 
EGFP fragment, generating pAc5-VP1FL-EGFP. 
cDNA of D. immigrans and D. subobscura was made using Promega MMLV-RT together 
with Promega RNasin Plus according to manufacturer’s instructions. Subsequently, 
DimmNV VP1 and DsubNV VP1 sequences were PCR amplified from D. immigrans and 
D. subobscura cDNA and cloned as full-length and deletion constructs downstream 
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of the V5-His tag in pAc5-V5-His-Ntag.
The D. immigrans AGO2 cDNA sequence (Genbank KF362118), including 
parts of the 5’ and 3’ UTRs, was PCR amplified using the primer pair 
5’-TGCAGCAAAAATTAGAAGCAAA-3’ and 5’-AGCCGTACCTAGAACCAGCA-3’. The 
resulting PCR product was used as a template in a nested PCR using primer 
pair 5’-AGTTCTAGACCGCGGGAATGGGTAAAAAGAACAAGTTCAAACCA-3’ and 
5’-AGTTCTAGACCGCGGGAAGCGCTGTGGCACAGCTTCCGC-3’. The nested PCR product 
was subsequently cloned into the pAFW vector using the SacII and SalI restriction 
sites. To fuse the DimmNV VP1∆N295 protein to the C-terminus of the maltose binding 
protein (MBP), we PCR amplified the VP1 coding sequence from pAc5.1-Ntag-
DimmNV VP1FL with primer pair 5’-AGTGGATCCCCAAAACTTCCAAGTGTACCTTCAAAG 
-3’ and 5’-GGTGTCGACTTAGTTTTGTTTATTTTTGTACCAATCGTTGG -3’. The resulting 
PCR product was cloned into the pMal-C2X vector (New England biolabs) using 
BamHI and SalI restriction sites, producing the pMal-C2X-DimmNV VP1∆N295 vector.
Cell culture and immunostaining 
Drosophila S2 cells were cultured as described previously [10]. For the localization 
of VP1 and AGO2 proteins, S2 cells were seeded in a 24-well plate at a density 
of 3x105 cells per well. The next day, cells were transfected with 800 ng of pAc5-
VP1FL-EGFP plasmid together with 800 ng of either pAFW-AGO2 or pCasper_FLAG-
HA-AGO2 plasmid using Effectene transfection reagent (Qiagen) according to the 
manufacturer’s protocol. Three days after transfection, the cells were resuspended 
and seeded on concanavalin A (ConA) coated coverslips [75]. After a 2-hour incubation, 
the cells were fixed for 5 minutes with 4% paraformaldehyde, and permeabilized in 
PBS/0.1% Triton for 10 minutes, followed by incubation in blocking buffer (PBS/0.1% 
Triton/5% FCS) for 1 hour. For AGO2 detection, the cells were incubated with anti-
FLAG antibody (Sigma), diluted 1:200 in blocking buffer, for 1 hour. Subsequently, the 
samples were stained with Alexa Fluor 594-conjugated secondary goat anti-rabbit 
antibody (1:400 dilution) for 1 hour. Nuclei were visualized using Hoechst staining 
(1:15000 dilution) in PBS/0.1% Triton, for 10 minutes, after which the coverslips were 
mounted with Mowiol. Samples were analyzed using an Olympus FV1000 confocal 
laser scanning microscope. 
RNA silencing reporter assays 
Double-stranded RNA was generated by in vitro transcription using T7 
promoter-flanked PCR fragments as a template, as described previously 
[76]. For production of AGO2 dsRNA, a part of the coding sequence or 3’ 
untranslated region of Dmel AGO2 was PCR amplified using primer combination 
5’-TAATACGACTCACTATAGGGAGATACTATGGTGAAGAACGGGTCG-3’ and 
5’-TAATACGACTCACTATAGGGAGAGAACATGTCCTCAATCTCCTCC-3’, or primer 
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combination 5’-TAATACGACTCACTATAGGGAGAGCAACGTATTGAATCTTATT-3’ and 
5’-TAATACGACTCACTATAGGGAGAAGAACAATATTTGGCGGACC-3’, respectively. 
miRNA and RNAi sensor assays were performed as described [10,76]. For hairpin-
induced silencing of the RLuc reporter, 5x104 S2 cells were seeded per well in a 96-
well plate. The seeded cells were co-transfected with 10 ng pMT-FLuc, 10 ng pMT-
RLuc, 50 ng pRmHa-Renilla-hairpin, and 50 ng of expression plasmids encoding 
VP1 and/or AGO per well using Effectene transfection reagent (Qiagen). The pAc5-
Ntag-DmelNV VP1∆284 and pAc5-Ntag-DimmNV VP1∆N295 plasmids were used for VP1 
expression. For knockdown of endogenous AGO2, 5 ng of AGO2 dsRNA or control 
dsRNA was co-transfected along with reporter plasmids. Two days after transfection, 
the expression of the luciferase reporter and the pRmHA-Renilla-hairpin was induced 
by the addition of 0.5 mM CuSO4 per well. The next day, cells were lysed and FLuc 
and RLuc activity was measured with the Dual luciferase reporter assay system 
(Promega) according to manufacturer’s protocol.
Immunoprecipitation and western blotting
For immunoprecipitations, S2 cells were seeded in 6-well plates at a density of 2x106 
cells per well. The next day, cells were transfected with AGO2 and/or VP1 expression 
plasmids using Effectene transfection reagent (Qiagen). Expression plasmids 
encoding DmelNV VP1∆N351, DmelNV VP1∆N284, or DimmNV VP1∆N295 were used for co-
immunoprecipitation experiments. Three days post transfection, cells were washed 
twice with PBS and subsequently resuspended in lysis buffer (30 mM HEPES-KOH, 
150 mM NaCl, 2 mM Mg(OAc), 0.1% NP-40, 5 mM DTT) supplemented with protease 
inhibitor cocktail (Roche). After incubation on ice for 10 minutes, the samples were 
passed forty times through a 25-gauge needle, followed by incubation on ice for 10 
minutes. Subsequently, cell lysates were centrifuged at 13,000 rpm for 30 minutes 
and a sample of the supernatant was taken to analyze the input for IP. To remove 
proteins that non-specifically bind to the IP beads, the remaining supernatant was 
incubated with Pierce protein G agarose at 4 ºC for 5 hours while mixing end-over-end. 
Next, the protein G agarose was separated from the supernatant by centrifugation, 
after which the supernatant was incubated overnight with anti-V5 agarose affinity 
gel (Invitrogen) at 4 ºC while mixing end-over-end. The next day, the anti-V5 agarose 
was separated from the supernatant by centrifugation, and a sample was taken from 
the supernatant. After the remaining supernatant was removed, the V5-agarose was 
washed three times with lysis buffer, and three times with either wash buffer 150 (25 
mM Tris-Cl, 150 mM NaCl) or wash buffer 200 (25 mM Tris-Cl, 200 mM NaCl). All wash 
steps were done with 40 to 60 times beads volume of wash buffer. Subsequently, 
the beads were boiled in SDS sample buffer at 95 ºC for 10 minutes, followed by a 
brief centrifugation step to collect the beads at the bottom of the tube. The proteins 
in the supernatant were then separated on a SDS-PAGE gel, after which they were 
120
Chapter 5
transferred onto a nitrocellulose membrane by western blot. Primary antibodies 
used for western blot detection were anti-FLAG-M2 (1:1000 dilution; Sigma), anti-V5 
(1:5000 dilution; Invitrogen), anti-AGO2 (1:500 dilution; generously provided by 
the Siomi lab), and anti-tubulin-alpha (1:1000 dilution, Sanbio), and secondary 
antibodies were goat anti-mouse-IRdye680 (1:15000 dilution; LI-COR), and goat anti-
rabbit-IRdye800 (1:15000 dilution; LI-COR). All western blots were scanned using an 
Odyssey infrared imager (LI-COR biosciences)
Purification of recombinant protein 
To purify recombinant MBP-DimmNV VP1∆N295 protein, the pMal-C2X-DimmNV 
VP1∆N295 plasmid was transformed into the Escherichia coli BL21 (DE3) strain. 
Subsequently, expression of the recombinant protein was induced by addition of 
0.2 mM IPTG. Recombinant protein expression was allowed to proceed overnight at 
18 ºC. The next day, recombinant MBP-DimmNV VP1∆N295 was purified using amylose 
resin (New England biolabs) according to the manufacturer’s protocol. The purified 
protein was subsequently transferred to a dialysis membrane (MWCO 12-14 kDa) 
and incubated overnight in dialysis buffer (20 mM Tris-Cl, 0.5 mM EDTA, 5 mM MgCl2, 
1 mM DTT, 140 mM NaCl, 2.7 mM KCl) at 4 ºC, followed by a second dialysis step for 
5 hours at 4 ºC. The dialyzed protein solution was stored at -80 ºC in dialysis buffer 
containing 30% glycerol. 
Slicer assays
A new D. immigrans line was established from flies collected in June 2012 in 
Edinburgh (Coordinates 55.921N, 3.193W). D. immigrans was cultured similarly as D. 
melanogaster on standard media. Embryo lysates were generated from D. immigrans 
and from an RNAi-competent D. melanogaster laboratory control strain (w1118). In vitro 
target RNA cleavage assays in D. melanogaster embryo lysates were performed as 
described [10]. Minor changes were incorporated for the slicer assay in D. immigrans 
embryo lysate: the reaction contained 0.9 mM MgCl2 and was allowed to proceed 
for 5 hours at 25 ºC before RNA extraction. Suppressor activities of MBP-DmelNV 
VP1∆N284 and MBP-DimmNV VP1∆N295 proteins were tested in these Slicer assays.
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Figure S1: Nora virus VP1-EGFP fusion protein 
suppresses RNAi. An RNAi sensor assay in Drosophila 
S2 cells was performed to analyze the ability of a VP1-
EGFP fusion protein to suppress RNAi. S2 cells were 
transfected with plasmids encoding Firefly luciferase 
(FLuc) and Renilla luciferase (RLuc) reporter along 
with a control vector (Vector) or a plasmid encoding 
the full-length VP1 sequence fused at its C-terminus 
to enhanced green fluorescent protein (VP1FL-EGFP). 
Control siRNA (Ctrl siRNA) or a siRNA targeting FLuc 
(FLuc siRNA) were cotransfected to induce silencing of 
FLuc. FLuc counts were normalized to RLuc counts and 
presented as fold silencing relative to Ctrl siRNA. Bars 
represent means and standard deviations of three 
independent biological replicates.
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Figure S3: DsubNV VP1 and DimmNV VP1 do not suppress RNAi in D. melanogaster cells. (A) 
Western blot analysis of V5-tagged full-length (FL) or N-terminal deletion (∆N) constructs of DsubNV VP1 
or DmelNV VP1. VP1 proteins were detected with anti-V5 (α-V5) antibody. Tubulin (α-tub) was used as 
a loading control. (B) RNAi sensor assay in S2 cells. Firefly luciferase (FLuc) and Renilla luciferase (RLuc) 
reporter plasmids were cotransfected with plasmids encoding either DmelNV VP1, DsubNV VP1, or a 
control vector (Vector). Two days after transfection, cells were soaked in medium containing FLuc dsRNA 
or control dsRNA. One day later, luciferase activities were measured and FLuc counts were normalized 
to RLuc counts and expressed as fold silencing relative to the non-hairpin control transfection (C) RNAi 
sensor assay in S2 cells using full-length (FL) constructs of DmelNV VP1, DimmNV VP1, and DsubNV VP1. 
The assay was done as described in panel B, only siRNAs against FLuc (FLuc siRNA) or a control siRNA 
(Ctrl siRNA) were cotransfected with the plasmids instead of soaking the cells in dsRNA. Bars represent 
means and standard deviations of three independent biological replicates.
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Abstract
R NA interference (RNAi) is a crucial antiviral defense mechanism in insects, including the major mosquito species that transmit important human viruses. To counteract the potent antiviral RNAi pathway, insect viruses 
encode RNAi suppressors. However, whether mosquito viruses generally suppress 
the RNAi pathway remains unclear. We therefore set out to study RNAi suppression 
by Culex Y virus (CYV), a member of the Birnaviridae family that was recently isolated 
from Culex pipiens mosquitoes. Using well-established RNAi reporter assays, we 
show that RNAi is suppressed in cells infected with CYV and that the viral VP3 protein 
is responsible for RNAi antagonism. In contrast, VP3 did not affect the microRNA 
(miRNA) pathway, nor were expression levels of endogenous miRNAs affected by 
CYV infection. We used recombinant VP3, purified from Escherichia coli, to investigate 
the RNAi-suppressive activity of VP3 in more detail. We demonstrate that VP3 binds 
long double-stranded RNA (dsRNA) as well as small-interfering RNAs (siRNAs) in 
electrophoretic mobility shift assays. In agreement with its dsRNA-binding activity, 
VP3 interfered with Dicer-mediated cleavage of long dsRNA into siRNAs in cell 
extracts. Slicing of target RNAs by a pre-assembled RNA-induced silencing complex 
was not affected by VP3. Finally, we show that the RNAi-suppressive activity of VP3 is 
conserved in Drosophila X virus, a birnavirus that persistently infects Drosophila cell 
cultures. Together, our results suggest that the antiviral RNAi machinery drives the 
evolution of RNAi antagonists in mosquito viruses.
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Introduction
RNA interference (RNAi) is a cellular mechanism that regulates gene expression 
in a broad range of eukaryotes. In plants, insects, nematodes, and fungi, the RNAi 
pathway also acts as an antiviral defense mechanism [1]. For insects, the antiviral 
RNAi pathway is most extensively studied in Drosophila melanogaster. The current 
model for antiviral RNAi in Drosophila is that virus-derived double-stranded RNA 
(dsRNA) is processed by Dicer-2 (Dcr-2) into viral small-interfering RNA (vsiRNA) 
duplexes that associate with an Argonaute-2 (AGO2) containing RNA-induced 
silencing complex (RISC). One strand of the vsiRNA duplex is retained in RISC to 
guide the identification and cleavage (slicing) of complementary viral RNAs [2]. The 
detection of virus-derived small RNAs during infections in Drosophila supports this 
model [3-11]. Moreover, the hypersensitivity of Drosophila RNAi pathway mutants 
to virus infections confirms the important role of RNAi in antiviral defense [3,5,6,12-
15]. In turn, insect viruses encode viral suppressors of RNAi (VSRs) to counteract the 
antiviral RNAi pathway. For example, the Flock House virus (FHV) B2 and Drosophila 
C virus (DCV) 1A proteins bind and shield long dsRNA from Dcr-2 cleavage [13,16-
18]. FHV B2 additionally binds siRNA duplexes, which inhibits their loading into 
RISC [17]. Recently, the 1A protein of Cricket paralysis virus (CrPV) and viral protein 
1 (VP1) of Nora virus were shown to inhibit AGO2 Slicer activity [8,19]. Most VSRs 
that target the same step in the RNAi pathway do not share sequence identity or 
structural conservation. Thus, insect viruses independently evolved a diverse set of 
RNAi antagonists that suppress the antiviral RNAi pathway by distinct mechanisms.
Mosquitoes are important vectors for the transmission of arthropod-borne viruses 
(arboviruses) that can cause serious diseases in humans, such as Dengue virus 
(DENV), West Nile virus (WNV), Japanese encephalitis virus, and Yellow fever virus 
[20]. In addition, mosquitoes are hosts to a diverse array of viruses that are not 
transmitted to vertebrates [21-24]. As was observed in virus infections of Drosophila, 
virus-derived small RNAs are detected in mosquitoes and mosquito cell lines 
infected with arboviruses and mosquito-restricted viruses [22,25-30]. In addition, 
knockdown of RNAi pathway components in mosquitoes results in higher virus titers 
after infection with different arboviruses [31-35]. These results show that also in 
mosquitoes, the RNAi pathway serves as an important antiviral defense mechanism. 
Despite the antiviral activity of the RNAi pathway against a broad range of viruses, 
reports on VSR activity in viruses that infect mosquitoes are limited to the genera 
Alphanodavirus (Nodaviridae family) and Flavivirus (Flaviviridae family). 
Nodamura virus, like FHV a member of the Alphanodavirus genus, was first isolated 
from Culex tritaeniorhynchus mosquitoes near the Japanese village Nodamura [36]. 
Successful experimental infections in a range of vertebrates in combination with 
the detection of neutralizing antibodies in Japanese pigs, suggest that Nodamura 
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virus is a mosquito-transmitted arbovirus [37]. The B2 protein of Nodamura virus, 
like FHV B2, inhibits RNAi by binding long dsRNA as well as siRNA duplexes [38,39]. 
More recently, the non-coding subgenomic flavivirus RNA (sfRNA) of WNV and 
DENV was shown to suppress RNAi [40]. sfRNA is abundantly produced during 
flavivirus infection as a result of incomplete degradation of the genomic RNA [41]. 
Probably because of their stem-loop structure, sfRNA molecules compete with Dicer 
substrates, thereby decreasing Dicer activity. DENV non-structural protein 4B (NS4B) 
was also shown to interfere with Dicer function, by a mechanism independent of 
dsRNA binding [32].
The identification and characterization of viral immune antagonists may provide 
important insight into the mechanisms, components, and regulators of immune 
pathways [42,43]. For example, the Slicer antagonism of two unrelated RNA viruses 
indicates that slicing of viral target RNAs is an important aspect of the antiviral 
RNAi response [8,19]. To begin to understand the diversity of RNAi suppressive 
activities in mosquito viruses, we set out to identify an RNAi suppressor in the 
mosquito-restricted Culex Y virus (CYV). CYV is a bisegmented dsRNA virus of the 
Entomobirnavirus genus of the Birnaviridae family that was recently isolated from 
hibernating Culex pipiens complex mosquitoes in Germany [23]. The non-enveloped 
CYV particles contain two dsRNA genome segments that are predicted to encode five 
viral proteins (VPs). Isolation of the highly related Espirito Santo virus and Mosquito 
X virus in Brazil and China, respectively, indicates that these birnaviruses are widely 
distributed in nature [22,24]. The high degree of similarity between Espirito Santo 
virus, Mosquito X virus, and CYV suggests that they are strains of a single species 
within the Entomobirnavirus genus.
Here, we show that CYV and Drosophila X virus (DXV), like CYV a member of the 
Entomobirnavirus genus, suppress the RNAi pathway during infection. We mapped 
the RNAi suppressor activity to VP3, and demonstrate that VP3 is able to bind long 
dsRNA as well as siRNAs and that it inhibits Dcr-2-mediated cleavage of long dsRNA. 
To our knowledge, we describe the first VSR from a mosquito-restricted virus. 
Moreover, together with the VSR activities identified in Nodamura virus, WNV and 
DENV, these data show that the antiviral activity of the RNAi pathway in mosquitoes 
drives the evolution of VSRs in both arboviruses and mosquito-restricted viruses.
Results
The CYV VP3 protein suppresses RNAi
The identification of vsiRNAs in infections with Mosquito X virus, DXV, and Drosophila 
birnavirus as well as the enhanced sensitivity of R2D2 and AGO2 mutant flies to 
DXV infection indicates that entomobirnaviruses are a target of the antiviral RNAi 
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machinery [11,15,22]. Hence, we deemed it likely that members of this genus would 
encode VSRs. We therefore used well-established reporter assays in S2 cells to 
determine whether CYV counteracts RNAi [44]. In these assays, the effect of virus 
infection or expression of individual viral proteins on RNAi-mediated silencing of a 
firefly luciferase (FLuc) reporter is monitored. We first determined whether RNAi is 
suppressed in cells that are infected with CYV. To this end, we measured luciferase 
activities in mock- and CYV-infected cells that were co-transfected with the FLuc 
reporter plasmid and 113-nt in vitro transcribed FLuc dsRNA. A Renilla luciferase 
(RLuc) reporter plasmid was included as a normalization control. As expected, in 
mock-infected cells, the FLuc reporter was efficiently silenced (~600-fold) by dsRNA 
treatment (Fig. 1A). However, dsRNA-mediated silencing of the FLuc reporter was 
strongly suppressed (to ~6-fold) in CYV-infected cells (Fig. 1A). CYV infection also 
suppressed silencing of the FLuc reporter (from ~15-fold to ~3-fold) when we 
induced RNAi with 21-nt synthetic siRNA duplexes (Fig. 1B). These data show that 
CYV infection inhibits RNAi induced by dsRNA as well as siRNAs.
To identify the viral proteins responsible for CYV-mediated RNAi suppression, we 
generated expression constructs for the five proteins (VP1 to VP5) that are predicted 
to be encoded by the CYV genome (Fig. 2A). Expression of all five proteins in 
transfected cells was confirmed by Western blot analysis (Fig. 2B). We then tested 
the individual viral proteins for VSR activity in our RNAi reporter assays. Cells were 
co-transfected with the FLuc and RLuc reporter plasmids and an expression plasmid 
for one of the viral proteins. The FLuc reporter was silenced by dsRNA feeding two 
days after transfection to allow expression of the viral proteins before the induction 
of RNAi. Of the five viral proteins, only VP3 suppressed silencing of the FLuc reporter 
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Figure 1: RNAi is suppressed during CYV infection. (A) dsRNA-induced RNAi reporter assay in infected 
S2 cells. Mock- and CYV-infected S2 cells were transfected with firefly (FLuc) and Renilla luciferase (RLuc) 
expression plasmids together with a non-silencing control dsRNA (dsCtrl) or FLuc dsRNA (dsFLuc). 
The next day, luciferase activities were measured. FLuc counts were normalized to RLuc counts and 
presented as fold silencing relative to dsCtrl. (B) siRNA-induced RNAi reporter assay in infected S2 cells. 
The experiment was performed as in (A), but RNAi was induced by co-transfection of non-silencing control 
siRNA (siCtrl) or FLuc siRNA (siFLuc). Bars in (A) and (B) represent averages and standard deviation of 
three independent samples.
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to a similar extent as the positive control CrPV 1A [19] (from ~15-fold to background 
levels, Fig. 2C). However, VP3 did not inhibit silencing of the FLuc reporter when 
RNAi was induced by co-transfection of siRNAs along with the luciferase and VP3 
expression plasmids (Fig. 2D). This is in contrast to the AGO2 antagonists Nora 
virus VP1 and CrPV 1A that effectively suppress siRNA-induced RNAi in reporter 
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Figure 2: CYV VP3 suppresses RNAi. (A) Schematic representation of the bisegmented dsRNA genome 
of CYV. Genome segment A encodes a polyprotein precursor of VP2 (capsid), VP4 (protease) and VP3 
(ribonucleoprotein). A VP5 protein, homologous to DXV VP5, may be expressed in the -1 reading frame. 
Unlike DXV VP5, which initiates with a canonical AUG codon, expression of CYV VP5 would require 
initiation by a non-AUG codon. To ensure efficient expression, we introduced an AUG start codon in 
the CYV VP5 expression plasmid. Genome segment B encodes VP1 (RNA-dependent RNA polymerase). 
(B) Western blot analysis of CYV protein expression. Drosophila S2 cells were transfected with plasmids 
encoding the CYV VP1 to VP5 proteins fused to the V5-epitope tag at their N-termini. Cells were 
harvested and lysed four days after transfection and expression was analyzed by Western blot using 
anti-V5 antibodies. (C) dsRNA-induced RNAi reporter assay in S2 cells. Firefly (FLuc) and Renilla luciferase 
(RLuc) expression plasmids were co-transfected into Drosophila S2 cells together with an empty control 
vector (Vector) or a plasmid encoding one of the CYV proteins (VP1 to VP5). A plasmid expressing the 
CrPV 1A protein was used as positive control. Two days after transfection, the cells were soaked in 
medium containing non-specific control dsRNA (dsCtrl) or FLuc dsRNA (dsFLuc). The next day, luciferase 
activities were measured. FLuc counts were normalized to RLuc counts and presented as fold silencing 
relative to dsCtrl. (D) siRNA-induced RNAi reporter assay in S2 cells. The experiment was done as in 
(C), except that non-specific control siRNA (siCtrl) or FLuc siRNA (siFLuc) were co-transfected with the 
plasmids to induce silencing. Nora virus VP1 (Nora VP1) was used as a positive control. Bars in (C) and 
(D) represent averages and standard deviation of three independent samples.
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assays (Fig 2D and [8,19]. The inability of CYV VP3 to suppress siRNA-induced RNAi 
under these conditions seems at odds with the reduced efficiency of siRNA-induced 
RNAi in infected cells (Fig 1B). However, in Figure 1, the cells were infected prior 
to transfection, whereas in Figure 2D, siRNAs were cotransfected along with the 
expression plasmids. Most likely, the siRNAs are incorporated into RISC before 
VP3 is expressed at sufficiently high levels. These data therefore suggest that VP3 
suppresses the RNAi pathway at a step that precedes target cleavage by AGO2.
CYV VP3 does not inhibit the miRNA pathway
The RNAi pathway shares basic features with the microRNA (miRNA) pathway. Both 
pathways depend on Dicer proteins for the generation of small RNAs that guide the 
recognition and silencing of complementary RNAs by Ago proteins. The Dicer and Ago 
proteins in the RNAi and miRNA pathways are, however, different. The RNAi pathway 
depends on Dcr-2 and AGO2 for small RNA biogenesis and function, whereas the 
miRNA pathway predominantly depends on Dcr-1 and AGO1. To investigate whether 
the miRNA pathway is affected by CYV infection, we compared the expression levels 
of the mature miRNAs miR-2b and miR-252 in mock- and CYV-infected cells. The miR-
2b and miR-252 levels were not altered after CYV infection (Fig. 3A), which indicates 
that CYV does not affect miRNA biogenesis. To confirm and extend these results, 
A B
miR-12 miR-1
Ve
cto
r
Ve
cto
r
No
ra 
VP
1
CY
V V
P3
ds
AG
O1
ds
AG
O2
0
1
2
3
4
Fo
ld
 s
ile
nc
in
g
miR-2b
5.8S RNA
miR-252
5.8S RNA
CYVMock
Figure 3: CYV does not affect miRNA biogenesis and function. (A) Northern blot analysis of mature 
miRNAs in mock- and CYV-infected S2 cells. Mature miR-2b and miR-252 were detected with radiolabelled 
probes. Ethidium bromide staining of the 5.8S ribosomal RNA band was used as a loading control. (B) 
miRNA sensor assay in S2 cells. A plasmid encoding the firefly luciferase (FLuc) reporter fused to the 
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we used a miRNA sensor assay to determine whether the CYV VP3 protein inhibits 
miRNA function. Cells were transfected with an expression plasmid encoding a FLuc 
reporter with miR-1 target sites in its 3’ UTR along with plasmids encoding a primary 
miR-1 transcript and the CYV VP3 protein. Again, an RLuc reporter plasmid was 
co-transfected for normalization purposes. As anticipated, the FLuc reporter was 
silenced (~2-fold) by miR-1 in a miRNA pathway-dependent fashion, since silencing 
was fully suppressed by knockdown of AGO1, but not by knockdown of AGO2 (Fig. 
3B). Silencing of the FLuc reporter was not affected by co-expression of either CYV 
VP3 or Nora virus VP1 (Fig. 3B). These data indicate that the VP3 VSR activity does not 
affect the biogenesis nor the function of miRNAs.
The VSR activity of VP3 is conserved in DXV
Having identified CYV VP3 as a suppressor of RNAi, we analyzed whether the 
VSR activity of this protein is conserved in DXV, an entomobirnavirus that infects 
Drosophila. To this end, we first studied RNAi suppression in cells infected with DXV. 
As observed for CYV, dsRNA-mediated silencing of the FLuc reporter was strongly 
suppressed (from ~1400-fold to ~150-fold) in cells infected with DXV (Fig. 4A). We 
then tested the DXV VP3 protein for VSR activity. DXV VP3 suppressed silencing of 
the FLuc reporter (from ~15-fold to background levels) when RNAi was induced by 
dsRNA feeding two days after transfection of the luciferase and VP3 expression 
plasmids (Fig. 4B), similar to our observations with CYV VP3. In addition, DXV VP3 
mildly suppressed silencing of the FLuc reporter (from ~23-fold to ~9-fold) when we 
induced RNAi by co-transfection of siRNAs with the luciferase and VP3 expression 
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Figure 4: RNAi is suppressed by DXV infection and DXV VP3 expression. (A) dsRNA-induced RNAi 
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averages and standard deviations of three independent samples.
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plasmids (Fig. 4C). These results indicate that the VSR activity of VP3 is conserved in 
DXV.
CYV and DXV VP3 inhibit dicing of dsRNA
VSRs can target different aspects of the RNAi machinery, such as Dcr-2-mediated 
cleavage of dsRNA and slicing of target RNAs by AGO2. To characterize the VSR 
activity of CYV and DXV VP3 in more detail, we performed a series of biochemical 
assays using maltose-binding protein (MBP)-tagged recombinant proteins purified 
from Escherichia coli.
We first tested whether the recombinant VP3 proteins interfere with dicing of dsRNA, 
the initiation phase of the RNAi pathway. We incubated radioactively-labelled 126-
nt dsRNA in Drosophila melanogaster S2 and Aedes albopictus U4.4 cell extracts and 
monitored its processing into 21-nt siRNAs on denaturing polyacrylamide gels. The 
dsRNA was efficiently processed into siRNAs in extracts from both cell types (Fig. 
5A, lanes 10 and 15). Processing of the dsRNA was, however, inhibited in a dose-
dependent manner in the presence of increasing concentrations of both CYV and 
DXV VP3 (Fig. 5A, lanes 3-8 and 11-13), and in the presence of DCV 1A, a VSR that 
is known to interact with dsRNA [13] (Fig. 5A, lane 1). As expected, MBP alone did 
not inhibit dsRNA processing (Fig. 5A, lanes 9 and 14). These data indicate that the 
entomobirnavirus VP3 proteins interfere with siRNA production by Dcr-2. Importantly, 
inhibition of dsRNA cleavage into siRNAs was also observed in cells infected with 
CYV. The dsRNA was almost completely processed in extracts from mock-infected 
cells (Fig. 5B, lane 5), but no dsRNA processing was observed in extracts from CYV-
infected cells (Fig. 5B, lane 1). Titration of CYV-infected cell extracts into mock-
infected cell extracts abolished dsRNA processing (Fig. 5B, lanes 2-4), which confirms 
the presence of a dsRNA processing inhibitor in CYV-infected cells. 
We next tested whether the recombinant VP3 proteins are capable of interfering 
with slicing of target RNAs, the effector phase of the RNAi pathway. For this purpose, 
a radioactively 5’ cap-labelled target RNA, consisting of 492-nt of the FLuc coding 
sequence, was incubated in Drosophila embryo extracts in the presence of an FLuc-
specific siRNA that triggers its cleavage. Cleavage of the target RNA results in the 
production of a 164-nt 5’ cleavage product that can be visualized on a denaturing 
polyacrylamide gel. As expected, cleavage of the target RNA was induced by the 
FLuc-specific siRNA, but not by a non-specific control siRNA (Fig. 5C, lanes 1 and 2). 
Neither MBP alone (Fig. 5C, lanes 3,4, and 14), nor CYV or DXV VP3 (Fig. 5C, lanes 
6-11), inhibited target RNA cleavage. Complete inhibition of target RNA cleavage was, 
however, seen in the presence of the positive control Nora virus VP1, an established 
VSR that interferes with the Slicer activity of AGO2 [8] (Fig. 5C, lane 13). These results 
demonstrate that the entomobirnavirus VP3 proteins do not interfere with target 
RNA cleavage by AGO2.
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Figure 5: DXV and CYV inhibit Dicer, but not Slicer activity. (A) Processing of dsRNA in cell extracts 
from Drosophila melanogaster S2 (left panel) and Aedes albopictus U4.4 cells (right panel). Uniformly 
radiolabelled 126-nt dsRNA was incubated in S2 or U4.4 cell extracts together with the indicated 
recombinant proteins. Processing of the dsRNA into 21-nt siRNAs was monitored by denaturing 
polyacrylamide gel electrophoresis followed by autoradiography. Protein concentrations of maltose-
binding protein (MBP)-tagged DXV and CYV VP3 proteins were 3 μM (lanes 3,6,11), 0.3 μM (lanes 4,7,12), 
and 0.03 μM (lanes 5,8,13). Glutathione S-transferase (GST)-tagged DCV 1A (lane 1; 1.5 μM) was used as 
a positive control; GST (lane 2; 1.5 μM) and MBP (lanes 9,14; 3 μM) were used as negative controls. (B) 
Dicer assay in mock- and CYV-infected S2 cell extracts. Radiolabelled 126-nt blunt dsRNA was incubated 
in mixtures of CYV- and mock-infected S2 cell extracts and siRNA production was monitored as in (A). 
(C) In vitro RNA cleavage (Slicer) assay in Drosophila melanogaster embryo lysate. Embryo lysates were 
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0.3 μM (lanes 4,8,11,13,14). The FLuc target RNA and cleavage product were separated on a denaturing 
polyacrylamide gel and visualized by autoradiography.
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CYV and DXV VP3 possess siRNA and dsRNA-binding activity
Many VSRs employ dsRNA binding as a mechanism to suppress RNAi [13,16,18,45]. 
The ability of the entomobirnavirus VP3 proteins to inhibit Dcr-2-mediated cleavage 
of dsRNA into siRNAs suggests a similar strategy of RNAi suppression. To study 
whether these proteins indeed possess dsRNA-binding activity, we performed EMSAs 
using the recombinant VP3 proteins and different radioactively labelled probes.
First, we incubated 126-nt blunt dsRNA with serial dilutions of the recombinant VP3 
proteins and resolved dsRNA-protein complexes on native polyacrylamide gels. As 
expected, incubation of dsRNA with MBP alone (Fig. 6A, lane 17) did not alter its 
mobility when compared to the control reaction without recombinant protein (Fig. 
6A, lane 18). However, the mobility of the dsRNA was inhibited in a dose-dependent 
manner by the VP3 proteins of both DXV (Fig. 6A, lanes 1-7) and CYV (Fig. 6A, lanes 
9-15). DXV and CYV VP3 displayed similar affinities for dsRNA, with dissociation 
constants of 166.1 +/- 33.2 nM and 115.6 +/- 24.5 nM, respectively (Fig. 6A).
The dsRNA-binding activity of the entomobirnavirus VP3 proteins most likely 
suppresses RNAi by inhibiting dsRNA processing by Dcr-2. However, inhibition of siRNA 
production cannot fully explain the RNAi suppressive activity in entomobirnavirus 
infection, since RNAi was suppressed in CYV-infected cells when RNAi was induced 
with synthetic siRNAs (Fig. 1B). This observation indicates that CYV targets additional 
steps of the RNAi pathway, such as loading of siRNAs into RISC or slicing of target 
RNAs by AGO2. Since our biochemical assays indicate that the VP3 proteins do not 
interfere with the AGO2 Slicer activity (Fig. 5C), we tested whether these proteins 
have the potential to scavenge siRNAs to prevent their incorporation into RISC. To 
this end, we tested serial dilutions of the recombinant VP3 proteins in EMSAs with 
21-nt siRNA duplexes containing 2-nt 3’ overhangs. When compared to the control 
reaction without recombinant protein (Fig. 6B, lane 18), the mobility of the siRNAs 
was inhibited in a dose-dependent manner after incubation with the VP3 proteins 
of CYV (Fig. 6B, lanes 9-15) and DXV (Fig. 6B, lanes 1-7), but not after incubation with 
MBP alone (Fig. 6B, lane 17). As for long dsRNA, CYV and DXV VP3 showed similar 
affinities for siRNAs, with dissociation constants of 2.6 +/- 1.4 µM and 5.9 +/- 1.6 µM, 
respectively (Fig. 6B). Interestingly, both proteins also bound 21- and 19-nt blunt 
dsRNA, but only showed weak binding to a 23-nt miRNA duplex (Fig. 6C), consistent 
with the observation that VP3 does not inhibit the miRNA pathway (Fig. 3B). Binding 
was RNA-specific, as neither VP3 protein was able to interact with 21-nt dsDNA (Fig. 
6C). Taken together, our data indicate that the entomobirnavirus VP3 proteins are 
RNAi suppressors that bind both long dsRNA as well as siRNAs. The dsRNA-binding 
activity of the VP3 proteins inhibits dsRNA processing into siRNAs and, presumably, 
loading of siRNAs into RISC.
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Figure 6: DXV and CYV VP3 bind dsRNA independent of length. (A) Electrophoretic mobility shift 
assay (EMSA) for binding of MBP-tagged DXV and CYV VP3 proteins to radiolabelled 126-nt blunt dsRNA 
(left panel). Two-fold dilutions, starting at 400 nM, were used for DXV VP3 (lanes 1-7), and CYV VP3 
(lanes 9-15). In addition, buffer (No protein, lane 18) or 400 nM of MBP (lane 17) were used as negative 
controls. The shift assay is representative for three independent experiments. The fraction of bound 
probe was quantified for the different protein concentrations (right panels). Data points represent 
average and standard deviation of samples from three independent experiments. (B) EMSA for binding 
of MBP-tagged DXV and CYV VP3 proteins to radiolabelled 21-nt siRNAs with 2-nt 3’ overhangs. The 
assay was performed as in (A), except that two-fold protein dilutions of DXV (lanes 1-7) and CYV VP3 
(lanes 9-15), starting at 10 μM, were used. The MBP concentration was 10 μM (lane 17). (C) EMSAs using 
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Discussion
Viruses employ many different strategies to suppress or evade the innate and 
adaptive immune responses of their hosts. In arthropods, RNAi has antiviral activity 
against all major classes of insect viruses, including (+) and (-) strand RNA, dsRNA 
and DNA viruses [3,6,12-15,18,46]. Nevertheless, RNAi suppression has thus far only 
been identified in (+) strand RNA virus infections [13,18,19]. How widespread viral 
RNAi antagonism is, and, more specifically, whether other classes of viruses encode 
RNAi suppressors remains unclear. Here, we show that the antiviral RNAi pathway 
is inhibited during infections with mosquito and Drosophila dsRNA viruses from the 
Entomobirnavirus genus (Birnaviridae family). 
We mapped the VSR activity to VP3, a multifunctional protein that is involved in 
many aspects of the viral replication cycle. Most of our knowledge on the role of VP3 
in birnavirus replication is derived from experiments with infectious bursal disease 
virus (IBDV) and infectious pancreatic necrosis virus (IPNV), members from the genera 
Avibirnavirus and Aquabirnavirus, respectively. In these viruses, the VP3 proteins act 
as scaffolds during capsid assembly by interacting with the viral genome as well as 
with the viral VP1 (RNA-dependent RNA polymerase), pVP2 (capsid) and other VP3 
proteins [47-51]. Our data reveal yet another function of VP3. We demonstrate that 
the entomobirnavirus VP3 proteins possess dsRNA- and siRNA-binding activity and 
inhibit Dicer-mediated siRNA production.
In principle, any dsRNA-binding protein has the potential to inhibit RNAi when 
overexpressed. Even a dsRNA-binding protein from E. coli, a species that is not 
targeted by an RNAi response, suppressed RNAi under overexpression conditions 
[52]. It has been previously shown that the IBDV, IPNV and DXV VP3 proteins have the 
capacity to suppress RNAi [53]. However, these studies were done in a heterologous 
system and the in vivo relevance in a relevant host remained unclear. Our study now 
provides evidence that both CYV and DXV infections suppress the RNAi response in 
insect cells.
dsRNA is an important activator of innate immune pathways, such as the interferon 
response in vertebrates and antiviral RNAi in invertebrates. To avoid recognition 
by the host’s immune system, viruses have evolved different mechanisms to shield 
their dsRNA. The genomes of most dsRNA viruses, for example, are replicated in 
specialized viral cores that encapsulate the dsRNA genome throughout the viral 
replication cycle [54]. These viral cores are very common among dsRNA viruses, but 
different RNA and DNA probes. Each probe was incubated with the MBP-tagged VP3 proteins of DXV 
and CYV or, as negative controls, with MBP or buffer (No protein). In the EMSAs with 21-nt siRNAs (2-nt 
3’ overhangs), 21-nt dsRNAs (blunt), and 19-nt dsRNAs (blunt), four-fold dilutions of DXV and CYV VP3 
were used starting at a concentration of 10 μM. In the 23-nt miRNA and 21-nt dsDNA EMSAs, DXV VP3 
and CYV VP3 were analyzed at a concentration of 10 μM. MBP was used as a negative control at 10 μM 
in all EMSAs.
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they are absent from birnaviruses. Instead, studies with IBDV and IPNV have shown 
that birnaviruses form ribonucleoprotein (RNP) complexes consisting of the dsRNA 
genome and the VP1 and VP3 proteins [55,56]. Since VP3 binds homogenously along 
the dsRNA genome, the RNP complexes are thought to prevent the activation of 
cellular immune pathways. Our observation that the VP3 proteins of CYV and DXV 
inhibit RNAi by dsRNA-binding supports this hypothesis. Entomobirnaviruses most 
likely form similar RNP complexes that shield the viral genome from the antiviral 
activity of the RNAi pathway. Nevertheless, the detection of vsiRNAs in cells infected 
with DXV, Drosophila birnavirus and Mosquito X virus implies that some viral dsRNA 
is available for Dcr-2 [11,22]. By RNP complex formation, VP3 probably limits the 
accessibility of the viral genome for Dcr-2, but it cannot prevent that some viral 
dsRNA is processed into siRNAs. These siRNAs may be loaded into RISC, where they 
guide cleavage of single-stranded viral transcripts, thereby adding another level of 
antiviral activity. We observed that the CYV and DXV VP3 proteins do not only bind 
long dsRNA, but also siRNA duplexes. These data suggest that VP3 does not merely 
protect the viral genome against Dcr-2, but that it also scavenges siRNAs to prevent 
their incorporation into RISC. Thus, entomobirnavirus VP3 proteins counteract 
multiple aspects of the antiviral RNAi machinery. The identification of a VSR in CYV 
indicates that the mosquito antiviral RNAi pathway has the potency to drive the 
evolution of RNAi antagonists in mosquito viruses.
Materials and methods
Cells and viruses
Drosophila melanogaster S2, and Aedes albopictus U4.4 and C6/36 cells were cultured 
as described previously [8,30,57]. CYV [23] and DXV (kindly provided by JL Imler) 
were propagated in S2 cells and titered by end-point dilution in C6/36 and S2 cells, 
respectively.
Plasmids
The following plasmids were described previously: pAWH-CrPV 1A [19], pAc5-V5-His-
VP1∆N351, pMal-C2X-VP1∆N284 [8], pGEX-DCV 1A, pMT-FLuc, pMT-RLuc [13], pMT-FLuc-
miR1, pMT-pri-miR1, pMT-pri-miR12 [58]. 
To clone the individual CYV and DXV open reading frames (ORFs) into insect expression 
plasmids, RNA was isolated from CYV- and DXV-infected S2 cells using Isol-RNA Lysis 
Reagent (5 PRIME). The isolated RNA was then used in a cDNA synthesis reaction 
with the Taqman Reverse Transcription Reagents (Life Technologies) and random 
hexamers. The CYV VP1 to VP5 and DXV VP3 ORFs were PCR amplified from the 
cDNA with primers that introduce either BsiWI and NotI (CYV VP1 to VP5) or Acc65I 
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and NotI (DXV VP3) restriction site into the amplified fragment (Table 1). The PCR 
fragments were digested with the appropriate enzymes and cloned into the Acc65I 
and NotI restriction sites of the pAc5.1-V5-His-Ntag plasmid [8]. 
Table 1: Sequences of the DNA and RNA oligonucleotides
Primer/probe name Primer/probe sequence
CYV-VP1-F 5’-ACGTCGTACGCAAAATGAGTGACATATTCAACCAGCAGG-3’
CYV-VP1-R 5’-ACGTGCGGCCGCCAGTTCAACCTTTGCACGACGAAC-3’
CYV-VP2-F 5’-ACGTCGTACGCAAAATGAATACCTCAAACGAATACCTCA-3’
CYV-VP2-R 5’-ACGTGCGGCCGCCATGAGTGTGCACTCTTGATCCTC-3’
CYV-VP3-F* 5’-ACGTCGTACGCAAAATGGCCAGCGTGCCTTTCTCAAACA-3’
CYV-VP3-R* 5’-ACGTGCGGCCGCCAGATCATCTCTGATTCTCCACCG-3’
CYV-VP4-F 5’-ACGTCGTACGCAAAATGGCTGACACCCCAATAGGTGATA-3’
CYV-VP4-R 5’-ACGTGCGGCCGCCAGGAGCTTGCAGTCCAGTGGTTT-3’
CYV-VP5-F 5’-ACGTCGTACGCAAAATGCTATCAACTATTCGACGGAAAG-3’
CYV-VP5-R 5’-ACGTGCGGCCGCCAAGTACAATCCCTTGCCTTGCAA-3’
CYV-VP3-F1† 5’-AGTGGATCCGCCAGCGTGCCTTTCTCA-3’
CYV-VP3-R1† 5’-GGTAAGCTTTCAGATCATCTCTGATTCTCCACC-3’
DXV-VP3-F1* 5’-ACGTGGTACCCAAAATGAACCCATTCATGAACACG-3’
DXV-VP3-R1* 5’-ACGTGCGGCCGCCATACAATGTCATTGTCCTCTCC-3’
DXV-VP3-F2† 5’-AGTGGATCCGCGAGCATGAACCCATTCATG-3’
DXV-VP3-R2† 5’-GGTAAGCTTTTATACAATGTCATTGTCCTCTCCACG-3’
miR-2b probe 5’-GCTCCTCAAAGCTGGCTGTGATA-3’
miR-252 probe 5’-CTCCTGCGGCACTAGTACTTA-3’
FLuc-F1 5’-TAATACGACTCACTATAGGGAGATATGAAGAGATACGCCCTGGTT-3’
FLuc-F2 5’-GGGAGATATGAAGAGATACG-3’
FLuc-R1 5’-GGGAGAATAGCTTCTGCCAACC-3’
FLuc-R2 5’-TAATACGACTCACTATAGGGAGAATAGCTTCTGCCAACCGAAC-3’
Blunt-19nt-F 5’-UGAGGUAGUAGGUUGUAUA-3’
Blunt-19nt-R 5’-UAUACAACCUACUACCUCA-3’
Blunt-21nt-R 5’-ACUAUACAACCUACUACCUCA-3’
siRNA guide 5’-UGAGGUAGUAGGUUGUAUAGU-3’
siRNA passenger 5’-UAUACAACCUACUACCUCUCU-3’
miR-2b-3p 5’-UAUCACAGCCAGCUUUGAGGAGC-3’
miR-2b-2-5p 5’-UUCUUCAAAGUGGUUGUGAAAUG-3’
Blunt-dsDNA-F 5’-TGAGGTAGTAGGTTGTATAGT-3’
Blunt-dsDNA-R 5’-ACTATACAACCTACTACCTCA-3’
*Primers used for cloning into insect expression vector
†Primers used for cloning into bacterial expression vector
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To generate bacterial expression constructs, the CYV and DXV VP3 ORFs were 
amplified from the cDNA with primers that introduce BamHI and HindIII restriction 
sites into the amplified fragment (Table 1). The PCR fragments were digested with 
BamHI and HindIII and cloned into the corresponding restriction sites of pMAL-C2X 
(New England Biolabs).
Western blot analysis
To analyze the protein products of the CYV insect-expression plasmids, S2 cells were 
seeded at a density of 2.5x105 cells per well in a 24-well plate. The seeded cells were 
transfected with 400 ng of CYV expression plasmid or an empty control plasmid, using 
Effectene Transfection Reagent (Qiagen). Four days after transfection, the cells were 
lysed in 100 μL Laemli buffer and incubated at 95 ºC for 10 minutes. Subsequently, 
40 µL of lysate was separated on a 12.5% SDS-PAGE gel and transferred to a 0.2 µm 
nitrocellulose membrane (Bio-Rad). The membrane was then incubated in blocking 
buffer (5% (wt/vol) non-fat dry milk in PBS/0.1% tween) for 1 hour followed by 
incubation with anti-V5 antibodies (Invitrogen, 1:5000 dilution in blocking buffer) for 
1 hour. After three washes of 5 minutes with PBS/0.1% tween, the membrane was 
incubated with Goat anti-Mouse antibodies conjugated to Alexa Fluor 680 (LI-COR, 
1:15000 dilution in PBS/0.1% tween). The bound antibodies were visualized using an 
Odyssey infrared imager (LI-COR).
RNAi sensor assays
The RNAi and miRNA sensor assays with the insect CYV and DXV protein expression 
constructs were performed as described previously [8,44]. To assess RNAi suppressor 
activity during infection, CYV- and DXV-infected S2 cells were co-transfected with 13.5 
ng pMT-FLuc, 3 ng pMT-RLuc, and either 10 ng of dsRNA or 2 pmol of siRNAs using 
the Effectene Transfection Reagent (Qiagen). Expression of the luciferase reporter 
plasmids was induced the following day by the addition of 0.5 mM CuSO4 to the 
culture medium. The next day, the cells were lysed and FLuc and RLuc activities were 
measured using the Dual-Luciferase Reporter Assay System (Promega).  
Small RNA Northern blots
For the detection of miRNAs in infected cells, RNA was isolated from mock- and CYV-
infected S2 cells using Isol-RNA Lysis Reagent. Subsequently, 10 µg of total RNA was 
separated on a 12% denaturing polyacrylamide gel and transferred to a Hybond 
NX nylon membrane (GE Healthcare). The RNA was cross-linked to the membrane 
using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) [59]. Next, the blots 
were hybridized in ULTRAhyb-oligo hybridization buffer (Ambion) containing 32P end-
labelled DNA oligonucleotide probes (miR-2b probe or miR252 probe, Table 1). The 
blots were washed and the radioactive signal was visualized using autoradiography.
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Protein purification
The bacterial CYV and DXV VP3 expression constructs and the parental pMAL-C2X 
plasmid were transformed into E. coli BL21 (DE3) cells. When the bacterial cultures 
had reached an OD600 of 1.0, expression of the recombinant proteins was induced by 
the addition of 0.2 mM IPTG, followed by overnight incubation at 18ºC. Recombinant 
proteins were purified on amylose resin columns (New England Biolabs) according 
to manufacturer’s protocol. Recombinant proteins were dialyzed and stored as 
described previously [8]. Protein concentrations were determined by a Bradford 
assay (Bio-Rad). 
Radioactively labelled probes
For the production of uniformly labelled 126-nt blunt dsRNA, two FLuc DNA 
fragments were amplified by PCR using primers that introduce a T7 promoter 
sequence on either the 5’ or 3’ end of the amplified fragment (Table 1). The PCR 
products were used in in vitro transcription reactions in the presence of α-[32P]-
UTP and T7 RNA polymerase. The RNA strands were annealed and unincorporated 
nucleotides were removed using a G-25 Sephadex column (Roche). The dsRNA was 
then purified from an 8% native polyacrylamide gel. For EMSAs with synthetic small 
RNA or DNA duplexes, oligonucleotides were annealed, end-labelled using γ-[32P]-
ATP and polynucleotide kinase (Roche), and purified using a G-25 Sephadex column. 
For sequences, see Table 1. Oligonucleotides siRNA guide and Blunt-21nt-R were 
annealed to generate 21-nt blunt dsRNA.
EMSAs, Dicer and Slicer assays
EMSAs were performed as described previously [8,13].  Gel shifts of 126-nt blunt 
dsRNA were analyzed on 6% native polyacrylamide gels and those of small dsRNA 
and dsDNA duplexes on 12% native polyacrylamide gels. Radioactive signals were 
visualized using the Bio-Rad FX molecular imager and quantified with ImageJ, version 
1.47K [60].
Dicer assays in S2 and U4.4 cell lysates and Slicer assays in embryo extracts were 
done as described previously [8,30]. In the Slicer assays, the recombinant proteins 
were added to the embryo lysate 30 minutes after the addition of siRNA duplexes, 
to allow assembly of mature RISC. 
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T he discovery of small RNA-mediated regulatory networks had a major impact on many aspects of biology, including virology and immunology. More specific, the identification of RNA interference (RNAi) as an antiviral defense 
mechanism in plants, insects, nematodes and fungi led to a better understanding of 
virus-host interactions. In the following sections, the results from this thesis will be 
discussed in relation to the current literature on antiviral RNAi in insects.
Small RNAs during virus infection in Drosophila
An important prerequisite for an effective immune system is the ability to distinguish 
self from non-self. Since double-stranded RNA (dsRNA) is produced by viruses with 
positive (+) strand RNA, dsRNA, or DNA genomes, but absent from non-infected cells, 
it may act as an important danger signal [1]. Antiviral RNAi in insects is triggered by 
viral dsRNA that is sensed and processed by Dicer-2 (Dcr-2) into viral small interfering 
RNAs (vsiRNAs). Therefore, viruses have evolved mechanisms to protect their dsRNA 
from cleavage by Dcr-2. First, (+) strand RNA viruses shield their dsRNA replication 
intermediates in membranous vesicles, which may physically exclude Dcr-2 from the 
site of dsRNA production [2,3]. Second, some viruses, like Drosophila C virus (DCV) 
and Flock House virus (FHV), express dsRNA-binding proteins that may bind the 
replication intermediates and shield them from Dcr-2 cleavage [4-7]. In addition, the 
genomic RNA of most dsRNA viruses is protected by the viral capsid throughout the 
life cycle of the virus [8]. Nevertheless, we and others have detected vsiRNAs by deep 
sequencing, suggesting that viral dsRNA is accessible for Dcr-2 cleavage (Chapters 1 
and 3). These vsiRNAs may be derived from dsRNA genomes, dsRNA structures in 
viral single-stranded RNA (ssRNA) molecules, dsRNA replication intermediates, or 
dsRNA produced by convergent transcription of DNA viruses. As discussed below, 
the polarity and distribution of vsiRNAs across the viral genome provides important 
insight into the nature of the dsRNA precursor. 
Small RNA profiles of (+) strand RNA viruses
In chapter 3, we identified Nora virus 21-nt RNAs in persistently infected flies. 
These vsiRNAs exhibited signatures of Dcr-2 cleavage products, mapped in equal 
proportions to the genomic (+) and antigenomic (-) RNA strand, and showed a 
uniform distribution along the viral genome. Therefore, we concluded that the Nora 
virus replication intermediates are targets of Dcr-2. This finding is in agreement 
with a profile of Nora virus-derived small RNAs that were detected in a persistently 
infected cell line [9]. In contrast, a bias towards the genomic (+) strand was found for 
DCV-derived vsiRNAs in two independent reports [10,11]. Since Nora virus and DCV 
employ different mechanisms to suppress the antiviral RNAi pathway (Argonaute-2 
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antagonism and dsRNA binding, respectively), we hypothesize that the suppression 
mechanism might influence the small RNA profiles. We speculate that dsRNA 
replication intermediates are the preferred substrates for Dcr-2, whereas dsRNA 
structures within viral ssRNA molecules are inefficiently processed into vsiRNAs and 
contribute to a minor fraction of the total vsiRNA pool. However, since the 1A protein 
of DCV binds long dsRNA molecules, it might protect the replication intermediates 
from cleavage by Dcr-2. As a result, vsiRNAs that derive from dsRNA structures in 
ssRNA molecules may become the major fraction of vsiRNAs. This skews the vsiRNA 
population towards the (+) strand, as viral genomic RNAs of (+) polarity greatly 
outnumber the viral antigenomic (-) strand RNAs.
The hypothesis that viral suppressors of RNAi (VSRs) modulate vsiRNA profiles is 
supported by studies with FHV, which encodes the VSR protein B2 that binds replication 
intermediates [4,12]. While vsiRNAs were skewed towards the (+) strand in infections 
with wildtype FHV, they mapped in an equal ratio to the (+) and (-) RNA strand in 
infections with a FHV mutant that lacks the B2 protein [12]. Nora virus viral protein 
1 (VP1), on the other hand, counteracts the slicer activity of Argonaute-2 (AGO2), 
but does not inhibit Dcr-2 (Chapter 3), which leaves the replication intermediates 
accessible for Dcr-2. The observation that vsiRNAs map equally to both the (+) and (-) 
RNA strand in Nora virus infections is consistent with the proposed model. Whether 
the correlation between VSR mechanism and vsiRNA profile is generally applicable 
to RNA viruses remains to be established.
The uniform distribution of Nora virus vsiRNAs along the genome indicates that 
all regions of the viral genome are equally accessible for Dcr-2 cleavage. This is in 
contrast to FHV, for which prominent vsiRNA hotspots were observed in the central 
region and in the 5’ and 3’ untranslated regions (UTRs) of the viral genome [13-
15]. Since these hotspots mainly correspond to genomic regions that are retained 
in defective interfering (DI) RNAs, DI RNAs were proposed to be a major source of 
the FHV vsiRNAs [9,14]. DI RNAs contain large deletions of viral genes needed for 
replication and encapsidation, yet retain cis-acting RNA elements that allow them 
to be replicated by the RNA-dependent RNA polymerase (RdRP) of a parental helper 
virus. Due to their smaller genome size, FHV DI RNAs replicate more efficiently than 
wildtype genomic RNAs. This leads to an abundant production of DI dsRNAs, and 
therefore to an overrepresentation of vsiRNAs in these regions of the viral genome. 
The lack of hotspots in the Nora virus small RNA profile suggests that there is no 
prominent production of Nora virus DI RNAs during infection.
Factors influencing small RNA profiles
Small RNA profiles from virus-infected insects give important insight into the 
biogenesis of virus-derived siRNAs. Nevertheless, caution should be taken with the 
analysis of the small RNA profiles since several factors can influence the observed 
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profile. First, to enable massive parallel sequencing, adapter sequences need to be 
ligated to the 5’ and 3’ ends of the small RNAs. Recently, it was shown that base 
pairing between adapter and small RNA molecule increased the ligation efficiency, 
which leads to a sequencing bias [16]. Introduction of four random nucleotides at 
the end of the adapter resolved part of the cloning bias, as these modified adapters 
base pair with a more diverse population of siRNAs. To assess the effect of the 
cloning bias on vsiRNA profiles, a side-by-side comparison of conventional and 
modified adapters for viral small RNA cloning is needed. Second, the viral template 
sequence to which the small RNAs are mapped is a factor that influences the small 
RNA profile. Due to their error prone RdRP, RNA viruses accumulate mutations at 
a high frequency, which may lead to changes in the genome sequence compared 
to previously published sequences. Using the published genome sequence as a 
template to map the viral small RNAs could therefore lead to an inaccurate profile. 
Recently, a method was described to accurately reconstruct viral genomes from the 
sequenced small RNAs [11]. By using reconstituted viral genomes as a reference 
sequence, more accurate small RNA profiles can be acquired (Chapter 3) that give 
better insight into the dsRNA precursors of vsiRNAs. 
Drosophila AGO2 in antiviral defense
Viral siRNAs are mainly derived from replication intermediates for most (+) and 
(-) strand RNA viruses and from viral genomes of dsRNA viruses (viral small RNA 
profiles are discussed in chapter 1). Given their crucial roles during virus infection, 
dicing of viral dsRNA replication intermediates or dsRNA genomes could in theory 
be sufficient to control virus infections. This hypothesis, however, contradicts the 
observation that AGO2 and r2d2 knockout flies, in which Dcr-2 is fully functional, 
are hypersensitive to infections with viruses from various families [7,17-21]. The 
important role of AGO2 in antiviral defense is further supported by the identification 
of Nora virus VP1 and Cricket paralysis virus 1A (CrPV 1A) as RNAi suppressors that 
antagonize the catalytic activity of AGO2 (Chapter 3 and [22]). 
Interactions between VSRs and AGO2
Given the lack of amino acid sequence similarity between Nora virus VP1 and CrPV 1A, 
these VSRs likely evolved through convergent evolution. Since both proteins interact 
with AGO2 to inhibit its catalytic activity, the question rises whether they bind to 
the same site. Interestingly, several eukaryotic proteins utilize Glycine/Tryptophan 
(GW) and/or Tryptophan/Glycine (WG) motifs for their interaction with AGO proteins 
[23-26]. Presumably, the tryptophan residues dock into two hydrophobic pockets 
that reside in the PIWI domain of AGO proteins [27]. Similar to cellular proteins, 
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the viral RNAi suppressor from a plant virus, the P38 protein of turnip crinkle virus, 
depends on two GW motifs that mediate binding to the Arabidopsis AGO1 protein 
[28]. However, GW/WG motifs cannot account for the AGO2 interaction of Nora virus 
VP1 and CrPV 1A, since these proteins do not contain such motifs. Moreover, the 
residues that form the tryptophan-binding hydrophobic pockets in AGO proteins 
are not conserved in Drosophila AGO2 [27]. In contrast, these pockets are present in 
D. melanogaster AGO1, which interacts with the GW motif-containing protein GW182 
[23]. The lack of a tryptophan-binding pocket in Drosophila AGO2 suggests that this 
protein developed alternative mechanisms to interact with constituents of the RNA-
induced silencing complex (RISC). Nora virus VP1 and CrPV 1A may exploit these 
alternative mechanisms, thereby leaving the AGO1-dependent miRNA pathway 
undisturbed (Chapter 3 and [22]). Elucidation of the mechanisms that mediate the 
interaction of Nora virus VP1 and CrPV 1A with Drosophila AGO2 may, therefore, 
identify docking sites on AGO2 for interaction partners. 
Species-specific RNAi suppression
AGO2 and other components of the RNAi pathway (R2D2 and Dcr-2) are amongst 
the 3% fastest evolving genes in Drosophila species. The rapid evolution of AGO2 
resulted in a high divergence in amino acid sequence between the AGO2 proteins 
of different Drosophila species [29]. The persistent nature of Nora virus infections 
suggests that Nora virus VP1 co-evolves with and adapts to the AGO2 protein of 
its host. This may lead to effiecient, but host-specific suppression of AGO2, which 
might come at the cost of losing suppressor activity against AGO2 proteins from 
non-host Drosophila species. Indeed, we showed that the suppressor activity of the 
VP1 protein from a Nora-like virus detected in Drosophila immigrans (DimmNV), is 
host-specific and depends on its ability to interact with Dimm AGO2 (Chapter 5). 
The inability of DimmNV VP1 to bind and suppress D. melanogaster (Dmel) AGO2 
raises the question which VP1 residues are responsible for the host-specificity of 
the VP1 VSR activity. As the suppressor activity of both VP1 proteins is confined to 
the C-terminus, exchanging C-terminal amino acid motifs between DmelNV VP1 and 
DimmNV VP1 might give an answer to this question. At the same time, functional 
domains of Dmel and Dimm AGO2 could be exchanged to map the AGO2 amino 
acids required for an efficient VP1-AGO2 interaction. These approaches may not 
only reveal the VP1-AGO2 interaction domains, they could also provide a better 
mechanistic insight into how VP1 inhibits AGO2 slicer activity.
The ability of a virus to establish a productive infection in a given host species depends 
on multiple factors. One of the barriers that can determine host tropism is the 
host’s immune response. In vertebrates, the interferon response provides powerful 
antiviral activity that controls virus infections. The inability to suppress the interferon 
response in a non-host species restricts host tropism for several vertebrate-infecting 
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viruses, including Measles virus, Polio virus, Parainfluenza virus, and Respiratory 
Syncytial virus [30]. Similarly, the host-specific RNAi suppressor activity of DimmNV 
VP1 may limit DimmNV infections to D. immigrans. The recently reported infectious 
clone of DmelNV, which allows swapping the DmelNV VP1 sequence for the DimmNV 
VP1 sequence, provides an excellent tool to test this hypothesis. A similar approach 
could be used with regard to the host. As Dimm AGO2 is fully functional in a D. 
melanogaster background (Chapter 5), a Dimm AGO2 rescue construct could be 
introduced into D. melanogaster AGO2 knockout mutants. Successful infection of 
these transgenic flies, but not wildtype D. melanogaster, by a DmelNV-DimmNV VP1 
chimeric virus, would establish VP1 as a host-specificity determinant.
Role of RNAi in Nora virus infections
The detection of vsiRNAs and the identification of virus-encoded RNAi suppression 
strongly suggest that Nora virus is a target of the antiviral RNAi pathway in flies 
(Chapters 1 and 3). Nevertheless, Nora virus titers were reported not to be affected 
in flies with defects in the RNAi pathway, suggesting that RNAi does not control Nora 
virus replication [31]. Although this study seems to contradict the data presented 
in this thesis, these findings may not be mutually exclusive. As hypothesized by 
Habayeb et al. [31], a potent VSR that completely blocks RNAi activity might explain 
the apparent insensitivity of the virus to the antiviral activity of RNAi. Hence, 
although vsiRNAs are produced during Nora virus infection, their function might be 
efficiently blocked by VP1. Although plausible, this is not observed for FHV, DCV and 
CrPV. These viruses encode potent VSR proteins, yet they replicate to higher levels 
and induce increased mortality in RNAi pathway mutants [6,7,20]. To reconcile the 
results in this thesis with the results of Habayeb et al., and to obtain insight into 
the role of the RNAi suppressor in vivo, it is essential to study Nora virus infection 
in the absence of VP1 expression. The aforementioned infectious clone of Nora 
virus should allow the production of a Nora virus mutant that is deficient in VP1 VSR 
activity [32]. Subsequent infection of wildtype and RNAi mutant flies with the VP1-
deficient virus may resolve the (in)sensitivity of Nora virus to RNAi and the role of the 
VP1 suppressor therein.
Identification of viral RNAi antagonists in RNAi sensor assays
In chapter 2, we describe an in vitro RNAi reporter assay in S2 cells for the identification 
of potential VSRs. Established VSRs, like DCV 1A and CrPV 1A, efficiently suppress 
RNAi-mediated silencing of the reporter (Chapters 2 and 3). More importantly, using 
the RNAi reporter assay, we have identified the novel VSRs Nora virus VP1 and Culex 
Y virus (CYV) viral protein 3 (VP3) (Chapters 3 and 6). In addition, we made an attempt 
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to identify VSRs in two natural pathogens of Drosophila, Drosophila A virus (DAV) 
and Sigma virus [33,34]. DAV is a (+) strand RNA virus that contains two large open 
reading frames (ORFs), ORF1 and ORF2, which encode the RdRP and capsid proteins, 
respectively. We analyzed DAV ORF1 and ORF2, as well as a smaller ORF downstream 
of ORF1 in the -1 reading frame, in our reporter assay. Similarly, we tested the N 
(nucleocapsid), P (phosphoprotein), X (unknown function), M (matrix protein), and 
G (glycoprotein) proteins encoded by the (-) strand RNA genome of Sigma virus for 
VSR activity. Despite robust expression of the DAV and Sigma virus proteins in S2 
cells, none of these viral proteins showed clear suppression of dsRNA-induced RNAi 
(data not shown). These data suggest that DAV and Sigma virus do not encode a VSR 
protein. Nevertheless, DAV-derived vsiRNAs were detected in a persistently infected 
cell line [9], indicating that DAV is a target of the antiviral RNAi pathway. In addition, 
even though small RNA profiles are not yet reported for Sigma virus, vsiRNAs are 
detected in infections with vesicular stomatitis virus, a family member of Sigma virus 
[10,19]. Thus, although DAV and Sigma virus are both likely targets of the antiviral 
RNAi response, we were unable to detect VSR activity for these viruses using the 
current set-up of the RNAi sensor assay.
Although failure to detect RNAi suppressor activity in the sensor assay may suggest 
that a virus does not encode a VSR, it might also be caused by several other factors. 
First, the expression level of the viral proteins might be insufficient to detect RNAi 
suppressor activity. Second, a viral protein might depend on other viral proteins 
or processing from a polyprotein precursor for its functionality. Reporter assays 
with individual mature viral proteins, therefore, may fail to identify potential RNAi 
suppressors. Dependence on polyprotein processing was, for example, reported for 
inhibition of the interferon response in mammalian cells by Dengue virus (DENV). 
It was shown that the DENV non-structural (NS) proteins induce degradation of the 
immune signalling protein STAT2 when expressed from a replicon, but not when 
expressed as individual proteins [35]. Maturation of DENV NS5 through proteolytic 
processing was demonstrated to be essential for the STAT2 degrading activity [36]. 
Third, VSR activity is not limited to viral proteins, as non-coding viral RNAs can also 
mediate RNAi suppression. For example, high levels of adenovirus virus-associated 
(VA) RNAI and RNAII can saturate Dicer and thereby compete with other Dicer 
substrates [37]. Similarly, the subgenomic flavivirus RNAs (sfRNAs) of West Nile virus 
and DENV were shown to act as nucleic acid-based VSRs [38]. To overcome these 
limitations, RNAi sensor assays with infectious viruses can be performed, in which 
all viral proteins as well as potential non-coding RNAs are expressed at physiological 
levels.
Our results expose a fourth limitation of the RNAi sensor assay in S2 cells, since 
we found that viruses may encode RNAi suppressors whose activity is restricted 
to their natural host species. As S2 cells are derived from D. melanogaster, VSRs 
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from viruses that have a host species other than D. melanogaster may fail to show 
suppressor activity in our reporter assay (Chapter 5). Finally, spread of RNAi beyond 
the site of infection (systemic spread) was suggested to be essential for an effective 
antiviral immune response in Drosophila (discussed in the next section). Therefore, 
it is possible that some VSRs specifically inhibit systemic spread of an antiviral 
RNAi signal. An example of such a suppressor is the 2b protein from the plant 
virus Asparagus virus 2 (AV-2), which suppresses systemic silencing, but is unable 
to suppress local silencing [39]. Similarly, it was suggested that the P19 protein of 
Cymbidium Ringspot Tombusvirus specifically blocks systemic silencing but not local 
silencing [40]. As the RNAi sensor assay in S2 cells solely monitors cell-autonomous 
RNAi, it will not detect a VSR that only inhibits systemic spread of RNAi.
Systemic spread of RNAi in Drosophila?
Nora virus is an enteric virus that is transmitted via the fecal-oral route [41]. Despite 
the absence of an apparent pathogenic effect, the intestine of Nora virus-infected 
flies is abnormally fragile, and shows enlarged extracellular space between epithelial 
cells [41]. This suggests that the gut epithelial barrier is compromised during Nora 
virus persistent infections, which could allow the virus to disseminate into the 
hemolymph and to more distal sites. Indeed, we found Nora virus vsiRNAs in the head 
of infected flies as well as in the body (abdomen and thorax) and thorax (Chapter 3). 
The vsiRNAs in the head showed a uniform distribution along the viral genome and 
mapped in an equal ratio to the viral (+) and (-) RNA strands. Relative levels of Nora 
virus vsiRNAs were similar in head, body, and thorax, which may suggest active Nora 
virus RNA replication at these sites. Nevertheless, Habayeb and colleagues detected 
Nora virus RNA almost exclusively in the intestine of persistently infected flies, with 
only low levels of viral RNA in other tissues [41]. Therefore, it seems that the levels of 
small RNAs do not reflect virus titers. One explanation for the discrepancy between 
the reported tissue tropism and vsiRNA levels could be that the Nora virus small 
RNAs in the head originated from a putative spread of the RNAi response. 
Systemic spread of RNAi is characterized by dissemination of the silencing signal 
beyond its site of initiation [42]. In plants, systemic RNAi consists of a local short-
range spread as well as a systemic component that depends on a cellular RdRP 
for amplification of the silencing signal [43,44]. Both local and systemic spread 
of silencing in plants is mediated by siRNA duplexes, either protein-bound or not 
[43,44]. Extracellular small RNAs can also be detected in cell-free serum of mammals. 
These small RNAs, mainly microRNAs, are incorporated into exosomes and are 
suggested to provide a mechanism of intercellular communication [45]. Although 
the canonical antiviral RNAi pathway in insects seems to be a cell-autonomous 
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defense mechanism, a systemic RNAi response was suggested to occur during viral 
infections in Drosophila [46]. This systemic RNAi response seems to depend on the 
uptake of dsRNA, since dsRNA-uptake deficient flies are hypersensitive to DCV and 
Sindbis virus infection. Moreover, a sequence-specific silencing signal was shown 
to move ahead of a Sindbis virus infection. The authors suggested that through cell 
death, lysis, or a virus-induced shedding mechanism, viral dsRNA is released and 
taken up by non-infected cells that subsequently process the dsRNA. Similarly, Nora 
virus dsRNA molecules could be released during infection. Uptake of these dsRNA 
molecules by cells at distal sites would lead to the production of Nora virus vsiRNAs 
that bear the same characteristics as vsiRNAs derived from a dsRNA replication 
intermediate. In Drosophila, dicing of dsRNA typically results in 21-nt duplex siRNAs 
in which the two strands form a 19-nt base-paired duplex with 2-nt single-stranded 3’ 
overhangs. Indeed, Nora virus 21-nt RNA reads from the (+) and (-) RNA strands tend 
to overlap by 19 nt in the body and thorax. Strikingly, viral small RNAs in the head 
failed to show this signature (Chapter 3). A speculative hypothesis for the absence 
of this siRNA signature is that vsiRNAs in the head result from transport of single-
stranded siRNAs bound by AGO2 or another transporter. Regardless, the Nora virus 
small RNAs in the heads of infected flies may form the basis for future investigations 
of systemic RNAi in Drosophila.
Persistent vs. lethal infections in Drosophila
An acute virus infection may progress into a full-blown infection that causes disease 
and kills the host. Alternatively, the infection may be cleared from the host, resolved 
into a latent infection or result in a delicately balanced persistent infection. Although 
poorly understood, persistent infections without any pathogenic signs are commonly 
observed in insects and insect cell lines. For example, several Drosophila cell lines are 
persistently infected with multiple viruses, like FHV, DCV, or Nora virus [9,14,15]. At 
least for DCV and Nora virus, these persistent infections mimic the natural infections 
in vivo, as these viruses also establish persistent infections in flies [47,48]. Strikingly, 
opposed to DCV infection, high mortality is induced by infections with the closely 
related CrPV [49]. Since these viruses are close relatives, the question arises what 
determines the difference in their virulence. One study hypothesized that the 
potency and mechanism of the VSR is a key determinant for pathogenic outcome. 
[22]. This hypothesis was based on the observation that DCV has a mild VSR that 
shields long dsRNA from Dcr-2 cleavage, whereas CrPV encodes a potent VSR that 
inhibits AGO2-mediated target RNA cleavage. However, the identification of Nora 
virus VP1 contradicts this hypothesis, as Nora virus causes persistent infections, yet 
encodes a potent VSR that employs a similar mechanism as CrPV 1A (Chapter 3). This 
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suggests that the course of virus infections is at least partially determined by factors 
other than the mechanism of RNAi suppression.
Dicing and slicing during persistent infections
An alternative view on the establishment and maintenance of persistent infections 
came from the analysis of vsiRNAs in a cell line persistently infected with FHV 
[13]. Although FHV-derived vsiRNAs were abundantly produced, the bulk of these 
small RNAs were not associated with AGO2. Moreover, vsiRNAs failed to efficiently 
silence reporter constructs harbouring complementary target sequences. These 
results suggest that dicing of viral dsRNA, rather than target RNA cleavage by RISC, 
contributes to the persistent state of FHV infection. In analogy, we show that Nora 
virus small RNAs are produced in persistently infected flies (Chapter 3). Although we 
did not demonstrate AGO2 association of the vsiRNAs, the slicer antagonism of Nora 
virus VP1 implies that target RNA cleavage by AGO2 is essential for the antiviral activity 
of the RNAi pathway, also in persistent infections. Moreover, AGO2 knockdown 
in persistently infected cells increased the levels of FHV RNA, demonstrating that 
persistent FHV infections are limited, at least in part, by AGO2 [4,13,50]. 
Synthesis of viral cDNA in persistent infections
The production of DI RNAs may contribute to viral persistence of FHV. Due to their 
smaller size, DI RNAs have a replication advantage over the full-length genome, 
which results in a competition for viral and host factors needed for replication. 
Interestingly, a recent study showed that parts of the FHV RNA genome are reverse 
transcribed into cDNA forms during persistent infections in Drosophila cells and flies 
[51]. Sequencing of the FHV cDNA forms revealed FHV DNA fragments fused to long 
terminal repeat (LTR) retrotransposons, suggesting that retrotransposons provide 
the reverse transcriptase activity that is needed to produce the FHV cDNA fragments. 
Furthermore, the FHV cDNA fragments showed similar sequence rearrangements as 
FHV DI RNAs, which suggests that DI RNAs are either the template for or the product 
of the FHV cDNA forms. Mapping of FHV-derived siRNAs during persistent infections 
indicated that the FHV cDNA forms are transcribed and processed into vsiRNAs. 
Inhibition of reverse transcriptase activity during FHV infection reduced vsiRNA 
production and increased viral titers and cell death. This suggests that the formation 
of a FHV cDNA form contributes to the establishment of a persistent infection. Viral 
cDNA forms were also detected by PCR in cell lines persistently infected with DCV, 
Drosophila X virus, or Sindbis virus [51]. Strikingly, a Nora virus cDNA form could 
not be detected by southern blot in persistently infected Drosophila [47]. However, 
since the southern blot probe only covered a 371-nt region of ORF2, it remains 
possible that Nora virus cDNA forms of other genomic regions are produced during 
infection. As the virus-derived cDNA forms seem to contribute to the establishment 
161
General discussion
7
or maintenance of persistent infections, it would be of interest to determine if such 
cDNA forms are formed during pathogenic infections with CrPV. In addition, it would 
be worth investigating whether viruses have anti-reverse-transcriptase activity to 
counteract the production of virus-derived cDNA forms [52].
Tissue tropism and pathogenicity
The tissue tropism of a virus and the extent of tissue damage it inflicts are important 
factors that determine viral pathogenicity. The capacity to tolerate damage varies 
between tissues and organs, and depends on several intrinsic tissue properties 
[53]. Although the cell types in which Nora virus and DCV replicate during a natural 
infection remain elusive, it is suggested that these viruses replicate in the digestive 
tract [41,54]. Since the intestinal epithelium has a fast renewal rate, this tissue 
might have a high tolerance for tissue damage inflicted by DCV and Nora virus. This 
property might contribute to the non-pathogenic, persistent nature of Nora virus 
and DCV infections. Furthermore, the intestinal epithelium might form a barrier 
that prevents Nora virus and DCV from spreading to other tissues with a lower 
tolerance towards virus infections. Indeed, DCV infections can become pathogenic 
if the epithelial barrier of the intestine is overcome by injection of the virus in the 
body cavity (Chapter 4 and [18,55]). Specifically, pathogenesis might be caused 
by infection of the fat body, since suppression of RNAi in the fat body leads to an 
increased mortality after DCV infection (Chapter 4). In contrast, injection of Nora 
virus into the body cavity of flies fails to induce pathogenesis, but causes a persistent 
infection [41]. Whether this is caused by a difference in tissue tropism between Nora 
virus and DCV or other host and/or viral factors remains to be determined.  
Small RNA-mediated antiviral defense and viral counter-
defense in mosquitoes
In analogy to Nora virus and DCV, clinically important arthropod-borne (arbo-) 
viruses are known to cause persistent, non-pathogenic infections in their mosquito 
vector. Mosquitoes can become infected with arboviruses after ingestion of an 
infected blood meal. The ingested virus escapes the midgut to eventually end up 
in the salivary glands where it needs to accumulate to sufficiently high titers for 
successful transmission to a new vertebrate host during blood-feeding. Depending 
on environmental factors, such as temperature, accumulation of an adequate level 
of virus in the salivary glands is estimated to take a few days to a few weeks, a 
period in which fitness of the mosquito needs to be maintained for successful virus 
transmission [56,57]. Therefore, it is believed that arboviruses need to establish a 
non-pathogenic infection in their mosquito vector. In addition, mosquitoes can be 
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infected with mosquito-restricted viruses that are not transmitted to a vertebrate 
host. Detection of mosquito-restricted viruses in asymptomatic adult mosquitoes 
suggests that these viruses may also cause non-pathogenic persistent infections 
[58,59].
Viral suppression of RNAi in mosquitoes
Arboviruses and mosquito-restricted viruses are targets of the mosquito’s RNAi 
pathway, since vsiRNAs are detected during virus infections [60-66]. Furthermore, 
an increase in sensitivity to arbovirus infections is observed upon knockdown of 
RNAi pathway components ([67] and discussed in chapter 1). Therefore, it might 
be expected that these viruses encode VSRs to counteract the mosquito’s antiviral 
RNAi response. Indeed, in chapter 6 we found that the VP3 protein of the mosquito-
restricted entomobirnavirus CYV, which was recently isolated from Culex pipiens 
mosquitoes [68], suppresses RNAi. We showed that CYV VP3 is able to bind long 
dsRNA as well as siRNAs in vitro, which is likely responsible for the potent RNAi 
suppression observed during CYV infection. These results show that the antiviral 
activity of the mosquito’s RNAi pathway is potent enough to drive the evolution of 
VSR activity in mosquito-restricted viruses. 
Suppression of the RNAi pathway was for a long time not believed to be a common 
feature of arboviruses. Due to their dependence on non-pathogenic infections 
for successful transmission, it was assumed that evolution of a potent VSR in 
arboviruses is selected against in nature. Hence, expression of a potent VSR may 
lead to pathogenesis and death of the arthropod vector, jeopardizing the spread to 
vertebrate hosts. Indeed, as opposed to wildtype virus, recombinant Sindbis virus 
that expresses the FHV B2 protein proved to be pathogenic to mosquitoes following 
an infectious blood meal as well as after injection [69,70]. Nevertheless, in recent 
years, RNAi suppressive activities have been identified in a number of arboviruses. 
The first arbovirus shown to express an RNAi suppressor protein is Nodamura 
virus (NoV) (Nodaviridae), a family member of FHV [71,72]. NoV was first isolated 
from Culex tritaeniorhynchus mosquitoes near the Japanese village of Nodamura 
[73]. Later, neutralizing antibodies were detected in plasma from pigs in areas near 
Tokyo, thereby classifying NoV as an arbovirus [74]. Similar to FHV, NoV expresses a 
B2 protein that inhibits RNAi by shielding dsRNA from Dicer cleavage, and by binding 
of siRNAs to prevent RISC loading.
Recently, RNAi suppressor activity was reported for the non-coding subgenomic 
flavivirus RNA (sfRNA) of West Nile virus and DENV [38]. As sfRNA is a substrate for 
Dicer and abundantly produced during flavivirus infections, it was suggested that the 
sfRNAs saturate Dicer in a concentration-dependent manner. The nucleic acid-based 
VSR activity of the sfRNAs is remarkable, as VSR activity of plant and insect viruses 
is almost exclusively confined to viral proteins. Recently, the DENV non-structural 
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protein 4B (NS4B) was also reported to contain VSR activity [75]. Results from this 
study indicate that NS4B inhibits Dcr-2 activity independent of dsRNA binding. How 
the RNAi suppressor activities of sfRNA and NS4B affect DENV infection in vivo 
remains to be established. Altogether, these data show that both arboviruses and 
mosquito-restricted viruses counteract the mosquito’s antiviral RNAi pathway. 
Antiviral piRNAs in mosquitoes
Piwi-interacting RNAs (piRNAs) are endogenously encoded 24-30-nt small RNAs that 
form one of the three major classes of small silencing RNAs [76]. In Drosophila, piRNAs 
are abundantly produced in gonadal tissues, where they protect the integrity of the 
germline by repressing transposable elements. In addition, virus-derived piRNA-like 
small RNAs were detected in a Drosophila ovarian somatic sheet cell line, suggesting 
an antiviral function of the insect piRNA pathway [9]. Indeed, virus-derived piRNAs 
can be detected during arbovirus infections in mosquitoes and mosquito cell lines. 
In contrast to Drosophila, these piRNA-like viral small RNAs were also found in 
somatic tissues of mosquitoes [11,62,64,66,77]. This suggests that, in addition to 
the RNAi pathway, the mosquito piRNA pathway exerts antiviral activity in somatic 
tissues. The antiviral potential of the mosquito’s piRNA pathway was demonstrated 
in a recent report, which showed that knockdown of PIWI proteins in cell culture 
enhances Semliki Forest virus infection [77]. As these data indicate that mosquito 
viruses are inhibited by an antiviral piRNA response, it would be interesting to 
study whether mosquito viruses developed counter-defense mechanisms against 
the mosquito’s piRNA pathway. Interestingly, a recombinant Chikungunya virus 
expressing the FHV B2 protein (CHIKV-B2) was more cytopathic than the parental 
virus in cell lines that are defective in siRNA biogenesis [64]. Furthermore, the 
increase in pathogenicity of CHIKV-B2 infection in mosquitoes was associated with 
a 2-fold decrease in viral piRNAs. Therefore, the authors suggested that FHV B2 
inhibits the biogenesis of viral piRNAs in mosquito cell lines. Taken together, these 
results suggest a complex interaction between viruses and the antiviral siRNA and 
piRNA pathways in mosquitoes.
Future directions 
Experimental work in Drosophila significantly contributed to our current 
understanding of the antiviral RNAi response in insects. Nevertheless, many 
questions remain. For example, how and when is the viral dsRNA recognized during 
virus infections? What is the nature of the systemic silencing signal? How does 
RNAi contribute to the establishment of persistent infections? How do arboviruses 
suppress the RNAi response while maintaining a persistent infection? Given the 
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extensive genetic toolbox in Drosophila, studies in flies will continue to contribute 
novel insights into the antiviral RNAi response in insects. This may lead to a 
better understanding of antiviral RNAi in other insects, including important vector 
mosquitoes. Nevertheless, the course of infection of arboviruses differs greatly 
from virus infections in Drosophila, since arboviruses rely on dissemination to the 
salivary glands for their transmission. In addition, differences between Drosophila 
and mosquito antiviral defenses are apparent, as the piRNA pathway seems to 
play a more prominent role in mosquitoes. These observations emphasize the 
need for experimental infection models and genetic tools in mosquitoes. In-depth 
understanding of virus-host interactions in insects might lead to improved strategies 
to control arbovirus transmission.
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Summary
V iruses are microscopic particles that in their basic form consist of an RNA or DNA genome surrounded by a protective shell. As viruses are obligate intracellular parasites, they can only replicate within cells of a host organism. 
To enable their replication, viruses exploit cellular processes and resources of the 
host, which may lead to cell death and disease in the host. In turn, host organisms 
defend themselves by mounting an immune response that aims to restrict virus 
replication and spread. A productive immune response starts with the detection of 
the invading virus by cellular sensors that recognize pathogen associated molecular 
patterns (PAMPs), which are molecular structures that are conserved within classes 
of microbes. As double-stranded RNA (dsRNA) is produced during most virus 
infections, but not detected in non-infected cells, it is considered to be a major viral 
PAMP. In vertebrates, the detection of dsRNA induces the production of cytokines 
that serve as signal molecules to induce, amplify, and regulate innate and adaptive 
immune responses. Non-vertebrate animals, however, lack the innate and adaptive 
immune response of vertebrates. In insects, dsRNA triggers the RNA interference 
(RNAi) pathway, in which the enzyme Dicer-2 (Dcr-2) detects and cleaves the viral 
dsRNA molecules into small interfering RNA (siRNA) duplexes of approximately 
21 nucleotides in size (Chapter 1). Subsequently, siRNA duplexes are loaded into 
an RNA-induced silencing complex (RISC), a complex of proteins that contains at 
least the Argonaute-2 (AGO2) protein. One strand of the siRNA duplex is retained 
in RISC to guide the binding of complementary viral RNA sequences, which leads to 
AGO2 mediated cleavage (Slicing) of the viral RNA. Since efficient AGO2 Slicer activity 
depends on extensive basepairing between the siRNA guide strand and the target 
RNA, RNAi results in sequence specific silencing of RNA transcripts. 
Both Dcr-2 and AGO2-mediated cleavage of viral RNA molecules inhibits virus 
infection in insects. As a counter-defense, insect viruses encode viral suppressors 
of RNAi (VSRs) that counteract the antiviral activity of the RNAi pathway. Prior to the 
start of this PhD project, the Drosophila C virus (DCV) 1A protein and Flock House 
virus (FHV) B2 protein were the only VSRs identified in insect viruses. Both DCV 1A 
and FHV B2 can bind dsRNA molecules, thereby shielding them from Dcr-2 cleavage. 
FHV B2 is also able to prevent loading of siRNAs into RISC by binding siRNA duplexes. 
As only a limited number of insect VSRs were identified, we aimed in this thesis 
to identify and characterize new insect VSRs to gain a better understanding of the 
virus-host interactions in insects. In the next paragraphs the results of this thesis are 
summarized.
To screen for potential VSR proteins, we describe in chapter 2 an RNAi sensor 
assay in Drosophila melanogaster S2 cells. In this assay, we induce RNAi-mediated 
silencing of a firefly luciferase (FLuc) reporter gene, which decreases the amount of 
171
Summary
8
FLuc enzyme produced, to monitor RNAi efficiency. Hence, the more efficient the 
RNAi-mediated silencing of the FLuc reporter gene, the lower the FLuc production. 
To identify potential VSRs, we then perform this assay in the presence or absence 
of viral proteins. If a viral protein interferes with the RNAi-mediated silencing of 
the Fluc reporter, it is considered a putative VSR. Once a putative VSR is identified, 
additional reporter assays and biochemical experiments are needed to determine 
the RNAi suppressor mechanism in more detail.
Recently, Nora virus was identified as a natural pathogen of Drosophila that causes a 
non-lethal persistent infection. In chapter 3 we detected Nora virus-derived siRNAs 
in persistently infected Drosophila, showing that the antiviral RNAi pathway targets 
Nora virus. Using the RNAi sensor assay described in chapter 2, we identified viral 
protein 1 (VP1), the protein product of open reading frame 1, as a VSR. Furthermore, 
we showed that Nora virus VP1 and the unrelated Cricket paralysis virus 1A (CrPV1A) 
protein both suppressed AGO2-mediated RNA cleavage. Convergent evolution of 
AGO2 slicer antagonism in these two distantly related insect RNA viruses emphasizes 
the important role of AGO2 slicer activity in antiviral defense.
In chapter 4, we explored the possibility of using the VSR activity of VP1 to study 
the RNAi pathway in vivo. Expression of a VP1 construct in transgenic flies potently 
suppressed RNAi-mediated gene silencing. Similar to AGO2 knock-out flies, transgenic 
flies ubiquitously expressing VP1 or specifically expressing VP1 in the fat body were 
more sensitive to virus infection. Altogether, we established the VP1 transgenic fly as 
a useful tool to study RNAi regulated processes in vivo.
Host immune responses and viral immune antagonists can co-evolve in what is called 
an evolutionary arms race. As a result, viral immune antagonists adapt to efficiently 
counteract the immune response of their host species. In turn, this may lead to the 
inability to suppress the antiviral response in other species, which may restrict the 
host range of the virus. Therefore, we investigated in chapter 5 whether the VSR 
activity of VP1 can determine the host range of Nora virus. To this end, we isolated 
VP1 sequences from Nora-like viruses detected in the fruit fly species Drosophila 
immigrans (DimmNV VP1) and Drosophila subobscura (DsubNV VP1). We compared 
the VSR activity of these VP1 proteins to that of VP1 from Nora virus isolated from 
Drosophila melanogaster (DmelNV VP1), which we described in chapters 3 and 4. 
In contrast to DmelNV VP1, we were unable to detect RNAi suppressive activity  of 
DimmNV VP1 and DusbNV VP1 in D. melanogaster S2 cells. Instead, DimmNV VP1 
specifically interacted with, and suppressed the RNA cleavage activity of AGO2 from 
its natural host, D. immigrans. This RNAi suppressive activity was species-specific, as 
DimmNV VP1 did not interact with, and did not suppress the activity of AGO2 from its 
non-host species, D. melanogaster. Surprisingly, the DmelNV VP1 suppressor activity 
was not restricted to its host species, as it interacted with both the D. melanogaster 
and D. immigrans AGO2 proteins and suppressed the RNA cleavage activity of both 
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these AGO2 proteins. Nevertheless, we suggest that the specific adaptation of Nora 
virus VP1 to the host AGO2 protein can result in host-specific RNAi suppressor activity. 
Our results imply that RNAi suppressors may be host specificity determinants.
The RNAi pathway provides antiviral activity against a broad range of insect viruses 
with different genome structures. Nevertheless, insect VSRs were only detected 
in viruses with a positive stranded RNA genome. In addition, it is unclear whether 
mosquito viruses generally suppress the antiviral activity of the mosquito’s RNAi 
pathway. We therefore investigated in chapter 6 whether two dsRNA viruses, the 
entomobirnaviruses Culex Y virus (CYV) and Drosophila X virus (DXV), suppress the 
antiviral RNAi pathway. DXV is known to persistently infect Drosophila cell cultures; 
CYV was recently isolated from wild-caught Culex pipiens mosquitoes. We show 
that both CYV and DXV suppress RNAi in infected Drosophila S2 cells. Furthermore, 
we identified viral protein 3 (VP3) of both viruses as an RNAi suppressor protein 
in our RNAi sensor assay. Biochemical assays showed that both CYV VP3 and DXV 
VP3 bind long dsRNA as well as siRNAs. In line with the ability to bind long dsRNA, 
we demonstrate that the VP3 proteins of CYV and DXV can inhibit Dcr-2 mediated 
cleavage of dsRNA. In addition, binding of siRNAs by CYV and DXV VP3 suggests 
that they also scavenge siRNAs to prevent their incorporation into RISC. Therefore, 
our results imply that entomobirnaviruses suppress two steps of the antiviral RNAi 
pathway, dsRNA processing and RISC loading. Furthermore, our results suggest that 
mosquito viruses suppress the antiviral RNAi response in their host.
In chapter 7 the results of this thesis are discussed and suggestions for future 
investigations are made.
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Samenvatting
V irussen zijn microscopisch klein en bestaan uit genetische informatie, in de vorm van RNA of DNA, dat wordt omringd door een beschermend omhulsel. Omdat virussen intracellulaire parasieten zijn, kunnen ze alleen repliceren 
in de cellen van een gastheer. Hiertoe gebruiken virussen processen en grondstoffen 
van de gastheer. Dit kan leiden tot celdood en ziekteverschijnselen in de gastheer. 
De gastheer verdedigt zichzelf op zijn beurt door middel van een immuunreactie met 
als doel virusreplicatie en -verspreiding tegen te gaan. Een antivirale immuunreactie 
begint met de detectie van het infecterende virus door cellulaire sensoren die 
pathogeen-geassocieerde moleculaire patronen herkennen. Dit zijn moleculaire 
structuren die aanwezig zijn in bepaalde groepen ziekteverwekkers. Omdat de 
meeste virussen dubbelstrengs RNA (dsRNA) produceren tijdens een infectie en 
omdat dsRNA nauwelijks aanwezig is in gezonde cellen, wordt dsRNA gezien als 
een belangrijk virus-geassocieerd moleculair patroon. In gewervelde dieren leidt 
de detectie van dsRNA tot de productie van signaalmoleculen die aspecifieke en 
adaptieve immuunreacties induceren en reguleren. Ongewervelde dieren beschikken 
daarentegen niet over de aspecifieke en adaptieve immuunmechanismen van de 
gewervelden en zijn afhankelijk alternatieve antivirale immuunreacties. In insecten 
bijvoorbeeld, wordt dsRNA gedetecteerd door het enzym Dicer-2 (Dcr-2) dat het 
virale dsRNA knipt in kleinere dsRNA moleculen van ongeveer 21 nucleotiden: de 
zogenoemde “small interfering RNAs” (siRNAs). Vervolgens worden de siRNAs 
ingebouwd in een “RNA-induced silencing complex” (RISC): een eiwitcomplex waar in 
ieder geval het Argonaute-2 (AGO2) eiwit deel van uitmaakt. Eén streng van de siRNA 
blijft behouden in het RISC om complementaire virale sequenties te binden, wat 
leidt tot een AGO2-gemedieerde knip in het virale RNA. Het complete mechanisme, 
van dsRNA detectie door Dcr-2 tot het knippen van het virale RNA door AGO2, 
wordt aangeduid als RNA-interferentie (RNAi) (Hoofdstuk 1). Omdat de AGO2-
gemedieerde knip in het virale RNA afhangt van extensieve basenparing tussen de 
ingebouwde siRNA-streng en de virale RNA-sequentie, resulteert RNAi in sequentie-
specifieke afbraak van het virale RNA.
Door het knippen van viraal RNA door zowel Dcr-2 als AGO2 beperken insecten 
de replicatie en verspreiding van virussen. Echter, insectenvirussen produceren 
eiwitten die de antivirale activiteit van het RNAi-mechanisme onderdrukken (“viral 
suppressors of RNAi”, VSRs). Voordat dit promotieonderzoek begon, waren het 
1A-eiwit van Drosophila C virus (DCV) en het B2-eiwit van Flock House virus (FHV) 
de enige geïdentificeerde VSR-eiwitten van insectenvirussen. Zowel DCV 1A- als 
FHV B2-eiwitten kunnen binden aan dsRNA-moleculen waardoor deze eiwitten het 
dsRNA beschermen tegen het knippen door Dcr-2. Verder kan het FHV B2-eiwit 
siRNA moleculen binden, waardoor wordt voorkomen dat deze siRNAs ingebouwd 
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worden in het RISC. Omdat het aantal VSR-eiwitten van insectenvirussen beperkt 
was, had dit promotieonderzoek als doel nieuwe VSR-eiwitten te identificeren en te 
karakteriseren om daarmee meer inzicht te krijgen in de virus-gastheer interacties 
in insecten. In de volgende paragrafen zijn de resultaten van dit proefschrift 
samengevat.
Om nieuwe VSR-eiwitten te identificeren, hebben we een RNAi-sensorexperiment 
in Drosophila S2-cellen gebruikt zoals beschreven staat in hoofdstuk 2. In dit 
experiment induceren we RNAi-gemedieerde afbraak van een “Firefly luciferase” 
(FLuc) reporter-RNA. Dit leidt tot een lagere productie van het FLuc-enzym, waarmee 
de efficiëntie van de RNAi-gemedieerde afbraak wordt gemeten. Dus als de FLuc-
enzymproductie lager is, is de RNAi-gemedieerde afbraak van het FLuc reporter-RNA 
efficiënter. Om potentiële VSR-eiwitten te identificeren doen we dit experiment in de 
aan- of afwezigheid van virale eiwitten. Als in de aanwezigheid van een viraal eiwit de 
RNAi-gemedieerde afbraak van de FLuc-reporter geremd wordt, dan beschouwen 
we dit eiwit als een mogelijke VSR. Als een mogelijke VSR geïdentificeerd is, dan zijn 
aanvullende RNAi-sensorexperimenten en biochemische experimenten nodig om 
het mechanisme van RNAi-suppressie te bepalen.
Nora virus is recentelijk geïdentificeerd als een natuurlijk pathogeen van Drosophila 
dat een niet-lethale persistente infectie veroorzaakt. In hoofdstuk 3 hebben we 
Nora virus-specifieke siRNAs gedetecteerd in persistent geïnfecteerde Drosophila. 
Dit geeft aan dat het antivirale RNAi-mechanisme de Nora virus infectie detecteert. 
Door gebruik te maken van het RNAi-sensorexperiment uit hoofdstuk 2, hebben we 
“viral protein 1” (VP1), het eiwit dat wordt gecodeerd door het eerste open leesraam 
van Nora virus, kunnen identificeren als VSR. Verder hebben we aangetoond dat 
het VP1-eiwit van Nora virus en het 1A-eiwit van het niet-gerelateerde Cricket 
Paralysis virus (CrPV) beide de AGO2-gemedieerde knip van complementair RNA 
kunnen tegengaan. De detectie van de AGO2-antagonerende activiteit in deze niet-
gerelateerde insectenvirussen benadrukt de belangrijke rol van AGO2-gemedieerde 
RNA-afbraak tijdens de antivirale afweer in insecten.
In hoofdstuk 4 hebben we onderzocht of het mogelijk is om het VP1-eiwit van Nora 
virus te gebruiken voor het in vivo bestuderen van het RNAi-mechanisme. Expressie 
van het VP1-eiwit van Nora virus in transgene vliegen resulteerde in een efficiënte 
onderdrukking van het RNAi-mechanisme. Evenals vliegen die het AGO2 gen missen, 
waren transgene vliegen die VP1 produceerden in alle cellen of specifiek in cellen 
van de “fat body” gevoeliger voor een virusinfectie. In dit hoofdstuk hebben we laten 
zien dat transgene vliegen die het Nora virus VP1-eiwit tot expressie brengen een 
goed hulpmiddel zijn voor het bestuderen van RNAi-gereguleerde processen in vivo.
De immuunreacties van de gastheer en de virale antagonisten die deze 
immuunreacties tegengaan kunnen co-evolueren gedurende een zogenaamde 
evolutionaire wedloop. Gedurende deze tweestrijd kunnen virale immuun 
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antagonisten zich aanpassen aan de immuunreactie van de gastheer om deze 
efficiënt te onderdrukken. Dit kan leiden tot een situatie waarin het betreffende 
virus niet meer in staat is de antivirale immuunreactie in andere gastheersoorten te 
onderdrukken, waardoor het virus mogelijk gelimiteerd wordt in zijn gastheerbereik. 
Daarom hebben we in hoofdstuk 5 onderzocht of de VSR-activiteit van het VP1-
eiwit van Nora virus het gastheerbereik van Nora virus kan bepalen. Om deze vraag 
te beantwoorden, hebben we de VP1-coderende sequenties geïsoleerd van Nora 
virussen die gedetecteerd zijn in de fruitvliegsoorten Drosophila immigrans (DimmNV 
VP1) en Drosophila subobscura (DsubNV VP1). Vervolgens hebben we de VSR-
activiteiten van deze VP1-eiwitten vergeleken met die van het VP1-eiwit afkomstig 
uit Nora virus geïsoleerd uit Drosophila melanogaster (DmelNV VP1). In tegenstelling 
tot DmelNV VP1, hebben we geen VSR-activiteit kunnen detecteren voor DimmNV 
VP1 en DsubNV VP1 in D. melanogaster S2-cellen. Wel hebben we aangetoond dat 
DimmNV VP1 specifiek bindt aan AGO2 van zijn natuurlijke gastheer D. immigrans 
en hierdoor de AGO2-gemedieerde knip van complementair RNA kan tegengaan. 
Deze RNAi-suppressie was gastheer-specifiek, aangezien DimmNV VP1 niet bindt 
aan het AGO2-eiwit van D. melanogaster en niet de knip van complementair RNA kan 
tegengaan in deze gastheer. Opvallend was dat de VSR-activiteit van DmelNV VP1 niet 
gelimiteerd was tot één gastheer aangezien dit eiwit bond aan AGO2 van zowel D. 
melanogaster als D. immigrans en ook de knip van complementair RNA kon tegengaan 
in beide gastheren. Toch veronderstellen wij dat de evolutionaire aanpassing van 
het VP1-eiwit van Nora virus op het AGO2-eiwit van de gastheer ertoe kan leiden dat 
de VSR-activiteit van VP1 gastheer-specifiek wordt. Onze resultaten impliceren dat 
VSR-eiwitten mogelijk het gastheerbereik van insectenvirussen bepalen.
Het RNAi-mechanisme is een belangrijke immuunreactie tegen een breed scala 
aan insectenvirussen met verschillende genoomstructuren. Desalniettemin zijn 
VSR-eiwitten van insectenvirussen alleen gedetecteerd in virussen met een plus-
strengs RNA genoom. Verder is het onduidelijk of muggenvirussen in het algemeen 
de antivirale activiteit van het RNAi-mechanisme van de mug tegengaan. Daarom 
hebben we in hoofdstuk 6 bepaald of twee insectenvirussen met een dsRNA-
genoom, de entomobirnavirussen Culex Y virus (CYV) en Drosophila X virus (DXV), het 
antivirale RNAi-mechanisme onderdrukken. Van DXV is bekend dat het Drosophila 
cellen persistent kan infecteren en CYV is recentelijk geïsoleerd uit Culex pipiens 
muggen die afkomstig zijn uit de vrije natuur. Wij hebben in hoofdstuk 6 laten zien dat 
zowel CYV als DXV het RNAi-mechanisme in Drosophila S2 cellen kan onderdrukken. 
Verder hebben wij met behulp van ons RNAi-sensorexperiment een VSR-activiteit 
kunnen detecteren voor “viral protein 3” (VP3) van beide virussen. In biochemische 
experimenten binden CYV VP3 en DXV VP3 zowel lang dsRNA als siRNA-duplexen. 
Ook hebben we gevonden dat de VP3-eiwitten van CYV en DXV het knippen van 
dsRNA door Dcr-2 kunnen tegengaan, wat geheel in lijn is met het vermogen van 
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deze eiwitten om lang dsRNA te binden. Daarbij suggereert de binding van siRNAs 
door beide VP3-eiwitten dat ze ook kunnen voorkomen dat de siRNAs ingebouwd 
worden in het RISC. Daarom lijkt het erop dat entomobirnavirussen twee stappen 
in het RNAi mechanisme tegengaan, namelijk het knippen van dsRNA en het laden 
van het RISC. Verder suggereren onze resultaten dat ook muggenvirussen het RNAi-
mechanisme in de gastheer onderdrukken.
In hoofdstuk 7 worden de resultaten van dit promotieonderzoek bediscussieerd en 
worden er aanbevelingen gedaan voor vervolgonderzoek.
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